https://feedbagel.com/post/what-is-ai-mobile-app-development-and-how-to-get-building-yourself 2026-06-07T17:35:10.000Z monthly 0.5 https://feedbagel.com/post/what-are-the-stages-of-ai-app-development-a-step-by-step-lifecycle-guide 2026-06-07T17:15:23.000Z monthly 0.5 https://feedbagel.com/post/how-to-get-started-with-vibe-coding-for-free 2026-06-07T16:37:14.000Z monthly 0.5 https://feedbagel.com/post/6-best-ai-app-builders-for-app-creation 2026-06-07T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/how-to-fight-human-trafficking-and-online-scams 2026-06-08T11:16:00.000Z monthly 0.5 https://feedbagel.com/post/claude-mythos-chatgpt-55-and-cybersecurity 2026-05-28T16:00:00.000Z monthly 0.5 https://feedbagel.com/post/mpi-sp-is-part-of-the-first-open-source-silicon-distribution-with-production-gra 2026-05-26T10:54:00.000Z monthly 0.5 https://feedbagel.com/post/13-papers-accepted-at-ieee-sampp 2026-05-18T14:32:00.000Z monthly 0.5 https://feedbagel.com/post/exploitgym-can-ai-agents-turn-security-vulnerabilities-into-real-attacks 2026-05-18T09:00:00.000Z monthly 0.5 https://feedbagel.com/post/meeyoung-cha-awarded-the-order-of-science-and-technology-merit-by-the-south-kore 2026-05-08T09:14:00.000Z monthly 0.5 https://feedbagel.com/post/we-all-leave-digital-footprints-on-the-internet 2026-04-26T22:00:00.000Z monthly 0.5 https://feedbagel.com/post/preventing-the-digital-doomsday 2026-04-21T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/9-papers-accepted-at-chi26 2026-04-10T14:49:00.000Z monthly 0.5 https://feedbagel.com/post/mpi-sp-and-ruhr-university-bochum-establish-the-new-international-max-planck-res 2026-04-09T11:37:00.000Z monthly 0.5 https://feedbagel.com/post/encouraging-young-students-to-pursue-a-career-in-cyber-security-through-a-captur 2026-04-02T07:00:00.000Z monthly 0.5 https://feedbagel.com/post/heroes-unsung 2026-03-31T06:30:00.000Z monthly 0.5 https://feedbagel.com/post/the-4th-edition-of-the-hardware-reverse-engineering-workshop-was-a-great-success 2026-03-25T11:37:00.000Z monthly 0.5 https://feedbagel.com/post/beyond-facts-how-we-are-engaging-with-climate-change-discussions-for-cop30 2026-03-17T08:45:00.000Z monthly 0.5 https://feedbagel.com/post/6-talks-from-mpi-sp-scientists-at-the-2026-real-world-crypto-symposium 2026-03-12T10:16:00.000Z monthly 0.5 https://feedbagel.com/post/four-women-scientists-in-leadership-positions 2026-03-02T23:00:00.000Z monthly 0.5 https://feedbagel.com/post/mpi-sp-success-story-jeasurk-yang-becomes-assistant-professor-at-chonnam-nationa 2026-02-19T10:40:00.000Z monthly 0.5 https://feedbagel.com/post/mpi-sp-blog-a-chance-for-our-researchers-to-showcase-their-work-to-a-wider-audie 2026-02-11T12:47:00.000Z monthly 0.5 https://feedbagel.com/post/accelerating-post-quantum-cryptography-on-opentitan-based-designs-flexible-hardw 2026-02-11T11:00:00.000Z monthly 0.5 https://feedbagel.com/post/ai-swarms-could-fake-public-consensus-and-quietly-distort-democracy-science-poli 2026-01-22T19:06:00.000Z monthly 0.5 https://feedbagel.com/post/massive-investment-in-education-needed-to-unlock-young-peoples-potential-close-s 2026-07-08T21:43:09.000Z monthly 0.5 https://feedbagel.com/post/ending-poverty-an-act-of-justice-secretary-general-says-in-international-day-mes 2026-07-08T21:36:04.000Z monthly 0.5 https://feedbagel.com/post/security-council-isil-daesh-and-al-qaida-sanctions-committee-amends-one-entry-to 2026-07-08T21:09:50.000Z monthly 0.5 https://feedbagel.com/post/security-council-10190th-meeting-am-pm-women-peace-and-security 2026-07-08T11:48:41.000Z monthly 0.5 https://feedbagel.com/post/general-assembly-resumes-debate-on-ending-cuban-embargo-as-havana-leads-outcry-a 2026-07-07T20:58:48.000Z monthly 0.5 https://feedbagel.com/post/daily-press-briefing-by-the-office-of-the-spokesperson-for-the-secretary-general 2026-07-07T20:17:23.000Z monthly 0.5 https://feedbagel.com/post/speakers-urge-action-innovation-international-solidarity-to-implement-2030-agend 2026-07-07T17:36:54.000Z monthly 0.5 https://feedbagel.com/post/united-nations-remembrance-of-1995-genocide-in-srebrenica-to-be-held-at-headquar 2026-07-07T16:08:16.000Z monthly 0.5 https://feedbagel.com/post/general-assembly-99th-100th-meetings-am-pm-7-july-2026 2026-07-07T11:54:52.000Z monthly 0.5 https://feedbagel.com/post/daily-press-briefing-by-the-office-of-the-spokesperson-for-the-secretary-general-2 2026-07-06T21:38:21.000Z monthly 0.5 https://feedbagel.com/post/the-absorption-gap-why-every-company-has-ai-and-few-have-an-advantage 2026-07-03T14:05:51.000Z monthly 0.5 https://feedbagel.com/post/dspark-explained-how-deepseek-made-llm-serving-60-85-faster-without-losing-a-sin 2026-07-03T12:02:43.000Z monthly 0.5 https://feedbagel.com/post/you-are-not-behind-the-race-nobody-told-you-was-fake 2026-06-25T03:14:25.000Z monthly 0.5 https://feedbagel.com/post/multi-agent-coordination-in-2026-trust-isolation-and-the-cost-of-getting-it-wron 2026-06-24T23:50:40.000Z monthly 0.5 https://feedbagel.com/post/from-chat-completion-to-agent-swarms-how-loop-architecture-evolved 2026-06-24T23:04:51.000Z monthly 0.5 https://feedbagel.com/post/meet-posterboy-sudoall-now-has-an-agentic-publisher 2026-06-24T22:42:58.000Z monthly 0.5 https://feedbagel.com/post/the-agent-tool-loop-your-code-or-the-inference-runtime 2026-06-24T21:33:58.000Z monthly 0.5 https://feedbagel.com/post/stop-sending-every-prompt-to-your-flagship-model 2026-06-24T21:33:58.000Z monthly 0.5 https://feedbagel.com/post/one-gpu-two-bottlenecks-serving-vision-language-models-without-wasting-silicon 2026-06-24T21:33:58.000Z monthly 0.5 https://feedbagel.com/post/gemma-4-on-apple-silicon-all-four-models-compared-benchmarked-and-running-locall 2026-04-03T23:49:17.000Z monthly 0.5 https://feedbagel.com/post/broadcom-en-nvidia-blinken-uit-op-rood-wall-street 2026-07-08T20:15:25.000Z monthly 0.5 https://feedbagel.com/post/wk-dominantie-toont-hoe-voetbal-europees-succesverhaal-blijft 2026-07-08T20:10:39.000Z monthly 0.5 https://feedbagel.com/post/vlaams-parlement-keurt-begrotingsaanpassing-2026-goed-2 2026-07-08T19:35:19.000Z monthly 0.5 https://feedbagel.com/post/raad-van-state-trekt-streep-door-opvangweigering-aan-erkende-asielzoekers 2026-07-08T19:27:50.000Z monthly 0.5 https://feedbagel.com/post/stakingsdreiging-op-brussels-airport-afgewend 2026-07-08T18:55:56.000Z monthly 0.5 https://feedbagel.com/post/grilligheid-trump-voedt-debat-over-zin-van-jaarlijkse-navo-top 2026-07-08T18:40:01.000Z monthly 0.5 https://feedbagel.com/post/nergens-zonder-weg-in-beerzel 2026-07-08T18:30:53.000Z monthly 0.5 https://feedbagel.com/post/blind-varen-op-zoek-naar-een-exit-uit-de-iran-oorlog 2026-07-08T18:09:21.000Z monthly 0.5 https://feedbagel.com/post/israel-doodt-organisator-wk-uitzendingen-in-gaza 2026-07-08T16:53:09.000Z monthly 0.5 https://feedbagel.com/post/hittegolf-in-juni-was-dodelijkste-ooit-groot-verschil-tussen-vlaanderen-en-wallo 2026-07-08T16:33:44.000Z monthly 0.5 https://feedbagel.com/post/icml-2026-position-the-alignment-community-is-unintentionally-building-a-censors 2026-07-08T06:26:07.000Z monthly 0.5 https://feedbagel.com/post/icml-2026-high-accuracy-sampling-for-diffusion-models-and-log-concave-distributi 2026-07-07T13:15:38.000Z monthly 0.5 https://feedbagel.com/post/icml-2026-the-flexibility-trap-rethinking-the-value-of-arbitrary-order-in-diffus 2026-07-06T17:24:49.000Z monthly 0.5 https://feedbagel.com/post/adajepa-an-adaptive-latent-world-model 2026-07-06T05:17:08.000Z monthly 0.5 https://feedbagel.com/post/a-hippocampus-for-linear-attention-an-exact-memory-for-what-the-recurrent-state- 2026-07-05T06:55:58.000Z monthly 0.5 https://feedbagel.com/post/lacuna-a-research-map-for-machine-learning 2026-07-04T07:11:06.000Z monthly 0.5 https://feedbagel.com/post/dspark-confidence-scheduled-speculative-decoding-with-semi-autoregressive-genera-2 2026-07-03T17:57:33.000Z monthly 0.5 https://feedbagel.com/post/flow-reasoning-models-scaling-reasoning-through-iterative-self-refinement 2026-07-02T19:51:54.000Z monthly 0.5 https://feedbagel.com/post/autodata-an-agentic-data-scientist-to-create-high-quality-synthetic-data 2026-07-01T06:05:00.000Z monthly 0.5 https://feedbagel.com/post/tapered-language-models 2026-06-30T06:40:05.000Z monthly 0.5 https://feedbagel.com/post/probabilistic-tiny-recursive-model 2026-06-29T06:54:02.000Z monthly 0.5 https://feedbagel.com/post/megatrain-full-precision-training-of-100b-parameter-large-language-models-on-a-s 2026-06-28T06:43:04.000Z monthly 0.5 https://feedbagel.com/post/how-transparent-is-diffusiongemma 2026-06-27T06:17:00.000Z monthly 0.5 https://feedbagel.com/post/large-language-models-do-not-always-need-readable-language-2 2026-06-26T06:07:21.000Z monthly 0.5 https://feedbagel.com/post/you-dont-need-strong-assumptions-visual-representation-learning-via-temporal-dif 2026-06-25T06:35:53.000Z monthly 0.5 https://feedbagel.com/post/revisiting-the-platonic-representation-hypothesis-an-aristotelian-view 2026-06-24T06:17:04.000Z monthly 0.5 https://feedbagel.com/post/variable-width-transformers-former 2026-06-23T06:19:28.000Z monthly 0.5 https://feedbagel.com/post/measuring-progress-toward-agi-a-cognitive-framework 2026-06-22T06:08:56.000Z monthly 0.5 https://feedbagel.com/post/fixed-point-reasoners-stable-and-adaptive-deep-looped-transformers 2026-06-21T07:12:54.000Z monthly 0.5 https://feedbagel.com/post/topological-neural-operators-deep-math-version 2026-06-20T06:10:32.000Z monthly 0.5 https://feedbagel.com/post/argentinas-rigged-world-cup-run-is-becoming-impossible-to-defend 2026-07-08T16:30:00.000Z monthly 0.5 https://feedbagel.com/post/15-people-arrested-in-human-trafficking-probe-by-hungarian-police 2026-07-08T15:33:16.000Z monthly 0.5 https://feedbagel.com/post/russia-moves-closer-to-olympic-return-at-la-2028-after-ioc-lifts-ban 2026-07-08T13:00:00.000Z monthly 0.5 https://feedbagel.com/post/cristiano-ronaldo-and-his-world-cup-legacy 2026-07-08T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/magyar-and-zelenskyy-agree-on-future-bilateral-meeting-during-ankara-nato-summit 2026-07-08T11:00:00.000Z monthly 0.5 https://feedbagel.com/post/june-inflation-eases-to-17-per-cent-as-forint-strengthens 2026-07-08T10:00:00.000Z monthly 0.5 https://feedbagel.com/post/assassins-creed-black-flag-resynced-poised-to-outperform-shadows-at-launch 2026-07-08T09:00:00.000Z monthly 0.5 https://feedbagel.com/post/pakistanis-on-skilled-worker-visas-bring-six-times-as-many-dependants-to-britain 2026-07-08T08:30:00.000Z monthly 0.5 https://feedbagel.com/post/russell-kirks-conservative-mind-published-in-hungarian 2026-07-08T07:18:41.000Z monthly 0.5 https://feedbagel.com/post/hungarys-public-media-goes-dark-apologizes-for-years-of-lying-as-tisza-takes-ove 2026-07-07T15:33:40.000Z monthly 0.5 https://feedbagel.com/post/two-the-pitt-season-2-actors-earned-emmy-nominations-without-any-studio-support 2026-07-08T21:29:49.000Z monthly 0.5 https://feedbagel.com/post/greys-anatomy-star-breaks-silence-as-rumors-swirl-in-upended-maine-senate-race 2026-07-08T21:47:16.000Z monthly 0.5 https://feedbagel.com/post/olivia-rodrigo-partners-with-voter-registration-organization-head-count 2026-07-08T21:35:01.000Z monthly 0.5 https://feedbagel.com/post/white-house-inadvertently-calls-jd-vance-dumb-while-defending-his-glaring-mistak 2026-07-08T21:32:37.000Z monthly 0.5 https://feedbagel.com/post/gop-lawmaker-sued-by-ex-girlfriend-for-breaching-settlement-over-abuse-claims 2026-07-08T21:23:22.000Z monthly 0.5 https://feedbagel.com/post/study-on-audiovisual-content-for-young-audiences-analysis-report-released 2026-06-30T16:45:00.000Z monthly 0.5 https://feedbagel.com/post/telefilm-canada-invests-over-18-million-in-30-low-budget-english-market-and-indi 2026-06-17T18:24:43.000Z monthly 0.5 https://feedbagel.com/post/reminder-the-medium-to-large-scale-festivals-program-is-opening-soon 2026-06-12T14:50:00.000Z monthly 0.5 https://feedbagel.com/post/telefilm-canada-launches-the-reviewed-version-of-the-development-program 2026-06-10T19:02:53.000Z monthly 0.5 https://feedbagel.com/post/telefilm-canada-invests-in-8-minority-coproductions 2026-05-12T19:52:04.000Z monthly 0.5 https://feedbagel.com/post/telefilm-canada-launches-two-new-programs-following-the-review-of-the-promotion- 2026-05-07T15:00:00.000Z monthly 0.5 https://feedbagel.com/post/telefilm-canada-funds-23-medium-to-large-scale-film-festivals-from-across-canada 2026-04-27T17:00:34.000Z monthly 0.5 https://feedbagel.com/post/telefilm-canada-launches-the-reviewed-version-of-the-marketing-program 2026-04-23T20:02:27.000Z monthly 0.5 https://feedbagel.com/post/telefilm-canada-announces-second-opening-of-the-medium-to-large-scale-festivals- 2026-04-22T14:46:15.000Z monthly 0.5 https://feedbagel.com/post/telefilm-canada-unveils-the-strategic-orientation-framework-to-guide-the-review- 2026-04-20T17:27:36.000Z monthly 0.5 https://feedbagel.com/post/game-set-stay-luxury-cottages-with-tennis-courts 2026-06-29T09:13:12.000Z monthly 0.5 https://feedbagel.com/post/the-owner-diaries-mirefoot 2026-06-05T09:02:11.000Z monthly 0.5 https://feedbagel.com/post/best-peak-district-waterfalls-to-visit 2026-06-05T08:41:25.000Z monthly 0.5 https://feedbagel.com/post/discover-england-through-oenotourism 2026-05-21T14:04:29.000Z monthly 0.5 https://feedbagel.com/post/10-storybook-cottages-in-the-uk 2026-05-14T09:19:04.000Z monthly 0.5 https://feedbagel.com/post/luxury-cottages-with-saunas-in-the-uk 2026-05-01T09:03:22.000Z monthly 0.5 https://feedbagel.com/post/stay-close-feel-far 2026-03-05T10:42:02.000Z monthly 0.5 https://feedbagel.com/post/luxury-hen-party-houses-minimoon-cottages-in-the-uk 2026-02-19T15:08:58.000Z monthly 0.5 https://feedbagel.com/post/luxury-walking-holidays-in-the-uk 2026-01-22T14:24:09.000Z monthly 0.5 https://feedbagel.com/post/2026-travel-trends 2026-01-15T11:48:16.000Z monthly 0.5 https://feedbagel.com/post/the-battle-of-the-cups-how-a-hamptons-shop-is-predicting-political-wins 2024-08-29T10:01:57.000Z monthly 0.5 https://feedbagel.com/post/the-pizza-that-has-flipped-capri-upside-down 2024-08-16T12:01:29.000Z monthly 0.5 https://feedbagel.com/post/the-heart-of-amagansett-a-square-like-no-other 2024-06-07T12:02:44.000Z monthly 0.5 https://feedbagel.com/post/forever-vogue-it-girl-plum-sykes-dishes-about-her-latest-novel-set-in-the-new-ha 2024-05-14T12:02:37.000Z monthly 0.5 https://feedbagel.com/post/legendary-designer-zac-posen-dishes-on-his-latest-gig-costume-designing-for-feud 2024-01-31T13:17:37.000Z monthly 0.5 https://feedbagel.com/post/my-top-10-holiday-gift-ideas-for-2023 2023-12-20T13:05:55.000Z monthly 0.5 https://feedbagel.com/post/the-top-10-items-ill-be-wearing-on-repeat-this-fall 2023-10-11T12:44:30.000Z monthly 0.5 https://feedbagel.com/post/meet-the-photographer-who-shot-10-years-of-new-york-city-ballet-fashion-collabor 2023-10-04T10:12:22.000Z monthly 0.5 https://feedbagel.com/post/your-guide-to-whats-hot-happening-this-new-york-fashion-week 2023-09-06T12:34:45.000Z monthly 0.5 https://feedbagel.com/post/if-you-dont-pop-into-jackie-os-favorite-italian-shoe-store-did-you-really-visit- 2023-08-10T14:15:19.000Z monthly 0.5 https://feedbagel.com/post/72-hours-in-los-angeles-where-to-shop-eat-get-ready-for-a-big-night-out 2023-06-21T12:07:20.000Z monthly 0.5 https://feedbagel.com/post/7-new-stores-to-check-out-in-east-hampton-a-blossoming-shoppers-paradise 2023-05-24T13:26:05.000Z monthly 0.5 https://feedbagel.com/post/10-designer-dresses-for-your-23-summer-mood-board 2023-04-27T12:24:26.000Z monthly 0.5 https://feedbagel.com/post/meet-the-fashion-designer-of-the-moment-whos-dressed-rihanna-jlo-oprah 2023-04-11T13:12:50.000Z monthly 0.5 https://feedbagel.com/post/planning-a-2023-trip-to-paris-heres-your-itinerary 2023-03-30T12:53:24.000Z monthly 0.5 https://feedbagel.com/post/the-10-best-dressed-stars-at-the-2023-oscars 2023-03-13T13:07:34.000Z monthly 0.5 https://feedbagel.com/post/black-history-month-spotlight-lloyd-knight-principal-dancer-at-the-martha-graham 2023-03-01T16:36:52.000Z monthly 0.5 https://feedbagel.com/post/the-5-best-runway-shows-from-new-york-fashion-week-a-trend-forecast 2023-02-16T14:08:14.000Z monthly 0.5 https://feedbagel.com/post/5-questions-with-monica-bellucci 2023-02-08T14:15:48.000Z monthly 0.5 https://feedbagel.com/post/the-most-perfect-valentines-day-gifts-2023-lux-edition 2023-02-01T14:05:32.000Z monthly 0.5 https://feedbagel.com/post/3-rescued-after-vessel-sinks-on-stuart-lake-near-fort-st-james 2026-07-08T21:16:00.000Z monthly 0.5 https://feedbagel.com/post/bitter-feud-over-strata-control-at-surrey-condo-tower-hits-court 2026-07-08T21:15:00.000Z monthly 0.5 https://feedbagel.com/post/alberta-lands-13-billion-meta-data-centre-project 2026-07-08T21:03:00.000Z monthly 0.5 https://feedbagel.com/post/profits-from-okanagan-based-ponzi-scheme-targeted-by-bc-supreme-court 2026-07-08T20:00:00.000Z monthly 0.5 https://feedbagel.com/post/rcmp-rescue-11-people-from-overturned-canoe-in-burrard-inlet 2026-07-08T19:33:00.000Z monthly 0.5 https://feedbagel.com/post/the-moj-vancouver-loses-another-sports-talk-radio-station 2026-07-08T19:20:00.000Z monthly 0.5 https://feedbagel.com/post/abbotsford-canucks-2026-27-home-opener-date-revealed 2026-07-08T19:17:00.000Z monthly 0.5 https://feedbagel.com/post/woman-rescued-from-capsized-boat-off-richmond-dies-in-hospital-rcmp 2026-07-08T18:06:00.000Z monthly 0.5 https://feedbagel.com/post/surrey-cops-seize-estimated-66m-in-suspected-counterfeit-gear 2026-07-08T18:00:00.000Z monthly 0.5 https://feedbagel.com/post/chilliwack-chiefs-unveil-2026-27-schedule 2026-07-08T17:52:00.000Z monthly 0.5 https://feedbagel.com/post/lets-hear-from-you 2025-02-05T17:40:33.000Z monthly 0.5 https://feedbagel.com/post/nevada-is-the-gold-standard-for-wages 2024-08-18T18:42:53.000Z monthly 0.5 https://feedbagel.com/post/boosting-minority-voices-in-broadcast-ownership 2024-04-18T17:48:40.000Z monthly 0.5 https://feedbagel.com/post/horsford-accomplishments-in-2023 2024-01-11T19:47:23.000Z monthly 0.5 https://feedbagel.com/post/heat-islands-hurt-quality-of-life-in-southern-nevada 2023-11-15T20:46:29.000Z monthly 0.5 https://feedbagel.com/post/lending-to-black-small-business-owners-has-more-than-doubled 2023-10-17T21:28:09.000Z monthly 0.5 https://feedbagel.com/post/federal-funds-drive-investments-in-our-local-non-profits 2023-07-17T15:07:58.000Z monthly 0.5 https://feedbagel.com/post/supreme-court-allen-v-milligan-ruling-a-win-for-voting-rights-but-battles-remain 2023-06-15T17:48:50.000Z monthly 0.5 https://feedbagel.com/post/may-2023-edition-of-the-urban-voice-featuring-steven-horsford 2023-05-30T20:27:23.000Z monthly 0.5 https://feedbagel.com/post/uscis-casework-clinic 2023-03-06T20:20:09.000Z monthly 0.5 https://feedbagel.com/post/the-crisis-in-us-cancer-care-law-markets-and-privatization 2026-05-07T15:21:02.000Z monthly 0.5 https://feedbagel.com/post/the-supreme-courts-20242025-term-eroding-public-health-health-equity-and-access- 2026-05-07T15:20:59.000Z monthly 0.5 https://feedbagel.com/post/health-law-and-bigotry-distractions 2026-05-07T15:20:56.000Z monthly 0.5 https://feedbagel.com/post/loper-brights-deregulatory-synergies 2026-05-07T15:20:54.000Z monthly 0.5 https://feedbagel.com/post/the-deregulation-of-cancer 2026-05-07T15:20:51.000Z monthly 0.5 https://feedbagel.com/post/the-crime-victims-right-to-attend-the-trial-the-reascendant-national-consensus 2026-04-20T15:52:53.000Z monthly 0.5 https://feedbagel.com/post/in-defense-of-victim-impact-statements 2026-04-20T15:52:51.000Z monthly 0.5 https://feedbagel.com/post/protecting-crime-victims-in-federal-appellate-courts-the-need-to-broadly-constru 2026-04-20T15:52:48.000Z monthly 0.5 https://feedbagel.com/post/is-meat-the-new-tobacco-regulating-food-demand-in-the-age-of-climate-change 2026-04-20T15:52:43.000Z monthly 0.5 https://feedbagel.com/post/farming-with-trees-reforming-us-farm-policy-to-expand-agroforestry-and-mitigate- 2026-04-20T15:52:40.000Z monthly 0.5 https://feedbagel.com/post/resilient-carbon 2026-04-20T15:52:37.000Z monthly 0.5 https://feedbagel.com/post/ip-the-u-april-2026 2026-04-16T13:48:50.000Z monthly 0.5 https://feedbagel.com/post/strength-in-numbers-group-copyright-registration-of-online-news-articles-as-a-we 2026-04-08T17:28:51.000Z monthly 0.5 https://feedbagel.com/post/the-new-debate-over-history-justice-thomas-and-justice-barrett-on-the-future-of- 2026-04-08T17:28:50.000Z monthly 0.5 https://feedbagel.com/post/can-speech-policy-protect-public-health 2026-04-08T17:28:49.000Z monthly 0.5 https://feedbagel.com/post/the-shadow-of-the-rules-of-evidence-on-adr 2026-04-08T17:28:48.000Z monthly 0.5 https://feedbagel.com/post/the-plain-solution-to-federal-habeas 2026-04-08T17:28:48.000Z monthly 0.5 https://feedbagel.com/post/through-a-scanner-darkly-functional-neuroimaging-as-evidence-of-a-criminal-defen 2026-03-19T14:37:45.000Z monthly 0.5 https://feedbagel.com/post/the-eminence-of-imminence-and-the-myopia-of-markets 2026-03-19T14:37:42.000Z monthly 0.5 https://feedbagel.com/post/the-affective-blindness-of-evidence-law 2026-03-19T14:37:39.000Z monthly 0.5 https://feedbagel.com/post/rfc-10014-guidelines-for-characterizing-the-term-oam 2026-06-30T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/rfc-10007-clarification-to-processing-key-usage-values-during-certificate-revoca 2026-06-30T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/rfc-9980-post-quantum-cryptography-in-openpgp 2026-06-30T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/rfc-9942-cbor-object-signing-and-encryption-cose-receipts 2026-06-30T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/rfc-9978-bidirectional-forwarding-detection-bfd-stability 2026-06-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/rfc-9974-operations-administration-and-maintenance-oam-requirements-for-the-bit- 2026-06-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/rfc-9970-connected-identity-for-secure-telephone-identity-revisited-stir 2026-06-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/rfc-10005-bgp-link-bandwidth-extended-community 2026-06-26T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/rfc-9994-mpls-network-action-mna-sub-stack-specification-including-in-stack-netw 2026-06-26T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/rfc-9986-meticulous-keyed-isaac-for-bidirectional-forwarding-detection-bfd-optim 2026-06-19T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/rfc-9985-optimizing-bidirectional-forwarding-detection-bfd-authentication 2026-06-19T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/rfc-9958-post-quantum-cryptography-for-engineers 2026-06-18T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/rfc-9888-out-of-band-secure-telephone-identity-revisited-stir-for-service-provid 2026-06-18T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/ai-news 2026-01-28T17:26:00.000Z monthly 0.5 https://feedbagel.com/post/tri-i-program-news 2025-12-04T14:25:00.000Z monthly 0.5 https://feedbagel.com/post/graduate-school-of-medical-sciences-news 2025-11-05T19:26:00.000Z monthly 0.5 https://feedbagel.com/post/education-news 2025-11-05T18:05:00.000Z monthly 0.5 https://feedbagel.com/post/white-coat-class-of-2028 2024-12-20T17:06:47.000Z monthly 0.5 https://feedbagel.com/post/weill-cornell-medicine-commencement-2024 2024-12-20T17:03:52.000Z monthly 0.5 https://feedbagel.com/post/wcm-q-commencement-2024 2024-12-20T16:59:22.000Z monthly 0.5 https://feedbagel.com/post/match-day-2024 2024-12-20T16:54:10.000Z monthly 0.5 https://feedbagel.com/post/white-coat-class-of-2027 2024-12-20T16:50:03.000Z monthly 0.5 https://feedbagel.com/post/weill-cornell-medicine-commencement-2023 2024-12-20T16:43:22.000Z monthly 0.5 https://feedbagel.com/post/autonomous-ai-agents-in-ides-the-future-of-coding 2026-03-13T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/q-star-v3-self-correcting-ai-agent-that-eliminates-code-hallucinations 2026-03-13T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/swe-agent-20-open-source-autonomous-ai-software-engineering 2026-03-13T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/devin-the-first-fully-autonomous-ai-software-engineer 2026-03-13T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/promptfoo-local-llm-testing-and-red-teaming-for-production-ai 2026-03-13T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/hermes-agent-self-improving-ai-with-persistent-memory 2026-03-12T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/qwen-agent-native-tool-execution-framework-for-llm-applications 2026-03-11T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/agency-agents-transform-your-ide-into-a-multi-agent-ai-studio 2026-03-11T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/codebuff-multi-agent-ai-coding-that-actually-works 2026-03-10T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/claude-code-skills-transform-ai-assistants-into-domain-experts 2026-03-09T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gitnexus-zero-server-code-intelligence-for-ai-agents-that-actually-works 2026-03-09T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/superset-the-first-ide-for-orchestrating-multiple-ai-coding-agents 2026-03-06T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/moonshine-5x-faster-speech-recognition-for-edge-devices 2026-03-05T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/deerflow-20-the-runtime-infrastructure-ai-agents-actually-need 2026-03-04T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/agent-skills-context-engineering-framework-for-ai-agents 2026-02-26T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/cloudflare-agents-stateful-ai-at-the-edge-without-the-database-hassle 2026-02-24T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/timesfm-zero-shot-time-series-forecasting-without-training-data 2026-02-22T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/wifi-densepose-see-through-walls-with-wifi-signals-and-rust 2026-02-19T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/tambo-ai-react-sdk-for-generative-ui-with-ai-agents 2026-02-17T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/claude-code-hooks-mastery-deterministic-ai-control-agent-orchestration 2026-02-12T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/github-agentic-workflows-write-cicd-in-natural-language 2026-02-10T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/claude-mem-persistent-memory-for-claude-code-across-sessions 2026-02-05T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/memu-persistent-memory-framework-for-247-proactive-ai-agents 2026-02-03T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/pi-monorepo-a-unified-toolkit-for-building-ai-agents 2026-02-01T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/flashmla-deepseeks-cuda-kernels-for-lightning-fast-llm-inference 2026-01-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/moltbot-local-first-ai-assistant-for-every-messaging-channel 2026-01-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/quantum-rl-matches-classical-deep-rl-with-100x-fewer-parameters 2026-01-28T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/remotion-create-videos-programmatically-with-react 2026-01-27T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/network-topology-predicts-pruning-success-what-neural-curvature-reveals 2026-01-26T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/pageindex-vectorless-rag-with-reasoning-based-document-retrieval 2026-01-25T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/github-trending-discover-what-developers-are-building-right-now 2026-01-24T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/github-copilot-sdk-embedding-ai-agents-in-any-application 2026-01-23T11:17:14.000Z monthly 0.5 https://feedbagel.com/post/learnable-attention-priors-fix-the-attention-sink-problem-what-goat-reveals 2026-01-23T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/eigent-local-multi-agent-ai-desktop-for-privacy-first-workflows 2026-01-22T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/14x-lower-gradient-variance-what-grade-reveals-about-llm-alignment 2026-01-21T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/blendermcp-controlling-blender-with-claude-through-natural-language 2026-01-20T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/models-learn-to-think-when-forced-to-forget-digital-metabolism-revealed 2026-01-19T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/dexter-self-validating-ai-agent-for-financial-research 2026-01-18T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/devika-open-source-ai-software-engineer-for-full-development-cycles 2026-01-17T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/transformers-run-bellman-ford-what-the-geometry-of-thought-reveals 2026-01-16T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/deep-live-cam-real-time-face-swapping-with-one-image 2026-01-15T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/chatdev-20-zero-code-multi-agent-ai-platform-that-changes-everything 2026-01-14T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/chatdev-20-from-virtual-company-to-zero-code-multi-agent-platform 2026-01-14T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/ralph-for-claude-code-autonomous-ai-loops-with-smart-exit-detection 2026-01-14T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/987-accuracy-on-length-generalization-what-rewritenets-reveals-about-transformer 2026-01-14T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/987-accuracy-on-length-generalization-what-rewritenets-reveals-about-transformer-2 2026-01-14T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/stop-ai-agents-from-writing-spaghetti-enforcing-tdd-with-superpowers 2026-01-13T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/beads-git-backed-memory-for-ai-agents-that-actually-remembers 2026-01-13T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/stop-ai-agents-from-writing-spaghetti-enforcing-tdd-with-superpowers-2 2026-01-13T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/claude-code-autonomous-ai-agents-living-in-our-terminal 2026-01-13T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/beads-git-backed-memory-for-ai-agents-that-actually-remembers-2 2026-01-13T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/time-making-reasoning-models-10x-cheaper-by-thinking-only-when-needed 2026-01-12T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/breaking-the-memory-wall-how-moeblaze-achieves-4x-faster-moe-training 2026-01-12T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/breaking-the-memory-wall-how-moeblaze-achieves-4x-faster-moe-training-2 2026-01-12T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/time-making-reasoning-models-10x-cheaper-by-thinking-only-when-needed-2 2026-01-12T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/why-continuous-fuzzing-isnt-enough-the-bugs-that-survive 2026-01-11T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/ui-tars-desktop-the-ai-agent-that-actually-sees-and-controls-our-computers 2026-01-11T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/ui-tars-desktop-the-ai-agent-that-actually-sees-and-controls-our-computers-2 2026-01-11T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/why-ai-is-pushing-us-all-toward-typescript-and-why-thats-good 2026-01-11T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/why-continuous-fuzzing-isnt-enough-the-bugs-that-survive-2 2026-01-11T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/opencode-the-open-source-ai-coding-agent-we-can-actually-own 2026-01-11T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/opencode-the-open-source-ai-coding-agent-that-frees-us-from-vendor-lock-in 2026-01-10T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/opencode-the-open-source-ai-coding-agent-that-frees-us-from-vendor-lock-in-2 2026-01-10T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/why-ai-is-settling-the-typed-vs-untyped-debate-for-us 2026-01-10T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/why-94-of-ai-code-errors-are-pushing-us-all-toward-typescript 2026-01-09T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/claude-code-the-agentic-terminal-assistant-that-actually-understands-your-codeba 2026-01-09T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/why-94-of-ai-code-errors-are-pushing-us-all-toward-typescript-2 2026-01-09T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/claude-code-the-agentic-terminal-assistant-that-actually-understands-your-codeba-2 2026-01-09T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/memvid-ai-agent-memory-in-a-single-portable-file 2026-01-08T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/memvid-ai-agent-memory-in-a-single-file-no-servers-required 2026-01-08T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/memvid-the-single-file-memory-layer-that-changes-ai-agent-development 2026-01-08T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/r2vpo-how-soft-constraints-fix-the-eureka-moment-problem-in-llm-training 2026-01-08T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/memvid-the-portable-memory-layer-that-eliminates-vector-database-hell 2026-01-08T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/bitnet-how-microsoft-made-100b-llms-run-on-your-laptop-cpu 2026-01-08T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/webgym-how-300k-tasks-finally-trained-ai-agents-to-use-real-websites 2026-01-08T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/webgym-why-ai-agents-fail-at-web-tasks-and-how-this-changes-it 2026-01-07T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/bitnet-how-microsoft-made-100b-models-run-on-your-laptop-cpu 2026-01-07T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/opencode-the-open-source-ai-coding-agent-that-works-with-any-model 2026-01-06T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/claude-4-opus-vs-gpt-5-the-ultimate-developer-benchmark 2026-01-05T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/when-ai-content-pipelines-meet-missing-data-a-real-time-debugging-story 2026-01-05T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/when-ai-agents-fail-a-real-pipeline-break-and-what-it-teaches-us 2026-01-05T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/the-hidden-trojan-in-your-ai-vocabulary-why-model-merging-isnt-safe 2026-01-05T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/the-hidden-trojan-how-model-merging-became-a-security-nightmare 2026-01-05T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/ai-hedge-fund-when-multiple-ai-agents-become-your-trading-council 2026-01-05T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/ai-hedge-fund-when-multiple-ai-agents-become-your-investment-committee 2026-01-05T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/ai-hedge-fund-building-investment-teams-from-ai-agents 2026-01-05T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/15-cursor-ai-tricks-that-10x-your-coding-speed 2026-01-04T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/pathway-the-python-framework-that-keeps-your-ai-from-working-with-stale-data 2026-01-04T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/model-context-protocol-mcp-the-new-standard-for-ai-tools 2026-01-03T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/rag-is-dead-long-live-agentic-rag 2026-01-02T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/the-rise-of-ai-agents-from-chatbots-to-autonomous-workers 2026-01-02T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/vibe-coding-the-new-way-to-build 2026-01-01T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/openai-codex-cli-ai-powered-terminal-is-here 2026-01-01T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/mastering-nextjs-15 2025-12-28T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/structured-outputs-the-end-of-json-parsing-nightmares 2025-12-28T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/apple-vision-pro-a-developers-perspective 2025-12-25T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/how-i-replaced-80-of-code-reviews-with-ai 2025-12-25T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/fine-tuning-in-2026-when-and-how-to-customize-llms 2025-12-22T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/self-hosting-llms-with-ollama 2025-12-20T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/design-systems-for-ai 2025-12-18T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/pediatric-readiness-modules-created-by-childrens-hospital-association-available- 2026-07-07T20:10:09.000Z monthly 0.5 https://feedbagel.com/post/pediatric-readiness-symposium-brings-regional-partners-together-to-strengthen-em 2026-05-21T18:00:51.000Z monthly 0.5 https://feedbagel.com/post/help-improve-emergency-preparedness-for-autistic-children 2026-04-27T19:45:30.000Z monthly 0.5 https://feedbagel.com/post/ppn-hosting-webinar-for-school-nurses-to-improve-kids-safety-during-emergencies- 2026-04-17T18:57:31.000Z monthly 0.5 https://feedbagel.com/post/join-the-emsc-ppn-patient-youth-family-and-community-engagement-learning-network 2026-03-24T15:58:42.000Z monthly 0.5 https://feedbagel.com/post/ppn-featured-in-healthleaders-spotlight-on-pediatric-readiness-in-emergency-depa 2026-03-17T11:44:33.000Z monthly 0.5 https://feedbagel.com/post/dr-mary-fallat-discusses-system-level-changes-to-optimize-trauma-and-burn-care-f 2026-03-16T21:59:18.000Z monthly 0.5 https://feedbagel.com/post/ppn-partners-advance-pediatric-emergency-readiness-in-southeast-utah 2026-02-24T21:30:30.000Z monthly 0.5 https://feedbagel.com/post/ppn-launches-virtual-tabletop-exercise-series-2026 2026-01-28T19:54:40.000Z monthly 0.5 https://feedbagel.com/post/uh-rainbow-helping-to-make-americas-kids-more-disaster-resistant 2026-01-26T23:53:24.000Z monthly 0.5 https://feedbagel.com/post/powered-by-people-gopher-resources-ray-krantz-keeps-critical-minerals-in-motion monthly 0.5 https://feedbagel.com/post/datacenter-expansion-drives-growth-in-north-american-industrial-lead-battery-mar monthly 0.5 https://feedbagel.com/post/defending-critical-minerals-in-north-america-the-case-against-improper-battery-e monthly 0.5 https://feedbagel.com/post/5-questions-with-pacific-northwest-national-laboratorys-ed-thomsen monthly 0.5 https://feedbagel.com/post/bci-to-provide-world-class-safety-expertise-through-the-lead-training-academy-le monthly 0.5 https://feedbagel.com/post/bci-hosts-inaugural-meeting-of-new-sodium-battery-industry-group monthly 0.5 https://feedbagel.com/post/bci-applauds-rep-moores-legislation-to-update-45x-advanced-manufacturing-credits monthly 0.5 https://feedbagel.com/post/flow-batteries-north-america-returns-with-extended-programming-for-2026 monthly 0.5 https://feedbagel.com/post/bci-and-cru-publish-new-report-on-lead-battery-market-trends-through-2028 monthly 0.5 https://feedbagel.com/post/rochester-man-caught-with-half-pound-of-meth-accepts-plea-deal 2026-07-08T21:08:08.000Z monthly 0.5 https://feedbagel.com/post/minnesota-woman-pleads-guilty-to-threatening-state-house-speaker 2026-07-08T20:40:02.000Z monthly 0.5 https://feedbagel.com/post/county-road-32-north-of-lake-henry-closes-monday-for-resurfacing 2026-07-08T20:00:00.000Z monthly 0.5 https://feedbagel.com/post/wisconsin-state-fair-unveils-its-2026-best-new-food-drink-finalists 2026-07-08T19:48:09.000Z monthly 0.5 https://feedbagel.com/post/lawsuit-alleges-mayo-clinic-retaliated-against-ai-whistleblower 2026-07-08T18:55:03.000Z monthly 0.5 https://feedbagel.com/post/adventureland-one-of-the-most-affordable-theme-parks-to-visit 2026-07-08T18:32:41.000Z monthly 0.5 https://feedbagel.com/post/giordanos-pizza-opening-second-minnesota-location-next-week 2026-07-08T18:00:15.000Z monthly 0.5 https://feedbagel.com/post/kiss-the-blarney-stone-with-paul-shea-on-this-ireland-trip 2026-07-08T17:41:53.000Z monthly 0.5 https://feedbagel.com/post/culvers-is-opening-another-new-minnesota-restaurant 2026-07-08T17:41:20.000Z monthly 0.5 https://feedbagel.com/post/randy-travis-announces-new-music 2026-07-08T17:16:48.000Z monthly 0.5 https://feedbagel.com/post/legion-baseball-roundup-for-july-6th-and-7th 2026-07-08T16:57:36.000Z monthly 0.5 https://feedbagel.com/post/guy-fieri-confesses-his-ultimate-favorite-midwest-food-city 2026-07-08T16:57:26.000Z monthly 0.5 https://feedbagel.com/post/minnesota-grouse-numbers-are-dipping-right-on-schedule-with-their-natural-cycle 2026-07-08T16:50:55.000Z monthly 0.5 https://feedbagel.com/post/delta-just-brought-back-a-favorite-for-mn-travelers 2026-07-08T16:43:56.000Z monthly 0.5 https://feedbagel.com/post/canal-park-restaurant-lands-one-of-the-top-wine-awards-in-the-country 2026-07-08T16:41:46.000Z monthly 0.5 https://feedbagel.com/post/a-pop-up-splash-pad-a-zoo-sleepover-and-live-music-all-land-this-weekender 2026-07-08T16:36:07.000Z monthly 0.5 https://feedbagel.com/post/the-weird-things-you-start-seeing-on-minnesota-roads-in-july 2026-07-08T16:19:10.000Z monthly 0.5 https://feedbagel.com/post/watab-park-pavilion-hit-with-graffiti-twice-in-one-week 2026-07-08T16:18:14.000Z monthly 0.5 https://feedbagel.com/post/notorious-minnesota-vikings-love-boat-scandal-boat-for-sale-complete-with-player 2026-07-08T16:13:17.000Z monthly 0.5 https://feedbagel.com/post/10-fun-small-town-mn-festivals-to-check-out-before-summer-ends 2026-07-08T16:06:11.000Z monthly 0.5 https://feedbagel.com/post/iron-street-distillery-hosts-a-massive-fundraiser-festival-with-25-live-acts 2026-07-08T16:02:24.000Z monthly 0.5 https://feedbagel.com/post/metro-bus-west-transit-center-making-progress 2026-07-08T16:00:20.000Z monthly 0.5 https://feedbagel.com/post/popular-minnesota-marathon-announces-major-change 2026-07-08T15:33:57.000Z monthly 0.5 https://feedbagel.com/post/ashley-cooke-sneakily-took-this-from-the-marshals-set 2026-07-08T15:19:53.000Z monthly 0.5 https://feedbagel.com/post/delta-airlines-announces-upgrades-but-are-they-really 2026-07-08T14:58:20.000Z monthly 0.5 https://feedbagel.com/post/bunnie-xo-caught-kissing-a-reality-star-at-jelly-rolls-bar-2 2026-07-08T14:44:39.000Z monthly 0.5 https://feedbagel.com/post/volunteer-fire-departments-are-getting-new-gear-thanks-to-farm-lender 2026-07-08T14:22:38.000Z monthly 0.5 https://feedbagel.com/post/grrl-delayed-openings-across-all-32-branches-in-six-counties 2026-07-08T14:18:31.000Z monthly 0.5 https://feedbagel.com/post/rochester-man-charged-in-police-ramming-accused-of-copper-theft 2026-07-08T14:09:21.000Z monthly 0.5 https://feedbagel.com/post/nicole-kidman-marks-daughters-18th-birthday-with-rare-throwback-baby-pics-photos 2026-07-08T13:40:53.000Z monthly 0.5 https://feedbagel.com/post/ronnie-dunn-has-message-for-fans-after-hospital-visit 2026-07-08T13:26:48.000Z monthly 0.5 https://feedbagel.com/post/beloved-sparky-seal-show-at-como-zoo-marks-a-big-birthday-gallery 2026-07-08T13:01:19.000Z monthly 0.5 https://feedbagel.com/post/minnesota-falcon-cams-first-chick-has-officially-taken-flight 2026-07-08T12:55:49.000Z monthly 0.5 https://feedbagel.com/post/twin-cities-marathon-moving-to-later-in-the-fall 2026-07-08T12:46:33.000Z monthly 0.5 https://feedbagel.com/post/man-and-woman-injured-in-collision-at-red-wing-intersection 2026-07-08T12:24:56.000Z monthly 0.5 https://feedbagel.com/post/canada-alberta-national-school-food-program-to-feed-more-students 2026-07-08T21:30:00.000Z monthly 0.5 https://feedbagel.com/post/3-rescued-after-vessel-sinks-on-stuart-lake-near-fort-st-james-2 2026-07-08T21:16:00.000Z monthly 0.5 https://feedbagel.com/post/5-sylvan-lake-gulls-to-participate-in-wcbl-all-star-game 2026-07-08T21:12:00.000Z monthly 0.5 https://feedbagel.com/post/alberta-lands-13-billion-meta-data-centre-project-2 2026-07-08T22:03:00.000Z monthly 0.5 https://feedbagel.com/post/oliver-junior-hockey-franchise-unveils-team-name-jerseys-ahead-of-inaugural-seas 2026-07-08T20:46:20.000Z monthly 0.5 https://feedbagel.com/post/white-rock-man-arrested-in-major-us-federal-investigation-into-indian-organized- 2026-07-08T20:11:00.000Z monthly 0.5 https://feedbagel.com/post/cedar-lng-defends-live-aboard-plan-amid-fly-in-fly-out-concerns 2026-07-08T20:00:00.000Z monthly 0.5 https://feedbagel.com/post/profits-from-okanagan-based-ponzi-scheme-targeted-by-bc-supreme-court-2 2026-07-08T20:00:00.000Z monthly 0.5 https://feedbagel.com/post/trust-funding-celebrates-trails-music-in-the-park 2026-07-08T20:00:00.000Z monthly 0.5 https://feedbagel.com/post/bashaw-audience-dancin-in-the-aisles-for-tom-jones-tribute-show 2026-07-08T19:58:00.000Z monthly 0.5 https://feedbagel.com/post/not-entirely-artificial-not-that-intelligent-ai-and-communication-research-a-con 2026-01-05T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/big-data-discourses-big-data-discourses-introduction-to-the-special-section 2026-01-27T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/anti-media-media-a-normative-approach-to-media-positionality 2026-02-13T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/multilingual-misinformation-pathways-in-ethiopia-translation-chains-bridge-actor 2026-06-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/caty-borum-and-david-conrad-perez-radical-reality-documentary-storytelling-and-t 2026-06-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/not-entirely-artificial-not-that-intelligent-ai-and-communication-research-a-con-2 2026-01-05T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/big-data-discourses-a-model-of-frame-categories-for-analyzing-media-discourse-of 2026-01-27T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/rethinking-comparative-media-system-theory-from-ghana-toward-a-patronage-based-h 2026-06-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/elisabetta-ferrari-appropriate-negotiate-challenge-activist-imaginaries-and-the- 2026-06-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/big-data-discourses-reframing-datafication-news-media-discourses-on-big-data-and 2026-01-27T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/what-are-media-a-hedonic-model-for-the-second-digital-convergence 2026-06-12T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/tim-wu-the-age-of-extraction-how-tech-platforms-conquered-the-economy-and-threat 2026-06-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/big-data-discourses-ask-me-anything-how-chatgpt-got-hyped-into-being 2026-01-27T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/the-politics-of-diversity-netflix-and-the-transformation-of-korean-drama-product 2026-05-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/xiaochang-li-divination-engines-natural-language-processing-artificial-intellige 2026-06-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/big-data-discourses-curating-ai-into-being-hackshackers-as-amplifiers-of-journal 2026-01-27T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/from-navigating-discrimination-to-developing-professional-digital-intimacy-how-i 2026-05-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/katalin-feher-generative-ai-media-and-society 2026-06-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/big-data-discourses-data-feelings-everyday-affects-and-sensory-dimensions-of-per 2026-01-27T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/can-pandoras-box-be-closed-how-people-in-myanmar-access-and-identify-trustworthy 2026-05-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/anjali-nath-a-thousand-paper-cuts-us-empire-and-the-bureaucratic-life-of-war 2026-06-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/big-data-discourses-aesthetics-of-boundless-insight-on-the-scalar-ideology-of-th 2026-01-27T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/resilience-in-newsrooms-in-times-of-authoritarian-resurgence-we-went-from-the-sk 2026-05-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/wunpini-fatimata-mohammed-media-culture-and-decolonization-re-righting-the-subal 2026-06-12T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/big-data-discourse-a-new-source-of-the-self-a-critical-view-on-the-domestication 2026-01-27T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/freaks-and-raids-a-study-of-networked-harassment-and-misogyny-in-turkeys-authori 2026-05-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/christopher-pinney-with-the-photodemos-collective-eds-citizens-of-photography-th 2026-06-12T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/big-data-discourses-deceptive-stories-about-scale-digital-technology-public-serv 2026-01-27T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/visibility-under-constraint-format-publics-and-the-politics-of-visibility-on-tik 2026-05-14T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/zeynep-bulut-building-a-voice-sound-surface-skin 2026-06-12T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/big-data-discourses-data-in-indias-digital-public-infrastructure-dpi-a-deliberat 2026-01-27T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/when-identities-go-viral-themes-and-aversiveness-in-tiktok-discourse-on-kamala-h 2026-05-14T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/burcu-baykurt-smart-as-a-city-the-politics-of-test-bed-urbanism 2026-05-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/big-data-discourses-toward-disability-data-justice-a-critical-discussion-of-disa 2026-01-27T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/speculators-inside-the-slop-factory-shovelware-and-financialized-game-developmen 2026-05-14T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/bo-ruberg-how-to-queer-the-world-radical-worldbuilding-through-video-games 2026-05-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/big-data-discourses-cultural-motifs-of-big-data-in-user-generated-content-a-semi 2026-01-27T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/between-duty-and-discipline-kantian-ideals-and-techno-governmental-realities-in- 2026-04-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/benjamin-toff-ruth-palmer-and-rasmus-kleis-nielsen-avoiding-the-news-reluctant-a 2026-05-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/the-industrialization-of-digital-entrepreneurship-the-case-of-beauty-influencers 2026-04-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/phaedra-c-pezzullo-beyond-straw-men-plastic-pollution-and-networked-cultures-of- 2026-05-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/informational-sovereignty-the-commercial-and-geopolitical-risk-of-newsroom-depen 2026-04-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/noor-ghazal-aswad-searching-for-solidarity-revolutionary-dreams-and-radical-soci 2026-05-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/cultivating-self-care-health-television-and-the-internalization-of-individual-re 2026-04-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/dara-z-strolovitch-when-bad-things-happen-to-privileged-people-race-gender-and-w 2026-05-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/hybrid-platformism-thailands-online-political-media-landscape 2026-04-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/dal-yong-jin-cultural-production-of-hallyu-in-the-digital-platform-era-industry- 2026-05-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/navigating-credibility-on-tiktok-how-young-adults-evaluate-and-verify-informatio 2026-04-14T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/curtis-marez-producing-precarity-the-costs-of-making-tv-in-poor-places 2026-05-14T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/media-saturated-and-morally-contested-teenage-lives-no-space-or-time-for-nonmedi 2026-04-14T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/karrmen-crey-producing-sovereignty-the-rise-of-indigenous-media-in-canada 2026-05-14T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/angry-posts-myanmars-anti-military-rhetoric-on-the-internet 2026-04-14T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/robin-l-nabi-and-jessica-gall-myrick-eds-emotions-in-the-digital-world-exploring 2026-05-14T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/deep-state-conspiracism-andas-disinformation-a-journey-to-the-heart-of-democracy 2026-04-14T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/judit-bayer-digital-media-regulation-within-the-european-union-a-framework-for-a 2026-05-14T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/communicating-the-crisis-or-misinforming-the-public-analyzing-the-ai-generated-v 2026-04-14T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/francesco-casetti-screening-fears-on-protective-media 2026-05-14T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/shame-suspicion-surveillance-and-blame-the-neoliberal-undergirding-of-stigma-exp 2026-04-14T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/mora-matassi-and-pablo-j-boczkowski-to-know-is-to-compare-studying-social-media- 2026-05-14T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/the-ventriloquial-configuring-of-communication-international-communication-assoc 2026-03-27T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/emma-l-briant-and-vian-bakir-eds-routledge-handbook-of-the-influence-industry 2026-05-14T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/i-am-not-a-conspiracy-theorist-but-communicative-norms-in-conspiracy-theory-supp 2026-03-27T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/peter-neijens-theo-araujo-judith-moller-and-claes-de-vreese-eds-measuring-exposu 2026-05-14T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/the-quotidian-web-and-the-accidental-archive 2026-03-27T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/giota-alevizou-the-web-of-knowledge-encyclopedias-and-authority-in-the-digital-a 2026-04-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/digital-feminism-and-anti-feminism-in-interaction-relational-dynamics-and-hybrid 2026-03-27T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/rob-kitchin-critical-data-studies-an-a-to-z-guide-to-concepts-and-methods 2026-04-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/online-eudaemonic-spaces-for-students-during-covid-19-a-cross-national-compariso 2026-03-27T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/jeffrey-boase-the-digital-bind-constant-connectivity-and-the-reconfiguring-of-fa 2026-04-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/testing-the-effects-of-relative-newsworthiness-on-news-selection 2026-03-13T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/hector-beltran-code-work-hacking-across-the-usmexico-techno-borderlands 2026-04-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/personal-testimonials-and-empathy-in-environmental-risk-communicationtheir-effec 2026-02-26T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/karen-tongson-normporn-queer-viewers-and-the-tv-that-soothes-us 2026-04-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/when-over-the-top-is-over-the-top-a-political-economic-analysis-of-network-usage 2026-02-26T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/julieta-brambila-mexicos-resilient-journalists-how-reporters-manage-risk-and-cop 2026-04-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/the-short-video-format-conceptualizing-a-ubiquitous-artifact-of-visual-platforms 2026-02-26T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/fan-yang-disorienting-politics-chimerican-media-and-transpacific-entanglements 2026-04-14T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/closed-by-default-authoritarian-data-governance-and-civil-society-in-singapore 2026-02-26T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/oliver-l-haimson-trans-technologies 2026-03-27T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/enhancing-media-literacy-in-higher-education-an-experimental-study-on-misinforma 2026-02-26T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/matt-sienkiewicz-and-nick-marx-thats-not-funny-how-the-right-makes-comedy-work-f 2026-03-13T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/data-publics-an-empirical-and-comparative-approach-to-datafication 2026-02-26T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/mirca-madianou-technocolonialism-when-technology-for-good-is-harmful 2026-03-13T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/what-is-at-stake-the-co-encodingdecoding-model-of-humangenerative-artificial-int 2026-02-13T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/amit-m-schejter-baruch-shomron-muhammad-abu-jaffar-ghalia-abu-kaf-jonathan-mende 2026-03-13T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/drawing-the-faces-of-perpetual-foreigners-a-multimodal-narrative-analysis-of-sto 2026-02-13T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/vassil-girginov-and-katerina-girginova-eds-handbook-on-sport-and-culture 2026-03-13T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/voices-of-disagreement-participatory-media-and-agonistic-democracy-in-cyprus 2026-01-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/hanan-badr-and-karin-g-wilkins-eds-critical-communication-research-with-global-i 2026-03-13T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/performing-the-people-and-depleting-the-commons-bottom-up-populism-in-canada-and 2026-01-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/samuel-woolley-manufacturing-consensus-understanding-propaganda-in-the-era-of-au 2026-02-26T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/knowledge-and-expertise-in-the-digital-age-how-people-engage-with-sex-advice-on- 2026-01-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/ronnell-andersen-jones-and-sonja-r-west-eds-the-future-of-press-freedom-democrac 2026-02-26T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/understanding-public-concerns-about-fake-news-linking-social-media-news-use-cogn 2026-01-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/steffan-blayney-joey-hornsby-and-savannah-whaley-eds-the-body-productive-rethink 2026-02-26T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/regressive-futuring-zuckerbergs-rebranding-against-techlashs-crisis 2026-01-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/jathan-sadowski-the-mechanic-and-the-luddite-a-ruthless-criticism-of-technology- 2026-02-26T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/biased-judgment-or-lack-of-skill-the-role-of-news-consumption-in-misinformation- 2026-01-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/bohyeong-kim-critically-capitalist-the-spirit-of-asset-capitalism-in-south-korea 2026-02-13T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/decentering-technology-in-the-datafied-workplace-data-injustice-and-workers-expe 2026-01-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/catherine-dignazio-counting-feminicide-data-feminism-in-action 2026-02-13T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/communicating-mobile-borders-urban-conviviality-and-more-than-national-belonging 2026-01-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/nick-couldry-the-space-of-the-world-can-human-solidarity-survive-social-media-an 2026-02-13T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/political-manipulation-of-the-israel-hamas-conflict-on-whatsapp-in-india 2026-01-14T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/laila-shereen-sakr-arabic-glitch-technoculture-data-bodies-and-archives 2026-02-13T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/the-dark-side-of-algorithms-how-ethical-and-privacy-considerations-affect-indivi 2026-01-05T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/aeron-davis-political-communication-an-introduction-for-crisis-times-2nd-ed 2026-01-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/oneness-with-the-source-as-a-means-of-reducing-motivated-reasoning-about-climate 2026-01-05T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/thomas-s-mullaney-the-chinese-computer-a-global-history-of-the-information-age 2026-01-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/is-it-so-bothersome-that-a-woman-has-a-senior-position-false-empowerment-in-the- 2026-01-05T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/beth-a-haller-disabled-people-transforming-media-culture-for-a-more-inclusive-wo 2026-01-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/talking-about-the-voice-everyday-political-talk-about-indigenous-constitutional- 2026-01-05T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/alfred-l-martin-jr-fandom-for-us-by-us-the-pleasures-and-practices-of-black-audi 2026-01-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/global-communication-and-the-scalar-politics-of-race-tensions-in-transnational-a 2026-01-05T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/timothy-recuber-the-digital-departed-how-we-face-death-commemorate-life-and-chas 2026-01-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/expert-reports-as-epistemic-participation-knowing-and-doing-in-artificial-intell 2026-01-05T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/goran-bolin-and-per-stahlberg-managing-meaning-in-ukraine-information-communicat 2026-01-14T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/scrolling-past-suffering-ethnocentric-media-distrust-and-humanitarian-responsibi 2026-01-05T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/eviane-leidig-the-women-of-the-far-right-social-media-influencers-and-online-rad 2026-01-14T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/jabari-m-evans-hip-hop-civics-connected-learning-in-the-rap-classroom 2026-01-14T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/amanda-d-lotz-after-mass-media-storytelling-for-microaudiences-in-the-twenty-fir 2026-01-05T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/rodney-benson-mattias-hesserus-timothy-neff-and-julie-sedel-how-media-ownership- 2026-01-05T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/natalie-fenton-democratic-delusions-how-the-media-hollows-out-democracy-and-what 2026-01-05T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/michelle-cho-and-jesook-song-eds-mediating-gender-in-post-authoritarian-south-ko 2026-01-05T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/john-m-jordan-the-rise-of-the-algorithms-how-youtube-and-tiktok-conquered-the-wo 2026-01-05T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/sell-on-about-you-the-marketplace-opportunity-for-european-fashion-brands-live 2026-06-29T08:31:38.000Z monthly 0.5 https://feedbagel.com/post/marketplace-talk-junes-ecommerce-news-2026 2026-06-25T03:45:00.000Z monthly 0.5 https://feedbagel.com/post/the-macys-marketplace-playbook-how-to-launch-and-grow-live-session 2026-06-23T23:00:00.000Z monthly 0.5 https://feedbagel.com/post/tiktok-shop-europe-explained-opportunities-markets-and-growth-strategies-live-se 2026-06-22T23:00:00.000Z monthly 0.5 https://feedbagel.com/post/is-2026-the-right-time-to-invest-in-a-global-marketplace-expansion-tool 2026-06-19T05:30:00.000Z monthly 0.5 https://feedbagel.com/post/amazon-vendor-central-how-to-protect-margins-and-grow-in-2026 2026-06-12T13:28:05.000Z monthly 0.5 https://feedbagel.com/post/how-spreetail-launched-nearly-10000-skus-in-record-time 2026-06-10T09:50:41.000Z monthly 0.5 https://feedbagel.com/post/how-to-win-on-tiktok-shop-by-turning-discovery-into-sales 2026-06-04T13:40:09.000Z monthly 0.5 https://feedbagel.com/post/how-to-master-stock-management-across-marketplaces 2026-06-03T09:38:12.000Z monthly 0.5 https://feedbagel.com/post/dominate-amazon-prime-day-2026-10-winning-tips-for-ecommerce-success 2026-06-01T08:30:00.000Z monthly 0.5 https://feedbagel.com/post/jason-statham-unleashes-revenge-on-a-ship-in-mutiny-trailer 2026-07-08T21:53:41.000Z monthly 0.5 https://feedbagel.com/post/dave-grohl-announced-nirvanas-breed-as-opening-theme-song-to-the-guy-she-was-int 2026-07-08T19:51:26.000Z monthly 0.5 https://feedbagel.com/post/mondo-reveals-all-new-figure-set-inspired-by-the-real-ghostbusters-sdcc-2026 2026-07-08T19:12:00.000Z monthly 0.5 https://feedbagel.com/post/exclusive-listen-to-the-track-from-hbo-maxs-the-man-will-burn 2026-07-08T19:00:00.000Z monthly 0.5 https://feedbagel.com/post/nexons-blue-archive-developers-reveal-details-about-next-chapter-anime-expo-2026 2026-07-08T17:19:02.000Z monthly 0.5 https://feedbagel.com/post/spider-man-brand-new-day-soundtrack-teaser-plus-no-jamieson-in-film-says-jk-simm 2026-07-08T17:00:00.000Z monthly 0.5 https://feedbagel.com/post/ado-shares-new-song-for-devils-crest-with-trailer-and-visuals-anime-expo-2026 2026-07-08T16:36:12.000Z monthly 0.5 https://feedbagel.com/post/house-of-the-dragon-s3e03-review-ambitious-episode 2026-07-08T16:30:00.000Z monthly 0.5 https://feedbagel.com/post/first-gameplay-demo-at-miresi-invisible-future-and-booth-tour-anime-expo-2026 2026-07-08T07:19:25.000Z monthly 0.5 https://feedbagel.com/post/dc-spotlight-july-8-2026-clayface-rebuilds-basil-karlo-absolute-batman-reveals-h 2026-07-08T06:31:57.000Z monthly 0.5 https://feedbagel.com/post/flow-batteries-europe-joins-86-european-associations-in-signing-the-joint-declar 2026-07-07T09:01:13.000Z monthly 0.5 https://feedbagel.com/post/flow-batteries-europe-joins-eu-declaration-on-sustainable-data-centre-integratio 2026-06-05T07:33:30.000Z monthly 0.5 https://feedbagel.com/post/long-duration-energy-storage-must-be-a-pillar-of-europes-electrification-and-ene 2026-06-03T07:00:00.000Z monthly 0.5 https://feedbagel.com/post/fbes-feedback-on-rating-scheme-for-data-centres-in-the-eu-rating-scheme-for-data 2026-04-23T14:44:29.000Z monthly 0.5 https://feedbagel.com/post/fbe-welcomes-accelerateeu-but-calls-for-stronger-focus-on-long-duration-energy-s 2026-04-22T15:12:01.000Z monthly 0.5 https://feedbagel.com/post/insights-from-our-webinar-path-to-bankability-unlocking-investment-in-long-durat 2026-03-19T10:03:00.000Z monthly 0.5 https://feedbagel.com/post/fbe-webinar-path-to-bankability-unlocking-investment-in-long-duration-energy-sto 2026-02-26T08:57:03.000Z monthly 0.5 https://feedbagel.com/post/european-sustainable-energy-week-9-11-june-2026-brussels 2026-02-24T10:06:41.000Z monthly 0.5 https://feedbagel.com/post/energy-storage-summit-2026-24-25-february-2026-london 2026-02-24T09:53:50.000Z monthly 0.5 https://feedbagel.com/post/subin-oh 2026-07-08T15:20:26.000Z monthly 0.5 https://feedbagel.com/post/bruce-weinelt 2026-07-02T15:49:19.000Z monthly 0.5 https://feedbagel.com/post/erin-keller 2026-07-01T21:46:54.000Z monthly 0.5 https://feedbagel.com/post/lara-hodgson 2026-07-01T21:46:54.000Z monthly 0.5 https://feedbagel.com/post/mengyao-li 2026-07-01T17:46:40.000Z monthly 0.5 https://feedbagel.com/post/sukarno-mertoguno 2026-07-01T17:46:40.000Z monthly 0.5 https://feedbagel.com/post/cindy-xiong 2026-07-01T17:46:40.000Z monthly 0.5 https://feedbagel.com/post/heidi-biggs 2026-07-01T17:46:40.000Z monthly 0.5 https://feedbagel.com/post/sean-mulvanity 2026-06-13T00:21:10.000Z monthly 0.5 https://feedbagel.com/post/jack-weeks 2026-06-02T21:41:59.000Z monthly 0.5 https://feedbagel.com/post/tsuutina-nation-to-develop-new-community-west-of-calgary 2026-07-08T21:32:31.000Z monthly 0.5 https://feedbagel.com/post/from-the-2010-olympics-to-the-world-cup-vancouver-models-indigenous-inclusion 2026-07-08T17:24:40.000Z monthly 0.5 https://feedbagel.com/post/second-wildfire-triggers-upgraded-evacuation-order-near-boston-bar-bc-6 2026-07-08T16:49:00.000Z monthly 0.5 https://feedbagel.com/post/aamjiwnaang-first-nation-calls-on-the-crown-to-immediately-initiate-engagement-o 2026-07-07T22:38:19.000Z monthly 0.5 https://feedbagel.com/post/alberta-federation-of-labour-supports-first-nations-in-their-fight-against-separ 2026-07-07T21:51:34.000Z monthly 0.5 https://feedbagel.com/post/bc-wildfire-prompts-evacuations-and-heavy-smoke-warnings-in-fraser-canyon 2026-07-07T17:01:09.000Z monthly 0.5 https://feedbagel.com/post/one-home-lost-many-saved-as-wildfire-crews-battle-fort-simpson-blaze 2026-07-06T23:10:05.000Z monthly 0.5 https://feedbagel.com/post/premiers-smith-ford-unveil-proposed-west-east-oil-pipeline-route 2026-07-06T22:31:20.000Z monthly 0.5 https://feedbagel.com/post/manitoba-family-wants-answers-justice-after-25-year-old-dies-while-in-custody 2026-07-06T21:58:56.000Z monthly 0.5 https://feedbagel.com/post/new-book-critical-of-stalled-action-on-indigenous-policing-by-the-federal-govern 2026-07-06T20:41:24.000Z monthly 0.5 https://feedbagel.com/post/greensea-iq-to-provide-four-bayonet-250-augvs-for-the-marine-corps 2026-07-08T18:35:55.000Z monthly 0.5 https://feedbagel.com/post/multidisciplinary-scientific-expedition-sets-sail-july-10-aboard-the-ccgs-amunds 2026-07-08T18:48:49.000Z monthly 0.5 https://feedbagel.com/post/ecosubsea-rov-detects-invasive-marine-species-during-hull-cleaning 2026-07-08T18:01:15.000Z monthly 0.5 https://feedbagel.com/post/kongsberg-maritime-bcit-invest-in-future-marine-innovation-simulation-centre-of- 2026-07-08T17:54:22.000Z monthly 0.5 https://feedbagel.com/post/nextfloat-floating-wind-pilot-clears-key-spanish-regulatory-hurdle 2026-07-08T12:08:16.000Z monthly 0.5 https://feedbagel.com/post/acua-ocean-usv-collects-100-hours-of-continuous-multi-domain-data 2026-07-07T20:00:42.000Z monthly 0.5 https://feedbagel.com/post/dof-group-wins-contract-award-in-apac-region 2026-07-07T19:32:50.000Z monthly 0.5 https://feedbagel.com/post/subsea-hydrothermal-vents-discovered-in-the-doldrums-region 2026-07-07T19:20:13.000Z monthly 0.5 https://feedbagel.com/post/jaia-robotics-expands-team-to-meet-company-growth 2026-07-07T19:13:15.000Z monthly 0.5 https://feedbagel.com/post/bluenergies-confirms-offshore-liberia-exploration-remains-on-schedule 2026-07-07T19:07:07.000Z monthly 0.5 https://feedbagel.com/post/oceaneering-wins-offshore-brazil-contract-with-petrobras-for-rov-services 2026-07-07T14:28:39.000Z monthly 0.5 https://feedbagel.com/post/cobham-ultra-to-sell-ultra-maritime-to-lockheed-martin 2026-07-06T15:48:46.000Z monthly 0.5 https://feedbagel.com/post/seatrium-powers-first-electricity-export-to-singapore-grid-from-floating-platfor 2026-07-06T15:10:57.000Z monthly 0.5 https://feedbagel.com/post/iadc-brings-dredging-reclamation-seminar-to-bali-in-november-2026 2026-07-06T13:51:36.000Z monthly 0.5 https://feedbagel.com/post/kongsberg-supplies-technology-suite-for-nioz-rv-anna-weber-van-bosse 2026-07-06T13:39:18.000Z monthly 0.5 https://feedbagel.com/post/value-maritime-signs-commercial-representation-agreement-with-hai-cheung-china 2026-07-06T13:27:14.000Z monthly 0.5 https://feedbagel.com/post/teledyne-marine-opens-annual-global-photo-data-contest-2026 2026-07-06T13:35:08.000Z monthly 0.5 https://feedbagel.com/post/us-navy-tests-prototype-atmospheric-diving-system 2026-07-06T13:33:51.000Z monthly 0.5 https://feedbagel.com/post/fincantieri-strikes-four-deals-in-687m-underwater-expansion 2026-07-06T13:01:47.000Z monthly 0.5 https://feedbagel.com/post/52-ft-asv-mirage-splashes 2026-07-06T10:54:57.000Z monthly 0.5 https://feedbagel.com/post/ags-gia-name-scholarship-award-winners 2026-07-08T12:46:25.000Z monthly 0.5 https://feedbagel.com/post/namdia-reveals-new-rough-buyer-list 2026-07-08T10:01:48.000Z monthly 0.5 https://feedbagel.com/post/jewelers-of-america-reveals-recipients-of-2026-impact-initiative 2026-07-08T09:52:20.000Z monthly 0.5 https://feedbagel.com/post/i-want-rapaport-to-behave-like-the-tech-company-it-always-was 2026-07-08T07:33:40.000Z monthly 0.5 https://feedbagel.com/post/titan-sales-rise-amid-holiday-demand 2026-07-07T11:48:40.000Z monthly 0.5 https://feedbagel.com/post/burglars-steal-46m-worth-of-jewelry-from-french-museum 2026-07-07T10:06:54.000Z monthly 0.5 https://feedbagel.com/post/how-the-gia-identifies-gem-origin 2026-07-06T11:07:19.000Z monthly 0.5 https://feedbagel.com/post/pandora-launches-new-creative-platform 2026-07-05T10:27:21.000Z monthly 0.5 https://feedbagel.com/post/hong-kong-luxury-sales-continue-to-climb-in-may 2026-07-02T12:44:47.000Z monthly 0.5 https://feedbagel.com/post/adpa-partners-with-diamond-school-to-strengthen-african-trade 2026-07-02T11:42:24.000Z monthly 0.5 https://feedbagel.com/post/semi-pro-saint-laurent-draws-forge-1-1-to-open-canadian-championship-quarterfina-2 2026-07-08T21:42:16.000Z monthly 0.5 https://feedbagel.com/post/ryan-oulahen-to-coach-canadas-under-18-team-in-hlinka-gretzky-cup-8 2026-07-08T21:18:54.000Z monthly 0.5 https://feedbagel.com/post/three-people-rescued-after-boat-capsizes-near-fort-st-james-bc-3 2026-07-08T21:13:57.000Z monthly 0.5 https://feedbagel.com/post/mental-state-stable-for-father-who-killed-kids-bc-review-board-says-6 2026-07-08T20:35:53.000Z monthly 0.5 https://feedbagel.com/post/mental-state-stable-for-father-who-killed-kids-bc-review-board-says-7 2026-07-08T20:35:53.000Z monthly 0.5 https://feedbagel.com/post/what-was-in-us-indictments-targeting-alleged-canada-linked-crime-groups-5 2026-07-08T20:33:47.000Z monthly 0.5 https://feedbagel.com/post/what-was-in-us-indictments-targeting-alleged-canada-linked-crime-groups-6 2026-07-08T20:33:47.000Z monthly 0.5 https://feedbagel.com/post/senators-great-alfredsson-set-for-exciting-chapter-with-rival-maple-leafs-5 2026-07-08T20:22:44.000Z monthly 0.5 https://feedbagel.com/post/blackhawks-star-connor-bedard-to-miss-start-of-the-season-after-shoulder-surgery-7 2026-07-08T19:41:02.000Z monthly 0.5 https://feedbagel.com/post/justin-bieber-to-co-headline-fifa-world-cup-final-halftime-show-5 2026-07-08T19:37:32.000Z monthly 0.5 https://feedbagel.com/post/shenmue-ii-italian-patch-in-the-works 2026-06-28T10:17:47.000Z monthly 0.5 https://feedbagel.com/post/virtua-fighter-crossroads-announced-a-classic-series-with-a-new-outlook 2026-06-07T14:08:06.000Z monthly 0.5 https://feedbagel.com/post/eric-kelso-signed-prints-giveaway-sale 2026-06-04T21:35:55.000Z monthly 0.5 https://feedbagel.com/post/shenmue-figgyz-wave-3-poll-is-live 2026-06-03T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/shenmue-3-vr-mod-launches-grab-it-now 2026-05-31T18:22:58.000Z monthly 0.5 https://feedbagel.com/post/yu-suzuki-talks-shenmue-iii-enhanced-in-new-nintendo-life-interview 2026-05-28T17:32:49.000Z monthly 0.5 https://feedbagel.com/post/shenmue-3-enhanced-new-screenshots-from-inin-games 2026-05-13T10:28:38.000Z monthly 0.5 https://feedbagel.com/post/push-square-shares-uncovered-shenmue-art 2026-05-01T17:02:28.000Z monthly 0.5 https://feedbagel.com/post/shenmue-dojo-show-shenmue-3-enhanced-new-auction-artwork-discussion-s6ep3 2026-04-28T19:00:00.000Z monthly 0.5 https://feedbagel.com/post/huge-giveaway-wishlist-shenmue-3-enhanced-win-a-shed-load-of-prizes 2026-04-22T20:31:14.000Z monthly 0.5 https://feedbagel.com/post/from-compliance-to-intelligence-india039s-digital-pharma-evolution 2026-05-22T08:53:24.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-commencement-of-tender-offer-to-acquire-nuvalent-inc 2026-06-24T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/utebzi-tebipenem-pivoxil-approved-in-the-us-for-adults-with-complicated-urinary- 2026-06-17T16:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsks-momelotinib-granted-orphan-drug-designations-in-the-us-and-eu-for-vexas-syn 2026-06-12T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-enters-agreement-to-acquire-nuvalent-inc 2026-06-09T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/bepirovirsen-achieves-unprecedented-functional-cure-rates-with-potential-to-rede 2026-05-28T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-to-showcase-long-term-outcomes-and-pipeline-expansion-with-latest-oncology-r 2026-05-26T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsks-rsv-vaccine-arexvy-receives-expanded-approval-in-japan-for-adults-aged-1859 2026-05-18T07:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-enters-exclusive-collaboration-with-sbp-group-a-market-leader-in-hepatology- 2026-05-11T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-presents-latest-respiratory-research-to-advance-patient-care-at-ats-2026 2026-05-06T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-delivers-strong-q1-performance-and-start-to-2026 2026-04-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/bepirovirsen-accepted-for-priority-review-and-granted-breakthrough-therapy-desig 2026-04-28T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsks-investigational-liver-therapy-efimosfermin-receives-us-fda-breakthrough-the 2026-04-27T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/tesaro-a-gsk-subsidiary-provides-update-on-anaptysbio-inc-litigation 2026-04-27T07:00:00.000Z monthly 0.5 https://feedbagel.com/post/blenrep-belantamab-mafodotin-approved-in-china-for-treatment-of-2l-relapsedrefra 2026-04-20T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-completes-acquisition-of-35pharma-inc 2026-04-15T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-presents-positive-data-for-b7-h4-targeted-adc-in-gynaecological-cancers 2026-04-12T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/exdensur-depemokimab-approved-in-china-for-the-treatment-of-chronic-rhinosinusit 2026-04-08T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/exdensur-depemokimab-approved-in-china-for-the-treatment-of-severe-asthma 2026-03-30T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/bepirovirsen-accepted-for-regulatory-review-in-china-as-a-potential-first-in-cla 2026-03-30T07:05:00.000Z monthly 0.5 https://feedbagel.com/post/bepirovirsen-accepted-for-review-by-the-european-medicines-agency-as-a-potential 2026-03-27T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsks-b7-h3-targeted-antibody-drug-conjugate-risvutatug-rezetecan-granted-orphan- 2026-03-23T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/lynavoy-linerixibat-approved-by-the-us-fda-for-cholestatic-pruritus-in-patients- 2026-03-19T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsks-rsv-vaccine-arexvy-approved-in-us-for-expanded-age-indication-in-adults-age 2026-03-13T10:35:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-tops-antimicrobial-resistance-amr-benchmark-report 2026-03-10T11:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-alfasigma-announce-agreement-on-worldwide-rights-for-linerixibat 2026-03-09T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-completes-acquisition-of-rapt-therapeutics 2026-03-03T15:00:00.000Z monthly 0.5 https://feedbagel.com/post/bepirovirsen-accepted-for-regulatory-review-in-japan-as-a-potential-first-in-cla 2026-02-26T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/linerixibat-accepted-for-priority-review-in-china-for-cholestatic-pruritus-in-pa 2026-02-26T07:05:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-enters-agreement-to-acquire-35pharma-inc 2026-02-25T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-reports-positive-12-month-data-showing-investigational-bnab-loti 2026-02-25T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/tiktok-shop-uk-books-category-sees-250-growth 2026-07-08T12:25:00.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-presents-pipeline-data-for-two-investigational-hiv-treatment-the 2026-02-25T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcares-long-acting-cabenuva-cabotegravir-rilpivirine-for-hiv-demonstra 2026-02-18T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/exdensur-depemokimab-approved-by-the-european-commission-for-severe-asthma-with- 2026-02-17T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/97-of-consumers-now-consult-multiple-sources-before-buying 2026-07-08T10:38:09.000Z monthly 0.5 https://feedbagel.com/post/gsks-arexvy-associated-with-reductions-in-certain-rsv-related-risks-including-he 2026-02-17T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsks-rsv-vaccine-arexvy-accepted-for-regulatory-review-in-china-for-adults-aged- 2026-02-10T07:00:00.000Z monthly 0.5 https://feedbagel.com/post/quadient-expands-partnership-with-morrisons-to-grow-uk-locker-network 2026-07-08T10:25:25.000Z monthly 0.5 https://feedbagel.com/post/nucala-mepolizumab-approved-by-the-european-commission-for-the-treatment-of-chro 2026-02-06T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/depop-australia-makes-selling-free-with-introduction-of-buyer-fee 2026-07-07T07:28:11.000Z monthly 0.5 https://feedbagel.com/post/gsk-delivers-strong-2025-performance-and-re-affirms-long-term-outlooks 2026-02-04T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsks-rsv-vaccine-arexvy-receives-european-approval-for-expanded-use-in-all-adult 2026-01-26T07:00:00.000Z monthly 0.5 https://feedbagel.com/post/amazon-prime-day-australia-runs-for-7-days 2026-07-07T07:13:44.000Z monthly 0.5 https://feedbagel.com/post/trelegy-ellipta-approved-in-china-for-use-in-adults-with-uncontrolled-asthma 2026-01-23T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/amazon-buy-box-featured-offer-eligibility-change 2026-07-07T07:02:12.000Z monthly 0.5 https://feedbagel.com/post/gsk-enters-agreement-to-acquire-rapt-therapeutics 2026-01-20T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/how-green-is-your-delivery-are-carriers-greenwashing 2026-07-06T10:00:33.000Z monthly 0.5 https://feedbagel.com/post/gsk-pfizer-and-shionogi-agree-on-changes-to-viiv-healthcare-shareholding 2026-01-20T07:00:00.000Z monthly 0.5 https://feedbagel.com/post/43-uk-consumers-rearrange-their-day-for-late-deliveries 2026-07-06T08:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsks-shingrix-recombinant-zoster-vaccine-prefilled-syringe-presentation-approved 2026-01-07T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-positive-results-from-b-well-1-and-b-well-2-phase-iii-trials-for-b 2026-01-07T07:00:00.000Z monthly 0.5 https://feedbagel.com/post/england-goals-spark-instant-toy-sales-surge 2026-07-05T09:00:47.000Z monthly 0.5 https://feedbagel.com/post/exdensur-depemokimab-approved-in-japan-for-severe-asthma-and-chronic-rhinosinusi 2026-01-06T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/what-a-successful-tiktok-brand-week-looks-like 2026-07-03T06:23:00.000Z monthly 0.5 https://feedbagel.com/post/nucala-mepolizumab-approved-in-china-for-use-in-adults-with-chronic-obstructive- 2026-01-05T12:05:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-enters-agreement-with-us-government-to-lower-drug-prices-and-expand-access-t 2025-12-19T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/exdensur-depemokimab-approved-by-us-fda-for-the-treatment-of-severe-asthma 2025-12-16T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/exdensur-depemokimab-approved-in-the-uk-for-treatment-of-asthma-with-type-2-infl 2025-12-15T16:00:00.000Z monthly 0.5 https://feedbagel.com/post/nucala-mepolizumab-receives-positive-chmp-opinion-for-treatment-of-chronic-obstr 2025-12-12T13:55:00.000Z monthly 0.5 https://feedbagel.com/post/depemokimab-receives-positive-chmp-opinion-for-severe-asthma-with-type-2-inflamm 2025-12-12T13:50:00.000Z monthly 0.5 https://feedbagel.com/post/gsks-rsv-vaccine-arexvy-receives-positive-chmp-opinion-for-all-adults-18-years-a 2025-12-12T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/blujepa-gepotidacin-approved-by-us-fda-as-oral-option-for-treatment-of-uncomplic 2025-12-11T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk227-a-b7-h3-targeted-antibody-drug-conjugate-granted-orphan-drug-designation- 2025-12-10T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-data-at-ash-show-potential-to-redefine-outcomes-for-people-living-with-blood 2025-12-01T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/tesaro-a-gsk-subsidiary-initiates-litigation-against-anaptysbio-inc 2025-11-20T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-ltz-announce-strategic-collaboration-to-advance-novel-myeloid-cell-engag 2025-11-19T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-fleming-initiative-scientists-unite-to-target-amr-with-advanced-ai 2025-11-18T06:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-presents-data-from-its-advancing-liver-pipeline-at-aasld-2025 2025-11-07T13:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-delivers-strong-q3-performance-and-upgrades-2025-guidance 2025-10-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-empirico-enter-license-agreement-for-clinical-stage-first-in-class-oligo 2025-10-28T07:05:00.000Z monthly 0.5 https://feedbagel.com/post/gsks-b7-h3-targeted-antibody-drug-conjugate-gsk227-receives-orphan-drug-designat 2025-10-28T07:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-acquires-exclusive-rights-from-syndivia-for-antibody-drug-conjugate-adc-in-p 2025-10-27T07:00:00.000Z monthly 0.5 https://feedbagel.com/post/blenrep-approved-by-us-fda-for-use-in-treatment-of-relapsedrefractory-multiple-m 2025-10-23T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-positive-pivotal-phase-iii-data-for-next-generation-low-carbon-ver 2025-10-22T07:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsks-shingrix-new-prefilled-syringe-presentation-receives-positive-chmp-opinion 2025-10-21T07:05:00.000Z monthly 0.5 https://feedbagel.com/post/positive-pivot-po-phase-iii-data-show-tebipenem-hbrs-potential-as-the-first-oral 2025-10-21T07:00:00.000Z monthly 0.5 https://feedbagel.com/post/global-fund-welcomes-renewed-commitment-from-gsk-and-viiv-healthcare-to-expand-c 2025-10-20T21:00:00.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcares-clarity-study-shows-long-acting-cabotegravir-more-acceptable-th 2025-10-15T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsks-shingrix-approved-in-china-for-prevention-of-shingles-in-adults-aged-18-and 2025-10-14T07:00:00.000Z monthly 0.5 https://feedbagel.com/post/luke-miels-appointed-ceo-designate-for-gsk 2025-09-29T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-to-submit-label-update-for-wellcovorin-leucovorin-at-us-fdas-request 2025-09-22T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-to-invest-30-billion-in-rd-and-manufacturing-in-the-united-states-over-next- 2025-09-17T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-to-showcase-new-research-from-its-broad-respiratory-portfolio-at-the-europea 2025-09-15T17:00:00.000Z monthly 0.5 https://feedbagel.com/post/gepotidacin-accepted-for-priority-review-by-the-us-fda-for-the-oral-treatment-of 2025-08-11T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-provides-update-on-us-settlement-of-curevacbiontech-mrna-patent-litigation 2025-08-08T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-delivers-continued-strong-performance 2025-07-30T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-highlights-new-findings-on-dementia-and-alzheimers-disease-at-aaic-2025-buil 2025-07-29T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-hengrui-pharma-enter-agreements-to-develop-up-to-12-innovative-medicines 2025-07-28T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/blenrep-belantamab-mafodotin-combinations-approved-in-eu-for-treatment-of-relaps 2025-07-24T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-extension-of-us-food-and-drug-administration-review-period-for-ble 2025-07-23T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-provides-update-on-us-fda-advisory-committee-review-of-blenrep-belantamab-ma 2025-07-17T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/us-fda-approves-gsks-shingrix-in-a-prefilled-syringe-presentation 2025-07-17T07:00:00.000Z monthly 0.5 https://feedbagel.com/post/us-fda-accepts-application-to-review-expanded-use-of-gsks-rsv-vaccine-arexvy-for 2025-07-14T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-extends-voluntary-licensing-agreement-with-medicines-patent-pool 2025-07-14T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-data-show-89-of-treatment-naive-people-with-hiv-choose-to-switch 2025-07-14T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-presents-new-data-demonstrating-positive-real-world-impact-of-it 2025-07-08T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-completes-acquisition-of-efimosfermin-a-potential-best-in-class-specialty-me 2025-07-07T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/price-of-worlds-first-malaria-vaccine-rtss-for-children-in-endemic-countries-to- 2025-06-25T08:00:00.000Z monthly 0.5 https://feedbagel.com/post/linerixibat-accepted-for-review-by-the-european-medicines-agency-for-cholestatic 2025-06-23T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/japans-ministry-of-health-labour-and-welfare-accepts-regulatory-application-to-e 2025-06-20T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsks-rsv-vaccine-arexvy-accepted-for-regulatory-review-by-the-european-medicines 2025-06-13T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-licenses-shigella-vaccine-candidate-to-bharat-biotech-for-continued-developm 2025-06-12T09:00:00.000Z monthly 0.5 https://feedbagel.com/post/linerixibat-new-drug-application-nda-accepted-for-review-by-the-us-fda-for-chole 2025-06-02T06:06:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-data-at-asco-and-eha-showcase-latest-research-and-innovation-across-the-onco 2025-05-29T13:54:00.000Z monthly 0.5 https://feedbagel.com/post/pivot-po-phase-iii-study-for-tebipenem-hbr-stopped-early-for-efficacy-following- 2025-05-28T09:43:00.000Z monthly 0.5 https://feedbagel.com/post/blenrep-belantamab-mafodotin-combinations-receive-positive-chmp-opinion-in-relap 2025-05-23T12:57:00.000Z monthly 0.5 https://feedbagel.com/post/nucala-mepolizumab-approved-by-us-fda-for-use-in-adults-with-chronic-obstructive 2025-05-22T13:06:00.000Z monthly 0.5 https://feedbagel.com/post/blenrep-belantamab-mafodotin-combinations-approved-in-japan-for-treatment-of-rel 2025-05-19T06:06:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-to-acquire-efimosfermin-a-phase-iii-ready-potential-best-in-class-specialty- 2025-05-14T06:10:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-provides-update-on-belrestotug-development-programme 2025-05-13T12:55:00.000Z monthly 0.5 https://feedbagel.com/post/glisten-phase-iii-trial-results-show-linerixibat-significantly-improves-cholesta 2025-05-08T10:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-continues-to-advance-the-future-of-respiratory-medicine-and-patient-care-wit 2025-05-02T12:15:00.000Z monthly 0.5 https://feedbagel.com/post/nucala-mepolizumab-delivers-clinically-meaningful-and-statistically-significant- 2025-04-30T08:17:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-makes-strong-start-to-2025-with-growth-in-sales-profits-and-earnings 2025-04-30T07:00:00.000Z monthly 0.5 https://feedbagel.com/post/blenrep-belantamab-mafodotin-combinations-approved-by-uk-mhra-in-relapsedrefract 2025-04-17T12:15:00.000Z monthly 0.5 https://feedbagel.com/post/arexvy-recommended-for-adults-aged-50-59-at-increased-risk-for-severe-respirator 2025-04-16T16:05:00.000Z monthly 0.5 https://feedbagel.com/post/gsks-5-in-1-meningococcal-vaccine-penmenvy-receives-positive-recommendation-from 2025-04-16T16:05:00.000Z monthly 0.5 https://feedbagel.com/post/blujepa-gepotidacin-approved-by-us-fda-for-treatment-of-uncomplicated-urinary-tr 2025-03-25T16:50:48.000Z monthly 0.5 https://feedbagel.com/post/gsk-uk-dementia-research-institute-uk-dri-and-health-data-research-uk-hdr-uk-to- 2025-03-25T16:01:13.000Z monthly 0.5 https://feedbagel.com/post/gsks-application-to-expand-use-of-nucala-mepolizumab-for-the-treatment-of-copd-a 2025-03-24T06:12:19.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcares-investigational-broadly-neutralising-antibody-n6ls-successfully 2025-03-12T15:44:00.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-announces-new-implementation-study-data-showing-zero-cases-of-hi 2025-03-12T15:32:33.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-showcases-leadership-in-long-acting-injectables-innovation-at-cr 2025-03-11T15:50:26.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-continues-to-deliver-long-acting-injectable-hiv-innovation-with- 2025-03-09T09:12:30.000Z monthly 0.5 https://feedbagel.com/post/gsk-to-showcase-latest-research-at-the-international-rsv-symposium-to-advance-rs 2025-03-06T10:53:44.000Z monthly 0.5 https://feedbagel.com/post/depemokimab-applications-accepted-for-review-by-the-us-fda-for-asthma-with-type- 2025-03-03T06:16:59.000Z monthly 0.5 https://feedbagel.com/post/depemokimab-delivers-clinically-meaningful-and-statistically-significant-improve 2025-03-01T13:28:02.000Z monthly 0.5 https://feedbagel.com/post/gsk-plc-commences-share-buyback-programme 2025-02-24T06:59:16.000Z monthly 0.5 https://feedbagel.com/post/gsk-completes-acquisition-of-idrx-inc 2025-02-24T06:10:07.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-dr-gavin-screaton-to-join-the-board-as-non-executive-director 2025-02-21T07:00:15.000Z monthly 0.5 https://feedbagel.com/post/nucala-mepolizumab-application-for-copd-accepted-for-review-in-china 2025-02-20T06:16:34.000Z monthly 0.5 https://feedbagel.com/post/penmenvy-gsks-5-in-1-meningococcal-vaccine-approved-by-us-fda-to-help-protect-ag 2025-02-15T15:29:09.000Z monthly 0.5 https://feedbagel.com/post/gsk-delivers-strong-2024-performance-with-further-improvement-to-long-term-growt 2025-02-05T07:00:00.000Z monthly 0.5 https://feedbagel.com/post/european-commission-authorises-viiv-healthcares-long-acting-injectable-vocabria- 2025-01-31T09:42:21.000Z monthly 0.5 https://feedbagel.com/post/depemokimab-accepted-for-review-by-the-european-medicines-agency-for-use-in-asth 2025-01-28T07:16:13.000Z monthly 0.5 https://feedbagel.com/post/depemokimab-applications-accepted-for-review-in-china-and-japan-for-asthma-with- 2025-01-28T06:14:42.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-oxford-establish-the-gsk-oxford-cancer-immuno-prevention-programme-to-ad 2025-01-27T16:15:59.000Z monthly 0.5 https://feedbagel.com/post/gsks-shingrix-new-prefilled-syringe-presentation-accepted-for-review-by-european 2025-01-27T14:25:59.000Z monthly 0.5 https://feedbagel.com/post/european-commission-expands-jemperli-dostarlimab-plus-chemotherapy-approval-to-a 2025-01-20T07:00:36.000Z monthly 0.5 https://feedbagel.com/post/gsk-enters-agreement-to-acquire-idrx-inc 2025-01-13T06:08:06.000Z monthly 0.5 https://feedbagel.com/post/gsks-shingrix-new-prefilled-syringe-presentation-accepted-for-review-by-us-fda 2025-01-10T16:55:32.000Z monthly 0.5 https://feedbagel.com/post/gsks-b7-h3-targeted-antibody-drug-conjugate-gsk227-receives-us-fda-breakthrough- 2025-01-07T07:25:11.000Z monthly 0.5 https://feedbagel.com/post/gsks-nucala-mepolizumab-approved-in-china-for-treatment-of-adults-with-chronic-r 2025-01-03T06:12:29.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-first-trial-met-its-primary-endpoint-of-progression-free-survival- 2024-12-20T07:00:51.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-announces-chmp-positive-opinion-for-vocabria-rekambys-the-first- 2024-12-16T15:05:31.000Z monthly 0.5 https://feedbagel.com/post/gsks-b7-h3-targeted-antibody-drug-conjugate-gsk227-receives-ema-priority-medicin 2024-12-16T14:39:33.000Z monthly 0.5 https://feedbagel.com/post/jemperli-dostarlimab-receives-us-fda-breakthrough-therapy-designation-for-locall 2024-12-16T07:10:08.000Z monthly 0.5 https://feedbagel.com/post/jemperli-dostarlimab-plus-chemotherapy-receives-positive-chmp-opinion-to-expand- 2024-12-16T07:00:18.000Z monthly 0.5 https://feedbagel.com/post/blenrep-shows-significant-overall-survival-benefit-reducing-the-risk-of-death-by 2024-12-09T18:30:03.000Z monthly 0.5 https://feedbagel.com/post/us-fda-accepts-gsks-submission-for-the-use-of-nucala-mepolizumab-in-copd 2024-12-09T06:11:55.000Z monthly 0.5 https://feedbagel.com/post/blenrep-belantamab-mafodotin-combination-accepted-for-priority-review-in-china-i 2024-12-09T06:10:38.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-zhifei-revise-and-extend-strategic-vaccine-collaboration-in-china 2024-12-05T06:11:22.000Z monthly 0.5 https://feedbagel.com/post/first-single-dose-medicine-for-p-vivax-malaria-prequalified-by-who-and-included- 2024-12-04T09:29:00.000Z monthly 0.5 https://feedbagel.com/post/gsks-fully-liquid-menveo-meningococcal-vaccine-approved-by-european-commission 2024-11-27T13:13:58.000Z monthly 0.5 https://feedbagel.com/post/blenrep-combinations-accepted-for-review-by-the-us-fda-for-the-treatment-of-rela 2024-11-25T07:04:12.000Z monthly 0.5 https://feedbagel.com/post/arexvy-approval-expanded-to-adults-aged-50-59-at-increased-risk-of-severe-rsv-di 2024-11-22T18:46:04.000Z monthly 0.5 https://feedbagel.com/post/statement-gsk-continues-to-show-strong-leadership-in-its-access-to-medicines-ind 2024-11-19T13:16:33.000Z monthly 0.5 https://feedbagel.com/post/linerixibat-shows-positive-phase-iii-results-in-cholestatic-pruritus-relentless- 2024-11-19T06:07:45.000Z monthly 0.5 https://feedbagel.com/post/blenrep-shows-overall-survival-benefit-in-head-to-head-dreamm-7-phase-iii-trial- 2024-11-14T06:04:13.000Z monthly 0.5 https://feedbagel.com/post/gsk-highlights-key-data-from-hepatology-portfolio-at-the-aaslds-the-liver-meetin 2024-11-13T13:55:21.000Z monthly 0.5 https://feedbagel.com/post/new-gsk-sponsored-survey-reveals-unique-gaps-in-care-and-support-facing-patients 2024-11-12T13:00:55.000Z monthly 0.5 https://feedbagel.com/post/gsk-on-track-to-deliver-2024-outlooks-with-further-good-progress-made-in-rd 2024-10-30T07:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-enters-agreement-to-acquire-cmg1a46-from-chimagen-biosciences-to-expand-immu 2024-10-29T10:50:50.000Z monthly 0.5 https://feedbagel.com/post/new-data-for-arexvy-gsks-respiratory-syncytial-virus-vaccine-show-potential-to-h 2024-10-24T12:33:51.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-cambridge-university-announce-new-five-year-collaboration-in-kidney-and- 2024-10-21T14:35:44.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-shows-more-than-99-effectiveness-in-real-world-studies-for-apret 2024-10-16T10:41:08.000Z monthly 0.5 https://feedbagel.com/post/gepotidacin-accepted-for-priority-review-by-us-fda-for-treatment-of-uncomplicate 2024-10-16T07:00:50.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-positive-phase-iii-results-from-anchor-trials-for-depemokimab-in-c 2024-10-14T06:21:26.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-viiv-healthcare-to-showcase-advances-across-industry-leading-infectious- 2024-10-10T15:15:20.000Z monthly 0.5 https://feedbagel.com/post/statement-zantac-ranitidine-litigation-settlement-agreements-reached 2024-10-09T16:26:09.000Z monthly 0.5 https://feedbagel.com/post/gsk-presents-positive-data-for-arexvy-its-respiratory-syncytial-virus-rsv-vaccin 2024-10-08T16:26:09.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-to-triple-annual-supply-of-long-acting-hiv-prep-for-low-and-midd 2024-10-07T10:26:45.000Z monthly 0.5 https://feedbagel.com/post/gsks-menveo-meningococcal-vaccine-in-new-single-vial-fully-liquid-presentation-r 2024-09-24T15:22:53.000Z monthly 0.5 https://feedbagel.com/post/statement-zantac-ranitidine-litigation-russell-and-hughes-cases 2024-09-18T14:17:01.000Z monthly 0.5 https://feedbagel.com/post/blenrep-belantamab-mafodotin-combinations-in-relapsedrefractory-multiple-myeloma 2024-09-17T07:00:09.000Z monthly 0.5 https://feedbagel.com/post/blenrep-belantamab-mafodotin-in-combination-receives-breakthrough-therapy-design 2024-09-13T07:00:16.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-positive-headline-data-from-phase-ii-seasonal-influenza-mrna-vacci 2024-09-12T06:09:08.000Z monthly 0.5 https://feedbagel.com/post/gsk-provides-update-on-phase-iii-therapeutic-herpes-simplex-virus-hsv-vaccine-tr 2024-09-11T16:00:20.000Z monthly 0.5 https://feedbagel.com/post/statement-zantac-ranitidine-litigation-dixon-case 2024-09-11T14:17:00.000Z monthly 0.5 https://feedbagel.com/post/depemokimab-late-breaking-data-presented-at-ers-show-a-54-reduction-in-severe-as 2024-09-09T14:30:08.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-positive-results-from-phase-iii-trial-of-nucala-mepolizumab-in-cop 2024-09-06T08:03:28.000Z monthly 0.5 https://feedbagel.com/post/gsk-aims-to-redefine-the-future-of-respiratory-medicine-at-the-european-respirat 2024-09-03T07:00:24.000Z monthly 0.5 https://feedbagel.com/post/european-commission-approves-expanded-age-indication-for-gsks-arexvy-the-first-r 2024-08-29T07:00:37.000Z monthly 0.5 https://feedbagel.com/post/bepirovirsen-granted-senku-designation-in-japan-for-chronic-hepatitis-b 2024-08-28T07:00:01.000Z monthly 0.5 https://feedbagel.com/post/gsks-nucala-mepolizumab-approved-in-japan-for-treatment-of-adults-with-chronic-r 2024-08-28T07:00:01.000Z monthly 0.5 https://feedbagel.com/post/statement-zantac-ranitidine-litigation-delaware-supreme-court-to-review-superior 2024-08-27T14:17:01.000Z monthly 0.5 https://feedbagel.com/post/gsk-receives-us-fda-breakthrough-therapy-designation-for-its-b7-h3-targeted-anti 2024-08-20T09:14:39.000Z monthly 0.5 https://feedbagel.com/post/statement-zantac-ranitidine-litigation-florida-state-court-daubert-ruling-in-wil 2024-08-15T16:38:44.000Z monthly 0.5 https://feedbagel.com/post/statement-zantac-ranitidine-litigation-joiner-case 2024-08-05T17:57:20.000Z monthly 0.5 https://feedbagel.com/post/us-fda-expands-jemperli-dostarlimab-plus-chemotherapy-approval-to-all-adult-pati 2024-08-01T07:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-delivers-continued-strong-performance-and-upgrades-2024-guidance 2024-07-31T07:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-presents-new-data-at-the-alzheimers-association-international-conference-202 2024-07-30T11:07:16.000Z monthly 0.5 https://feedbagel.com/post/arexvy-gsks-respiratory-syncytial-virus-rsv-vaccine-receives-positive-european-m 2024-07-29T14:43:36.000Z monthly 0.5 https://feedbagel.com/post/statement-zantac-ranitidine-litigation-kimbrow-case 2024-07-29T00:24:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-flagship-pioneering-partner-to-discover-novel-medicines-and-vaccines 2024-07-29T00:06:00.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-premieres-early-data-showing-antiviral-activity-against-integras 2024-07-23T10:45:44.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-announces-positive-data-demonstrating-2-drug-regimen-dovato-is-a 2024-07-23T10:39:40.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-announces-positive-new-data-for-apretude-use-during-pregnancy-at 2024-07-23T10:32:34.000Z monthly 0.5 https://feedbagel.com/post/blenrep-belantamab-mafodotin-combinations-in-multiple-myeloma-application-accept 2024-07-19T06:08:23.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-to-announce-data-from-largest-head-to-head-randomised-clinical-t 2024-07-15T09:06:55.000Z monthly 0.5 https://feedbagel.com/post/brazil-and-thailand-become-first-malaria-endemic-countries-to-launch-new-single- 2024-07-05T09:00:23.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-curevac-to-restructure-collaboration-into-new-licensing-agreement 2024-07-03T17:02:17.000Z monthly 0.5 https://feedbagel.com/post/statement-zantac-ranitidine-litigation-gross-case 2024-06-28T12:38:48.000Z monthly 0.5 https://feedbagel.com/post/statement-us-centers-for-disease-control-and-preventions-advisory-committee-on-i 2024-06-26T19:29:19.000Z monthly 0.5 https://feedbagel.com/post/jemperli-dostarlimab-plus-chemotherapy-application-accepted-for-review-by-the-eu 2024-06-24T06:16:26.000Z monthly 0.5 https://feedbagel.com/post/gsks-omjjara-momelotinib-approved-in-japan-for-treatment-of-myelofibrosis 2024-06-24T06:01:14.000Z monthly 0.5 https://feedbagel.com/post/statement-zantac-ranitidine-litigation-kasza-case 2024-06-10T18:03:48.000Z monthly 0.5 https://feedbagel.com/post/statement-zantac-ranitidine-litigation-gsk-starts-process-for-appeal-of-recent-d 2024-06-10T16:34:32.000Z monthly 0.5 https://feedbagel.com/post/us-fda-approves-expanded-age-indication-for-gsks-arexvy-the-first-respiratory-sy 2024-06-07T13:01:49.000Z monthly 0.5 https://feedbagel.com/post/gsk-accelerates-oligonucleotide-platform-and-pipeline-medicines-with-acquisition 2024-06-06T11:54:25.000Z monthly 0.5 https://feedbagel.com/post/jemperli-dostarlimab-trial-continues-to-show-unprecedented-results-with-no-evide 2024-06-03T13:00:04.000Z monthly 0.5 https://feedbagel.com/post/blenrep-combination-reduced-the-risk-of-disease-progression-or-death-by-nearly-5 2024-06-02T15:46:40.000Z monthly 0.5 https://feedbagel.com/post/statement-zantac-ranitidine-litigation-delaware-state-court-daubert-ruling 2024-06-01T09:38:36.000Z monthly 0.5 https://feedbagel.com/post/statement-zantac-ranitidine-litigation-valadez-and-williams-cases 2024-05-23T13:44:13.000Z monthly 0.5 https://feedbagel.com/post/new-data-at-asco-showcases-the-transformational-potential-of-gsks-oncology-portf 2024-05-23T13:19:38.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-positive-results-from-phase-iii-severe-asthma-trials-of-depemokima 2024-05-21T06:33:29.000Z monthly 0.5 https://feedbagel.com/post/gsk-to-become-a-founding-partner-of-fleming-initiative-to-fight-antimicrobial-re 2024-05-16T00:01:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-makes-a-strong-start-to-2024-with-improving-outlook-for-the-year 2024-05-01T07:00:00.000Z monthly 0.5 https://feedbagel.com/post/us-fda-accepts-for-priority-review-gsks-application-for-an-expanded-indication-o 2024-04-24T07:00:00.000Z monthly 0.5 https://feedbagel.com/post/eagle-1-phase-iii-data-show-potential-for-gepotidacin-as-a-new-oral-treatment-op 2024-04-17T07:02:00.000Z monthly 0.5 https://feedbagel.com/post/new-long-term-data-show-shingrix-continues-to-provide-high-protection-against-sh 2024-04-17T07:00:33.000Z monthly 0.5 https://feedbagel.com/post/gsks-5-in-1-meningococcal-abcwy-vaccine-candidate-accepted-for-regulatory-review 2024-04-16T20:34:46.000Z monthly 0.5 https://feedbagel.com/post/positive-ruby-phase-iii-data-show-potential-for-jemperli-dostarlimab-combination 2024-03-16T09:43:06.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-positive-results-from-dreamm-8-phase-iii-trial-for-blenrep-versus- 2024-03-07T05:34:15.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-announces-interim-data-at-croi-indicating-superior-efficacy-of-l 2024-03-06T13:14:01.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-presents-phase-i-clinical-trial-findings-of-a-cabotegravir-long- 2024-03-04T12:32:24.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-dr-jeannie-lee-to-join-the-board-as-non-executive-director 2024-02-29T06:53:49.000Z monthly 0.5 https://feedbagel.com/post/statement-zantac-ranitidine-litigation 2024-02-29T06:21:29.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-to-present-data-for-its-next-generation-of-ultra-long-acting-tre 2024-02-28T12:32:24.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-positive-headline-results-from-eagle-1-phase-iii-trial-for-gepotid 2024-02-26T06:16:11.000Z monthly 0.5 https://feedbagel.com/post/latitude-phase-iii-interim-trial-data-indicates-viiv-healthcares-long-acting-inj 2024-02-21T18:25:12.000Z monthly 0.5 https://feedbagel.com/post/gsk-completes-acquisition-of-aiolos-bio 2024-02-15T06:15:59.000Z monthly 0.5 https://feedbagel.com/post/gsk-receives-us-fda-fast-track-designation-for-bepirovirsen-in-chronic-hepatitis 2024-02-12T06:26:44.000Z monthly 0.5 https://feedbagel.com/post/gsks-rsv-vaccine-arexvy-accepted-under-priority-review-in-us-for-the-prevention- 2024-02-06T14:39:50.000Z monthly 0.5 https://feedbagel.com/post/gsks-regulatory-application-for-shingrix-for-the-prevention-of-shingles-in-at-ri 2024-02-06T11:07:34.000Z monthly 0.5 https://feedbagel.com/post/dreamm-7-phase-iii-trial-shows-blenrep-combination-nearly-tripled-median-progres 2024-02-05T16:36:20.000Z monthly 0.5 https://feedbagel.com/post/statement-zantac-ranitidine-litigation-2 2024-02-01T07:01:27.000Z monthly 0.5 https://feedbagel.com/post/gsk-delivers-strong-2023-performance-and-upgrades-growth-outlooks 2024-01-31T07:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsks-rsv-vaccine-arexvy-accepted-for-regulatory-review-by-the-european-medicines-2 2024-01-29T19:19:25.000Z monthly 0.5 https://feedbagel.com/post/european-commission-authorises-gsks-omjjara-momelotinib 2024-01-29T05:45:31.000Z monthly 0.5 https://feedbagel.com/post/nucala-mepolizumab-approved-in-china-for-use-in-severe-asthma-with-an-eosinophil 2024-01-10T07:02:56.000Z monthly 0.5 https://feedbagel.com/post/gsk-enters-agreement-to-acquire-aiolos-bio 2024-01-09T06:33:03.000Z monthly 0.5 https://feedbagel.com/post/gsk-enters-exclusive-license-agreement-with-hansoh-for-hs-20093 2023-12-20T12:00:09.000Z monthly 0.5 https://feedbagel.com/post/jemperli-dostarlimab-plus-zejula-niraparib-combination-significantly-improved-pr 2023-12-18T05:46:38.000Z monthly 0.5 https://feedbagel.com/post/japans-ministry-of-health-labour-and-welfare-accepts-arexvy-rsv-vaccine-regulato 2023-12-12T05:57:29.000Z monthly 0.5 https://feedbagel.com/post/gsks-jemperli-dostarlimab-plus-chemotherapy-approved-as-the-first-and-only-front 2023-12-11T14:51:56.000Z monthly 0.5 https://feedbagel.com/post/new-global-analysis-across-five-cities-shows-inequities-in-adult-immunisation-up 2023-12-06T16:38:31.000Z monthly 0.5 https://feedbagel.com/post/new-global-survey-finds-widespread-misunderstandings-about-shingles-despite-its- 2023-11-30T08:31:21.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-positive-results-from-dreamm-7-head-to-head-phase-iii-trial-for-bl 2023-11-27T06:36:54.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-major-step-towards-sustainability-ambitions-with-advancement-of-lo 2023-11-21T08:00:35.000Z monthly 0.5 https://feedbagel.com/post/gsk-receives-positive-chmp-opinion-recommending-momelotinib-for-myelofibrosis-pa 2023-11-13T17:23:12.000Z monthly 0.5 https://feedbagel.com/post/strong-year-to-date-and-q3-performance-drives-upgrade-to-full-year-guidance 2023-11-01T07:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-enters-agreement-to-obtain-exclusive-license-for-jnj-3989-to-expand-the-deve 2023-10-31T10:36:20.000Z monthly 0.5 https://feedbagel.com/post/phase-iii-ruby-trial-of-jemperli-dostarlimab-plus-chemotherapy-meets-endpoint-of 2023-10-30T06:32:06.000Z monthly 0.5 https://feedbagel.com/post/gsk-launches-6m-programme-to-boost-stem-career-progression-for-young-people-from 2023-10-27T08:00:00.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-receives-approval-from-chinas-national-medical-products-administ 2023-10-26T07:04:27.000Z monthly 0.5 https://feedbagel.com/post/new-data-for-arexvy-gsks-rsv-vaccine-show-potential-to-help-protect-adults-aged- 2023-10-25T17:36:47.000Z monthly 0.5 https://feedbagel.com/post/gsk-enters-exclusive-license-agreement-with-hansoh-for-hs-20089 2023-10-20T11:28:53.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-to-present-23-abstracts-from-innovative-hiv-treatment-and-preven 2023-10-18T09:58:58.000Z monthly 0.5 https://feedbagel.com/post/gsk-highlights-new-data-in-non-small-cell-lung-cancer-and-endometrial-cancer-at- 2023-10-17T17:26:13.000Z monthly 0.5 https://feedbagel.com/post/gsk-receives-positive-chmp-opinion-recommending-approval-of-jemperli-dostarlimab 2023-10-16T09:58:24.000Z monthly 0.5 https://feedbagel.com/post/gsk-presents-scientific-advances-to-improve-patient-outcomes-at-the-american-ass 2023-10-11T10:53:02.000Z monthly 0.5 https://feedbagel.com/post/statement-zantac-ranitidine-litigation-3 2023-10-11T07:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-viiv-healthcare-to-present-scientific-advancements-in-their-industry-lea 2023-10-10T10:43:45.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-zhifei-announce-exclusive-strategic-vaccine-partnership-in-china 2023-10-09T17:57:53.000Z monthly 0.5 https://feedbagel.com/post/gsk-survey-finds-parents-know-less-about-meningitis-compared-to-some-other-child 2023-10-05T18:00:17.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-wendy-becker-to-join-the-board-as-non-executive-director 2023-09-27T15:00:00.000Z monthly 0.5 https://feedbagel.com/post/japans-ministry-of-health-labour-and-welfare-approves-gsks-arexvy-the-countrys-f 2023-09-25T06:59:59.000Z monthly 0.5 https://feedbagel.com/post/european-commission-authorises-viiv-healthcares-apretude-cabotegravir-long-actin 2023-09-19T14:59:57.000Z monthly 0.5 https://feedbagel.com/post/ojjaara-momelotinib-approved-in-the-us-as-the-first-and-only-treatment-indicated 2023-09-15T20:48:55.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-save-the-children-renew-award-winning-partnership-with-focus-on-zero-dos 2023-09-14T08:00:17.000Z monthly 0.5 https://feedbagel.com/post/gsk-regulatory-submission-for-momelotinib-for-the-treatment-of-myelofibrosis-acc 2023-09-11T07:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsks-regulatory-submission-accepted-for-review-by-japanese-regulator-for-use-of- 2023-09-01T06:55:44.000Z monthly 0.5 https://feedbagel.com/post/new-shingrix-data-demonstrate-100-vaccine-efficacy-in-the-prevention-of-shingles 2023-08-23T06:34:42.000Z monthly 0.5 https://feedbagel.com/post/new-research-published-in-science-highlights-potential-of-a-naturally-occurring- 2023-08-03T19:02:58.000Z monthly 0.5 https://feedbagel.com/post/jemperli-dostarlimab-plus-chemotherapy-approved-in-the-us-as-the-first-new-front 2023-07-31T18:14:20.000Z monthly 0.5 https://feedbagel.com/post/strong-performance-and-momentum-drive-upgraded-guidance 2023-07-26T07:00:00.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcares-cabotegravir-for-hiv-prevention-receives-positive-chmp-opinion- 2023-07-24T17:16:07.000Z monthly 0.5 https://feedbagel.com/post/new-analysis-shows-lost-ground-on-adult-immunisation-during-the-pandemic-with-10 2023-07-19T09:02:55.000Z monthly 0.5 https://feedbagel.com/post/medicines-and-healthcare-products-regulatory-agency-authorises-gsks-arexvy-the-f 2023-07-10T08:21:20.000Z monthly 0.5 https://feedbagel.com/post/gsk-completes-acquisition-of-bellus-health 2023-06-28T16:19:30.000Z monthly 0.5 https://feedbagel.com/post/gsk-receives-us-fda-fast-track-designation-for-investigational-vaccine-against-g 2023-06-27T06:02:50.000Z monthly 0.5 https://feedbagel.com/post/japans-ministry-of-health-labour-and-welfare-approves-shingrix-for-the-preventio 2023-06-26T07:02:24.000Z monthly 0.5 https://feedbagel.com/post/gsk-receives-positive-chmp-opinion-recommending-authorisation-of-daprodustat-for 2023-06-26T07:02:17.000Z monthly 0.5 https://feedbagel.com/post/statement-zantac-ranitidine-litigation-4 2023-06-23T07:01:04.000Z monthly 0.5 https://feedbagel.com/post/us-centers-for-disease-control-and-preventions-advisory-committee-on-immunizatio 2023-06-22T19:23:41.000Z monthly 0.5 https://feedbagel.com/post/gsk-shares-positive-data-for-arexvy-its-respiratory-syncytial-virus-rsv-older-ad 2023-06-21T06:37:50.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-extension-of-fda-review-period-for-momelotinib 2023-06-16T06:16:21.000Z monthly 0.5 https://feedbagel.com/post/european-commission-authorises-gsks-arexvy-the-first-respiratory-syncytial-virus 2023-06-07T16:28:39.000Z monthly 0.5 https://feedbagel.com/post/gsk-receives-us-fda-file-acceptance-for-jemperli-dostarlimab-plus-chemotherapy-f 2023-06-06T07:04:03.000Z monthly 0.5 https://feedbagel.com/post/gsk-presents-pivotal-data-at-espid-confirming-effectiveness-of-its-5-in-1-mening 2023-05-12T07:57:05.000Z monthly 0.5 https://feedbagel.com/post/statement-zantac-ranitidine-litigation-5 2023-05-12T06:53:22.000Z monthly 0.5 https://feedbagel.com/post/us-fda-approves-gsks-arexvy-the-worlds-first-respiratory-syncytial-virus-rsv-vac 2023-05-03T16:31:05.000Z monthly 0.5 https://feedbagel.com/post/gsks-respiratory-syncytial-virus-older-adult-vaccine-candidate-gains-positive-eu 2023-04-27T16:34:48.000Z monthly 0.5 https://feedbagel.com/post/gsk-momentum-continues-with-strong-start-to-2023 2023-04-26T07:00:00.000Z monthly 0.5 https://feedbagel.com/post/european-medicines-agency-validates-marketing-authorisation-application-for-jemp 2023-04-25T07:01:26.000Z monthly 0.5 https://feedbagel.com/post/gsk-reaches-agreement-to-acquire-late-stage-biopharmaceutical-company-bellus-hea 2023-04-18T08:19:22.000Z monthly 0.5 https://feedbagel.com/post/gepotidacins-positive-phase-iii-data-shows-potential-to-be-the-first-in-a-new-cl 2023-04-15T10:38:48.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-scynexis-announce-an-exclusive-agreement-to-commercialise-and-further-de 2023-03-30T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/medicines-patent-pool-signs-sublicences-with-aurobindo-cipla-and-viatris-to-prod 2023-03-30T07:00:42.000Z monthly 0.5 https://feedbagel.com/post/phase-iii-ruby-clinical-trial-demonstrates-potential-of-jemperli-dostarlimab-plu 2023-03-27T17:00:48.000Z monthly 0.5 https://feedbagel.com/post/statement-zantac-ranitidine-litigation-6 2023-03-24T10:00:00.000Z monthly 0.5 https://feedbagel.com/post/china-national-medical-products-administration-accepts-regulatory-submission-for 2023-03-14T11:25:40.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-positive-pivotal-phase-iii-data-for-5-in-1-meningococcal-abcwy-vac 2023-03-14T06:08:26.000Z monthly 0.5 https://feedbagel.com/post/us-fda-advisory-committee-votes-to-support-effectiveness-and-safety-of-gsks-resp 2023-03-01T15:17:05.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-announces-positive-data-demonstrating-long-acting-injectable-cab 2023-02-23T06:57:48.000Z monthly 0.5 https://feedbagel.com/post/amazing-ex-footballer-visits-town-on-episode-of-hit-bbc-show 2026-07-08T17:00:00.000Z monthly 0.5 https://feedbagel.com/post/landmark-new-england-journal-of-medicine-publication-reinforces-potential-of-gsk 2023-02-15T13:58:48.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-to-present-first-head-to-head-data-for-long-acting-hiv-treatment 2023-02-14T14:00:00.000Z monthly 0.5 https://feedbagel.com/post/worcestershire-pub-reopens-after-130000-investment 2026-07-08T17:00:00.000Z monthly 0.5 https://feedbagel.com/post/us-fda-grants-regular-approval-for-jemperli-for-the-treatment-of-patients-with-r 2023-02-10T07:48:47.000Z monthly 0.5 https://feedbagel.com/post/transport-service-welcomes-new-trustee-and-launches-search-for-fundraiser 2026-07-08T15:00:00.000Z monthly 0.5 https://feedbagel.com/post/kidderminster-pride-event-cancelled-due-to-significant-running-costs 2026-07-08T11:05:18.000Z monthly 0.5 https://feedbagel.com/post/floral-tributes-and-cards-left-at-boat-in-memory-of-amazing-man 2026-07-08T04:26:00.000Z monthly 0.5 https://feedbagel.com/post/us-fda-advisory-committee-votes-in-support-of-trials-designed-to-evaluate-jemper 2023-02-09T23:22:03.000Z monthly 0.5 https://feedbagel.com/post/forecast-reveals-how-hot-it-will-get-across-worcestershire-and-black-country 2026-07-08T17:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-results-from-17-year-retrospective-study-on-us-clinical-trial-dive 2023-02-06T12:00:55.000Z monthly 0.5 https://feedbagel.com/post/worcestershire-hero-ends-honeymoon-on-a-high-by-watching-england-win-at-azteca 2026-07-08T11:00:00.000Z monthly 0.5 https://feedbagel.com/post/jesduvroq-daprodustat-approved-by-us-fda-for-anaemia-of-chronic-kidney-disease-i 2023-02-01T13:57:25.000Z monthly 0.5 https://feedbagel.com/post/road-closed-due-to-likelihood-of-danger-caused-by-burst-water-main 2026-07-08T08:41:15.000Z monthly 0.5 https://feedbagel.com/post/investigation-finds-serious-and-unacceptable-breaches-by-severn-trent-water 2026-07-08T07:44:11.000Z monthly 0.5 https://feedbagel.com/post/gsk-delivers-strong-2022-performance-with-full-year-sales-of-293-billion-19-aer- 2023-02-01T07:00:00.000Z monthly 0.5 https://feedbagel.com/post/woman-taken-to-hospital-after-incident-near-lincomb-lock 2026-07-08T15:54:22.000Z monthly 0.5 https://feedbagel.com/post/benlysta-granted-orphan-drug-designation-by-us-fda-for-the-potential-treatment-o 2023-02-01T02:37:35.000Z monthly 0.5 https://feedbagel.com/post/reports-of-emergency-services-at-river-severn-in-stourport 2026-07-08T13:31:17.000Z monthly 0.5 https://feedbagel.com/post/vidprevtyn-beta-covid-19-booster-vaccine-developed-by-sanofi-and-gsk-approved-fo 2022-12-21T15:45:54.000Z monthly 0.5 https://feedbagel.com/post/i-made-biscoff-ice-cream-with-2-ingredients-and-no-fancy-machines-its-to-die-for 2026-07-08T12:07:26.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-wave-life-sciences-announce-collaboration-to-drive-discovery-and-develop 2022-12-13T09:27:31.000Z monthly 0.5 https://feedbagel.com/post/warning-to-uk-coffee-drinkers-as-prices-wont-fall-for-at-least-two-years 2026-07-08T10:36:36.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-new-global-headquarters-in-central-london 2022-12-12T13:00:00.000Z monthly 0.5 https://feedbagel.com/post/towns-multistorey-car-park-closed-for-several-days-as-new-operator-takes-over 2026-07-07T17:00:00.000Z monthly 0.5 https://feedbagel.com/post/incredible-line-up-of-guests-announced-for-this-years-bewdley-festival 2026-07-07T15:00:00.000Z monthly 0.5 https://feedbagel.com/post/new-data-at-ash-underscore-the-potential-for-durable-clinically-important-respon 2022-12-11T17:15:28.000Z monthly 0.5 https://feedbagel.com/post/trial-of-bewdley-man-accused-of-fraud-and-handling-stolen-caravans-dropped 2026-07-07T15:00:00.000Z monthly 0.5 https://feedbagel.com/post/perla-phase-ii-trial-of-jemperli-dostarlimab-plus-chemotherapy-shows-positive-re 2022-12-07T17:45:25.000Z monthly 0.5 https://feedbagel.com/post/bomb-squad-called-after-unexploded-device-found-in-property 2026-07-07T13:51:26.000Z monthly 0.5 https://feedbagel.com/post/as-it-happened-police-cordon-in-place-after-unexploded-device-found 2026-07-07T13:49:18.000Z monthly 0.5 https://feedbagel.com/post/statement-zantac-ranitidine-litigation-7 2022-12-07T06:18:45.000Z monthly 0.5 https://feedbagel.com/post/mums-plea-as-autistic-son-left-without-school-place-for-september 2026-07-07T11:00:00.000Z monthly 0.5 https://feedbagel.com/post/jemperli-dostarlimab-ruby-phase-iii-trial-met-its-primary-endpoint-in-a-planned- 2022-12-02T18:42:20.000Z monthly 0.5 https://feedbagel.com/post/bbc-filming-hit-detective-tv-show-at-worcestershire-pub 2026-07-07T17:00:00.000Z monthly 0.5 https://feedbagel.com/post/european-medicines-agency-accepts-marketing-authorisation-application-for-momelo 2022-12-02T07:07:59.000Z monthly 0.5 https://feedbagel.com/post/new-lettings-manager-appointed-at-halls-in-kidderminster 2026-07-07T04:06:00.000Z monthly 0.5 https://feedbagel.com/post/new-global-survey-reveals-opportunities-to-address-organ-damage-risk-with-people 2022-11-29T17:04:17.000Z monthly 0.5 https://feedbagel.com/post/rare-locomotive-joins-severn-valley-railway-gala 2026-07-07T04:02:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-provides-an-update-on-blenrep-belantamab-mafodotin-blmf-us-marketing-authori 2022-11-22T06:28:21.000Z monthly 0.5 https://feedbagel.com/post/regional-honours-for-landmark-kidderminster-restoration 2026-07-07T04:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-tops-access-to-medicine-index-atmi-for-eighth-consecutive-time 2022-11-15T13:00:00.000Z monthly 0.5 https://feedbagel.com/post/nigel-farage-resigns-as-mp-to-trigger-clacton-by-election-amid-donations-row-3 2026-07-07T14:15:10.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-positive-phase-iia-study-results-for-a-new-first-in-class-candidat 2022-11-14T11:03:30.000Z monthly 0.5 https://feedbagel.com/post/tesco-announces-major-change-to-grocery-delivery-slots-ahead-of-summer-holidays 2026-07-07T10:40:15.000Z monthly 0.5 https://feedbagel.com/post/gsk-provides-an-update-on-zejula-niraparib-us-prescribing-information 2022-11-11T07:00:45.000Z monthly 0.5 https://feedbagel.com/post/tributes-to-amazing-coffee-bar-owner-with-infectious-smile-who-has-died-aged-63 2026-07-06T17:00:00.000Z monthly 0.5 https://feedbagel.com/post/positive-data-for-bepirovirsen-from-b-clear-phase-iib-trial-presented-at-america 2022-11-08T14:58:15.000Z monthly 0.5 https://feedbagel.com/post/three-men-charged-with-burglary-offences 2026-07-06T11:23:37.000Z monthly 0.5 https://feedbagel.com/post/school-celebrates-unforgettable-100-year-anniversary 2026-07-06T11:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-provides-update-on-dreamm-3-phase-iii-trial-for-blenrep-in-relapsedrefractor 2022-11-07T06:25:10.000Z monthly 0.5 https://feedbagel.com/post/public-toilets-temporarily-closed-due-to-blockage 2026-07-06T10:15:44.000Z monthly 0.5 https://feedbagel.com/post/eagle-2-and-eagle-3-phase-iii-trials-for-gepotidacin-stopped-early-for-efficacy- 2022-11-03T07:02:29.000Z monthly 0.5 https://feedbagel.com/post/yellow-heat-health-alert-for-the-west-midlands-as-temperatures-expected-to-reach 2026-07-06T08:49:24.000Z monthly 0.5 https://feedbagel.com/post/gsks-respiratory-syncytial-virus-older-adult-vaccine-candidate-granted-priority- 2022-11-02T07:00:00.000Z monthly 0.5 https://feedbagel.com/post/member-of-popular-boyband-performs-in-worcestershire-town 2026-07-06T17:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-delivers-strong-q3-2022-sales-of-78-billion-18-aer-9-cer-and-total-eps-2559p 2022-11-02T07:00:00.000Z monthly 0.5 https://feedbagel.com/post/car-park-to-close-as-part-of-ongoing-improvement-works 2026-07-06T11:00:00.000Z monthly 0.5 https://feedbagel.com/post/european-medicines-agency-validates-viiv-healthcares-marketing-authorisation-app 2022-10-28T07:00:17.000Z monthly 0.5 https://feedbagel.com/post/1940s-event-called-fabulous-despite-disappointment-after-german-military-outfit- 2026-07-06T05:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-marketing-authorisation-application-for-respiratory-syncytial-virus-older-ad 2022-10-28T07:00:00.000Z monthly 0.5 https://feedbagel.com/post/karate-star-vows-to-make-late-dad-proud-after-world-championship-selection 2026-07-06T04:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-provides-update-on-contrast-phase-iii-programme-for-otilimab-in-the-treatmen 2022-10-27T07:00:00.000Z monthly 0.5 https://feedbagel.com/post/first-kidderminster-jigsaw-jam-proves-a-puzzle-solving-success 2026-07-06T15:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-reports-outcome-from-us-fda-advisory-committee-meeting-on-daprodustat-for-an 2022-10-27T00:27:58.000Z monthly 0.5 https://feedbagel.com/post/when-is-the-next-heatwave-parts-of-the-uk-to-see-temperatures-hit-34c-in-july-2 2026-07-06T14:11:00.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-presents-positive-proof-of-concept-findings-for-n6ls-an-investig 2022-10-25T15:00:00.000Z monthly 0.5 https://feedbagel.com/post/uk-shoppers-spot-new-tango-flavour-on-supermarket-shelves-that-is-best-ever 2026-07-06T12:28:56.000Z monthly 0.5 https://feedbagel.com/post/gsk-regulatory-submission-accepted-by-japanese-regulator-for-respiratory-syncyti 2022-10-21T07:00:00.000Z monthly 0.5 https://feedbagel.com/post/cadbury-confirms-it-has-shrunk-2-popular-products-in-move-dubbed-a-last-resort 2026-07-06T10:14:58.000Z monthly 0.5 https://feedbagel.com/post/new-data-show-shingrix-can-provide-at-least-10-years-of-protection-against-shing 2022-10-19T13:00:00.000Z monthly 0.5 https://feedbagel.com/post/boots-launches-new-oral-wegovy-weight-loss-pill-from-79-as-thousands-sign-up-2 2026-07-06T10:10:39.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-expanded-collaboration-with-tempus-in-precision-medicine-to-accele 2022-10-18T06:25:21.000Z monthly 0.5 https://feedbagel.com/post/aldi-5-vouchers-to-cover-england-fans-coffee-this-morning-but-act-quick 2026-07-06T10:09:36.000Z monthly 0.5 https://feedbagel.com/post/us-fda-approves-menveo-in-a-new-single-vial-presentation-to-help-prevent-disease 2022-10-17T07:00:00.000Z monthly 0.5 https://feedbagel.com/post/search-for-businesses-to-take-on-towns-post-office-service-amid-closure 2026-07-05T17:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsks-older-adult-respiratory-syncytial-virus-rsv-vaccine-candidate-shows-941-red 2022-10-13T06:22:40.000Z monthly 0.5 https://feedbagel.com/post/travel-agent-opens-doors-to-new-branch-inside-town-supermarket 2026-07-05T11:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-to-present-updates-on-its-industry-leading-infectious-disease-portfolio-at-i 2022-10-12T13:00:00.000Z monthly 0.5 https://feedbagel.com/post/new-gripping-channel-5-drama-to-explore-notorious-1990s-worcestershire-murder 2026-07-05T15:00:00.000Z monthly 0.5 https://feedbagel.com/post/youth-clubs-international-tournament-hopes-as-england-lift-1966-world-cup 2026-07-05T11:00:00.000Z monthly 0.5 https://feedbagel.com/post/us-fda-approves-boostrix-for-immunisation-during-pregnancy-for-the-prevention-of 2022-10-10T07:00:00.000Z monthly 0.5 https://feedbagel.com/post/i-tried-kidderminsters-new-nandos-and-this-is-what-i-thought 2026-07-05T05:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-positive-headline-results-from-perla-the-phase-ii-trial-of-jemperl 2022-10-05T07:00:00.000Z monthly 0.5 https://feedbagel.com/post/stourport-residents-urged-to-check-for-faster-full-fibre-broadband 2026-07-05T15:00:00.000Z monthly 0.5 https://feedbagel.com/post/iain-mackay-chief-financial-officer-to-retire-from-gsk-julie-brown-appointed-as- 2022-09-26T07:00:00.000Z monthly 0.5 https://feedbagel.com/post/kidderminster-theatre-students-land-west-end-and-touring-roles 2026-07-05T04:00:00.000Z monthly 0.5 https://feedbagel.com/post/oncologic-drugs-advisory-committee-to-review-zejula-overall-survival-data-from-t 2022-09-22T14:00:00.000Z monthly 0.5 https://feedbagel.com/post/delays-likely-as-busy-ring-road-in-town-set-to-close 2026-07-04T17:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-spero-therapeutics-announce-exclusive-licence-agreement-for-tebipenem-hb 2022-09-22T07:00:00.000Z monthly 0.5 https://feedbagel.com/post/club-launch-petition-over-plan-to-buy-part-of-country-park-amid-resident-concern 2026-07-04T17:00:00.000Z monthly 0.5 https://feedbagel.com/post/list-of-pubs-where-you-can-watch-mexico-v-england-in-wyre-forest 2026-07-04T15:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-microsoft-in-collaboration-with-the-centre-for-health-and-disease-studie 2022-09-21T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-launches-sustainable-procurement-programme-for-suppliers 2022-09-20T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/zejula-niraparib-shows-durable-and-sustained-long-term-progression-free-survival 2022-09-09T13:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-update-on-us-fda-regulatory-review-of-daprodustat-in-anaemia-of-ch 2022-09-06T13:00:00.000Z monthly 0.5 https://feedbagel.com/post/who-grants-prequalification-to-gsks-mosquirix-the-first-and-only-approved-malari 2022-09-06T12:00:10.000Z monthly 0.5 https://feedbagel.com/post/gsk-to-highlight-the-latest-advances-in-cancer-research-from-across-its-portfoli 2022-09-01T07:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-board-changes 2022-08-24T06:57:22.000Z monthly 0.5 https://feedbagel.com/post/us-fda-accepts-new-drug-application-for-gsks-momelotinib-for-the-treatment-of-my 2022-08-17T07:00:00.000Z monthly 0.5 https://feedbagel.com/post/statement-zantac-ranitidine-us-litigation 2022-08-16T18:05:56.000Z monthly 0.5 https://feedbagel.com/post/gsk-completes-acquisition-of-affinivax-inc 2022-08-16T01:20:09.000Z monthly 0.5 https://feedbagel.com/post/statement-zantac-ranitidine-litigation-8 2022-08-11T14:45:26.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-offer-to-repurchase-exchangeable-senior-notes-due-2023 2022-08-03T01:36:01.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-and-the-medicines-patent-pool-sign-new-voluntary-licensing-agree 2022-07-28T09:48:06.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-announces-new-data-at-aids-2022-from-unblinded-phase-of-hptn-084 2022-07-28T09:27:56.000Z monthly 0.5 https://feedbagel.com/post/gsk-signs-agreement-to-support-pandemic-preparedness-in-europe 2022-07-28T06:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-delivers-strong-q2-2022-sales-of-69-billion-19-at-aer-13-at-cer-and-total-ep 2022-07-27T06:46:37.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-to-present-new-data-from-innovative-hiv-treatment-and-prevention 2022-07-25T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/board-and-committee-changes 2022-07-22T16:00:00.000Z monthly 0.5 https://feedbagel.com/post/completion-of-gsk-share-consolidation 2022-07-18T15:54:10.000Z monthly 0.5 https://feedbagel.com/post/completion-of-the-demerger-of-haleon-and-share-consolidation-of-gsk 2022-07-18T07:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-gathers-global-experts-to-discuss-role-of-vaccines-in-protecting-people-and- 2022-07-07T14:41:09.000Z monthly 0.5 https://feedbagel.com/post/result-of-general-meeting 2022-07-06T14:30:07.000Z monthly 0.5 https://feedbagel.com/post/gsk-completes-acquisition-of-sierra-oncology 2022-07-01T15:19:34.000Z monthly 0.5 https://feedbagel.com/post/gsk-selects-target-the-future-grant-recipient-in-innovation-challenge-supporting 2022-06-29T15:54:06.000Z monthly 0.5 https://feedbagel.com/post/japans-ministry-of-health-labour-and-welfare-accepts-shingrix-regulatory-submiss 2022-06-28T15:41:25.000Z monthly 0.5 https://feedbagel.com/post/gsk-presents-promising-new-data-for-bepirovirsen-an-investigational-treatment-fo 2022-06-25T12:36:56.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-1-billion-rd-investment-over-ten-years-to-get-ahead-of-infectious- 2022-06-23T10:35:37.000Z monthly 0.5 https://feedbagel.com/post/gsk-to-present-new-data-from-the-b-clear-phase-iib-trial-for-bepirovirsen-in-chr 2022-06-15T15:25:51.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-positive-pivotal-phase-iii-data-for-its-respiratory-syncytial-viru 2022-06-10T18:14:28.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-us-fda-approval-of-priorix-for-the-prevention-of-measles-mumps-and 2022-06-06T18:10:21.000Z monthly 0.5 https://feedbagel.com/post/update-proposed-demerger-of-the-consumer-healthcare-business-from-gsk-to-form-ha 2022-06-01T18:00:27.000Z monthly 0.5 https://feedbagel.com/post/gsk-publishes-prospectus-and-circular-for-proposed-demerger-of-its-consumer-heal 2022-06-01T14:22:57.000Z monthly 0.5 https://feedbagel.com/post/gsk-to-acquire-clinical-stage-biopharmaceutical-company-affinivax-inc 2022-05-31T17:53:51.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-announces-marketing-approval-by-japans-ministry-of-health-labour 2022-05-31T17:24:42.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-further-appointments-to-designate-haleon-board 2022-05-30T16:58:35.000Z monthly 0.5 https://feedbagel.com/post/china-approves-cervarix-two-dose-vaccine-schedule-for-girls-aged-9-to-14-against 2022-05-27T17:38:58.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-commits-to-grant-voluntary-licence-for-patents-relating-to-cabot 2022-05-27T10:57:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-unveils-latest-research-advances-demonstrating-strength-of-its-portfolio-and 2022-05-26T11:49:45.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-dr-vishal-sikka-to-join-the-board-as-non-executive-director 2022-05-04T10:00:00.000Z monthly 0.5 https://feedbagel.com/post/sk-bioscience-and-gsks-adjuvanted-covid-19-vaccine-candidate-meets-coprimary-obj 2022-04-29T08:24:03.000Z monthly 0.5 https://feedbagel.com/post/gsk-delivers-strong-q1-2022-sales-of-98-billion-32-aer-32-cer-total-eps-359p-67- 2022-04-27T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/us-food-and-drug-administration-accepts-new-drug-application-for-daprodustat 2022-04-19T06:33:32.000Z monthly 0.5 https://feedbagel.com/post/gsk-reaches-agreement-to-acquire-late-stage-biopharmaceutical-company-sierra-onc 2022-04-13T06:35:13.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-announces-us-fda-approval-of-triumeq-pd-the-first-dispersible-si 2022-03-30T14:06:29.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-announces-label-update-for-its-long-acting-hiv-treatment-cabenuv 2022-03-24T13:49:51.000Z monthly 0.5 https://feedbagel.com/post/gsk-to-demonstrate-its-commitment-to-improving-outcomes-for-patients-with-gynaec 2022-03-15T11:47:57.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-appointments-to-designate-haleon-board 2022-03-15T10:00:00.000Z monthly 0.5 https://feedbagel.com/post/european-medicines-agency-ema-accepts-marketing-authorisation-application-for-da 2022-03-01T07:00:55.000Z monthly 0.5 https://feedbagel.com/post/gsk-introduces-haleon-to-investors 2022-02-28T10:45:43.000Z monthly 0.5 https://feedbagel.com/post/gsk-provides-further-update-on-phase-iii-rsv-maternal-vaccine-candidate-programm 2022-02-28T06:42:41.000Z monthly 0.5 https://feedbagel.com/post/medicago-and-gsk-announce-the-approval-by-health-canada-of-covifenz-an-adjuvante 2022-02-24T15:02:38.000Z monthly 0.5 https://feedbagel.com/post/sanofi-and-gsk-to-seek-regulatory-authorization-for-covid-19-vaccine 2022-02-23T09:58:13.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-independent-consumer-healthcare-company-is-to-be-called-haleon 2022-02-22T13:52:45.000Z monthly 0.5 https://feedbagel.com/post/gsk-provides-update-on-phase-iii-rsv-maternal-vaccine-candidate-programme 2022-02-18T06:41:34.000Z monthly 0.5 https://feedbagel.com/post/chinas-national-medical-products-administration-approves-benlysta-belimumab-for- 2022-02-10T08:42:33.000Z monthly 0.5 https://feedbagel.com/post/gsk-delivers-fy-2021-reported-sales-of-34-billion-stable-at-aer-5-cer-total-eps- 2022-02-09T15:05:33.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-to-present-new-long-term-findings-from-its-innovative-2-drug-and 2022-02-07T11:55:29.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-settlement-between-viiv-healthcare-and-gilead-sciences-inc-resolvi 2022-02-01T15:46:59.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-announces-us-fda-approval-of-cabenuva-cabotegravir-rilpivirine-f 2022-02-01T13:09:31.000Z monthly 0.5 https://feedbagel.com/post/tony-wood-appointed-chief-scientific-officer-designate-gsk 2022-01-19T02:01:12.000Z monthly 0.5 https://feedbagel.com/post/update-gsk-consumer-healthcare 2022-01-15T15:57:25.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-vir-biotechnology-announce-united-states-government-agreement-to-purchas 2022-01-11T11:44:48.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-announces-us-fda-approval-of-apretude-cabotegravir-extended-rele 2021-12-20T16:58:30.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-sir-dave-lewis-appointed-non-executive-chair-designate-of-independ 2021-12-20T01:20:42.000Z monthly 0.5 https://feedbagel.com/post/xevudy-sotrovimab-granted-marketing-authorisation-by-the-european-commission-for 2021-12-17T12:47:17.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-sanofi-announce-positive-preliminary-booster-data-for-their-covid-19-vac 2021-12-15T06:12:37.000Z monthly 0.5 https://feedbagel.com/post/new-data-presented-at-ash-2021-highlight-potential-of-blenrep-belantamab-mafodot 2021-12-13T13:00:19.000Z monthly 0.5 https://feedbagel.com/post/medicago-and-gsk-announce-positive-phase-3-efficacy-and-safety-results-for-adjuv 2021-12-07T11:56:09.000Z monthly 0.5 https://feedbagel.com/post/preclinical-studies-demonstrate-sotrovimab-retains-activity-against-the-full-com 2021-12-07T06:31:42.000Z monthly 0.5 https://feedbagel.com/post/gsk-welcomes-gavi-decision-to-fund-the-roll-out-of-malaria-vaccines-for-children 2021-12-02T17:42:55.000Z monthly 0.5 https://feedbagel.com/post/mhra-grants-conditional-marketing-authorisation1-for-covid-19-treatment-xevudy-s 2021-12-02T13:49:41.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-the-university-of-oxford-launch-new-oxford-gsk-institute-to-harness-adva 2021-12-02T07:42:06.000Z monthly 0.5 https://feedbagel.com/post/preclinical-data-demonstrate-sotrovimab-retains-activity-against-key-omicron-mut 2021-12-02T06:46:52.000Z monthly 0.5 https://feedbagel.com/post/gsk-unveils-target-the-future-a-global-multi-year-programme-to-help-address-key- 2021-12-01T11:33:36.000Z monthly 0.5 https://feedbagel.com/post/gsk-appoints-phil-dormitzer-md-phd-as-global-head-of-vaccines-rd 2021-11-30T12:43:44.000Z monthly 0.5 https://feedbagel.com/post/gsk-showcases-progress-from-the-dreamm-clinical-trial-programme-in-multiple-myel 2021-11-18T13:30:18.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-vir-biotechnology-announce-united-states-government-agreements-to-purcha 2021-11-17T11:38:01.000Z monthly 0.5 https://feedbagel.com/post/european-commission-approves-nucala-mepolizumab-in-three-additional-eosinophil-d 2021-11-17T06:39:47.000Z monthly 0.5 https://feedbagel.com/post/primary-endpoint-met-in-comet-tail-phase-iii-trial-evaluating-intramuscular-admi 2021-11-12T12:00:44.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-positive-phase-iii-efficacy-and-safety-data-for-daprodustat-in-pat 2021-11-05T16:57:22.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-presents-positive-interim-data-showing-vocabria-cabotegravir-and 2021-10-28T08:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-delivers-strong-q3-sales-of-91-billion-5-aer-10-cer-total-eps-233p-7-aer-3-c 2021-10-27T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-dr-harry-hal-c-dietz-md-to-join-the-board-as-non-executive-directo 2021-10-27T09:04:15.000Z monthly 0.5 https://feedbagel.com/post/gsk-consumer-healthcare-solidifies-commitment-to-pharmacists-with-3-year-pharmac 2021-10-26T09:14:13.000Z monthly 0.5 https://feedbagel.com/post/us-centers-for-disease-control-and-preventions-advisory-committee-on-immunizatio-2 2021-10-20T18:27:28.000Z monthly 0.5 https://feedbagel.com/post/less-talk-more-action-new-report-sponsored-by-viiv-healthcare-provides-roadmap-t 2021-10-20T13:39:58.000Z monthly 0.5 https://feedbagel.com/post/gsk-to-showcase-significant-scientific-advances-in-renal-care-at-the-american-so 2021-10-18T17:50:23.000Z monthly 0.5 https://feedbagel.com/post/gsk-unveils-plan-for-uk-headquarters-of-new-consumer-healthcare-company 2021-10-11T12:03:24.000Z monthly 0.5 https://feedbagel.com/post/gsk-welcomes-who-recommendation-for-broad-roll-out-of-its-rtssas01e-rtss-malaria 2021-10-06T16:21:30.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-submits-fda-application-for-first-dispersible-single-tablet-regi 2021-10-04T08:37:56.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-presents-three-year-switch-data-for-dovato-dolutegravirlamivudin 2021-09-29T07:48:14.000Z monthly 0.5 https://feedbagel.com/post/fda-grants-priority-review-to-viiv-healthcares-new-drug-application-for-cabotegr 2021-09-28T11:00:00.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-announces-exclusive-license-agreement-with-shionogi-to-develop-t 2021-09-28T10:17:21.000Z monthly 0.5 https://feedbagel.com/post/changing-attitudes-to-vaccination-after-the-covid-19-pandemic-could-increase-adu 2021-09-22T08:09:56.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-to-present-key-data-that-provides-further-support-for-the-use-of 2021-09-22T08:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-major-renewable-energy-investment-and-low-carbon-inhaler-programme 2021-09-20T09:56:39.000Z monthly 0.5 https://feedbagel.com/post/gsk-receives-chmp-positive-opinions-recommending-approval-of-nucala-mepolizumab- 2021-09-17T13:21:37.000Z monthly 0.5 https://feedbagel.com/post/gsk-to-highlight-continued-progress-in-oncology-pipeline-and-portfolio-with-data 2021-09-09T08:43:40.000Z monthly 0.5 https://feedbagel.com/post/gsk-consumer-healthcare-leads-oral-care-industry-with-launch-of-its-first-carbon 2021-09-06T08:00:42.000Z monthly 0.5 https://feedbagel.com/post/sk-bioscience-and-gsk-start-phase-3-trial-of-adjuvanted-covid-19-vaccine-candida 2021-08-31T06:39:59.000Z monthly 0.5 https://feedbagel.com/post/gsk-receives-fda-accelerated-approval-for-jemperli-dostarlimab-gxly-for-adult-pa 2021-08-17T20:56:07.000Z monthly 0.5 https://feedbagel.com/post/second-generation-mrna-covid-19-vaccine-candidate-cv2cov-demonstrates-improved-i 2021-08-16T11:50:11.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-fda-approval-for-nucala-mepolizumab-for-use-in-adults-with-chronic 2021-07-29T14:10:58.000Z monthly 0.5 https://feedbagel.com/post/gsk-delivers-strong-q2-sales-of-81-billion-6-aer-15-cer-total-eps-279p-39-aer-28 2021-07-28T12:06:30.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-vir-biotechnology-announce-joint-procurement-agreement-with-european-com 2021-07-28T11:13:44.000Z monthly 0.5 https://feedbagel.com/post/shingrix-approved-in-the-us-for-prevention-of-shingles-in-immunocompromised-adul 2021-07-26T14:25:34.000Z monthly 0.5 https://feedbagel.com/post/brian-mcnamara-appointed-ceo-designate-of-new-independent-consumer-healthcare-co 2021-07-22T14:45:00.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-presents-data-from-second-dovato-dolutegravirlamivudine-switch-s 2021-07-17T11:04:43.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-study-shows-new-long-acting-hiv-regimen-cabenuva-cabotegravirril 2021-07-17T10:53:45.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-to-present-new-data-from-diverse-portfolio-and-pipeline-of-2-dru 2021-07-17T10:36:28.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-positive-headline-results-from-five-phase-3-studies-of-daprodustat 2021-07-16T11:31:37.000Z monthly 0.5 https://feedbagel.com/post/gsk-unveils-plan-for-one-of-europes-largest-life-science-campuses-in-stevenage 2021-07-16T07:00:00.000Z monthly 0.5 https://feedbagel.com/post/new-study-shows-more-needs-to-be-done-to-raise-public-awareness-on-the-impact-of 2021-07-15T15:45:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-alector-announce-global-collaboration-in-immuno-neurology-for-two-clinic 2021-07-02T11:57:30.000Z monthly 0.5 https://feedbagel.com/post/elliott-advisors-uk-letter-to-gsk 2021-07-02T10:42:02.000Z monthly 0.5 https://feedbagel.com/post/new-gsk-to-deliver-step-change-in-growth-and-performance-over-next-ten-years-dri 2021-06-23T05:39:43.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-and-halozyme-enter-global-collaboration-and-license-agreement-fo 2021-06-22T16:32:27.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-vir-biotechnology-announce-continuing-progress-of-the-comet-clinical-dev 2021-06-21T12:00:24.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-iteos-therapeutics-announce-development-and-commercialisation-collaborat 2021-06-14T11:16:42.000Z monthly 0.5 https://feedbagel.com/post/gsk-to-showcase-scientific-advances-and-progress-in-oncology-at-asco-and-eha 2021-06-01T08:33:31.000Z monthly 0.5 https://feedbagel.com/post/sanofi-and-gsk-initiate-global-phase-3-clinical-efficacy-study-of-covid-19-vacci 2021-05-27T06:03:17.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-vir-biotechnology-announce-sotrovimab-vir-7831-receives-emergency-use-au 2021-05-26T18:18:33.000Z monthly 0.5 https://feedbagel.com/post/gsk-announced-as-a-principal-partner-of-cop26-un-climate-change-conference 2021-05-26T09:35:39.000Z monthly 0.5 https://feedbagel.com/post/ema-issues-positive-scientific-opinion-on-gsk-and-vir-biotechnologys-sotrovimab- 2021-05-21T12:52:14.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-sale-of-stake-in-innoviva-inc 2021-05-20T14:45:00.000Z monthly 0.5 https://feedbagel.com/post/medicago-and-gsk-announce-positive-interim-phase-2-results-for-adjuvanted-covid- 2021-05-18T06:00:55.000Z monthly 0.5 https://feedbagel.com/post/sanofi-and-gsk-covid-19-vaccine-candidate-demonstrates-strong-immune-responses-a 2021-05-17T06:30:12.000Z monthly 0.5 https://feedbagel.com/post/gsk-consumer-healthcare-commits-to-make-over-a-billion-toothpaste-tubes-recyclab 2021-05-13T07:33:43.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-vir-biotechnology-announce-the-start-of-the-ema-rolling-review-of-vir-78 2021-05-07T10:32:14.000Z monthly 0.5 https://feedbagel.com/post/european-commission-approves-benlysta-for-adult-patients-with-active-lupus-nephr 2021-05-05T08:35:25.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-initiates-rolling-submission-of-new-drug-application-with-us-fda 2021-05-04T10:45:04.000Z monthly 0.5 https://feedbagel.com/post/gsk-delivers-q1-sales-of-74-billion-18-aer-15-cer-total-eps-215p-32-aer-25-cer-a 2021-04-28T11:17:59.000Z monthly 0.5 https://feedbagel.com/post/european-commission-approves-gsks-jemperli-dostarlimab-the-first-anti-pd-1-thera 2021-04-23T08:04:37.000Z monthly 0.5 https://feedbagel.com/post/fda-grants-accelerated-approval-for-gsks-jemperli-dostarlimab-gxly-for-women-wit 2021-04-22T14:35:22.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-vir-biotechnology-announce-ema-review-of-dual-action-monoclonal-antibody 2021-04-15T14:53:38.000Z monthly 0.5 https://feedbagel.com/post/gsk-provides-update-on-feladilimab-an-investigational-inducible-t-cell-co-stimul 2021-04-14T16:50:12.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-dr-anne-beal-to-join-the-board-as-non-executive-director 2021-04-06T14:30:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-to-support-manufacture-of-novavax-covid-19-vaccine 2021-03-29T17:00:16.000Z monthly 0.5 https://feedbagel.com/post/lilly-vir-biotechnology-and-gsk-announce-positive-topline-data-from-the-phase-2- 2021-03-29T13:30:02.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-vir-biotechnology-announce-submission-of-emergency-use-authorization-req 2021-03-26T12:08:12.000Z monthly 0.5 https://feedbagel.com/post/gsk-receives-chmp-positive-opinion-recommending-approval-of-benlysta-for-adult-p 2021-03-26T11:42:10.000Z monthly 0.5 https://feedbagel.com/post/moncef-slaoui-departs-galvani-bioelectronics-board-of-directors 2021-03-24T12:04:57.000Z monthly 0.5 https://feedbagel.com/post/half-of-parents-surveyed-either-cancelled-or-delayed-their-childs-scheduled-meni 2021-03-24T07:57:40.000Z monthly 0.5 https://feedbagel.com/post/gsk-to-highlight-scientific-research-in-ovarian-and-endometrial-cancer-at-sgo-20 2021-03-19T12:42:41.000Z monthly 0.5 https://feedbagel.com/post/back-to-the-dentist-new-study-highlights-urgent-need-to-tackle-oral-healthcare-h 2021-03-18T12:12:49.000Z monthly 0.5 https://feedbagel.com/post/gsk-starts-the-first-phase-3-study-with-a-long-acting-anti-il-5-treatment-for-pa 2021-03-18T07:37:47.000Z monthly 0.5 https://feedbagel.com/post/medicago-and-gsk-start-phase-3-trial-of-adjuvanted-covid-19-vaccine-candidate 2021-03-16T11:00:00.000Z monthly 0.5 https://feedbagel.com/post/vir-biotechnology-and-gsk-announce-vir-7831-reduces-hospitalisation-and-risk-of- 2021-03-10T20:34:02.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-presents-positive-proof-of-concept-findings-for-gsk3640254-a-nov 2021-03-09T16:37:51.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-presents-data-for-long-acting-cabotegravir-and-rilpivirine-for-t 2021-03-06T19:10:24.000Z monthly 0.5 https://feedbagel.com/post/gsk-makes-landmark-pricing-agreement-for-rotavirus-vaccine-rotarix-for-use-with- 2021-03-04T13:23:14.000Z monthly 0.5 https://feedbagel.com/post/vir-biotechnology-and-gsk-provide-update-on-nih-sponsored-activ-3-trial-evaluati 2021-03-03T14:00:47.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-to-present-new-data-on-long-acting-regimens-for-hiv-prevention-a 2021-03-02T11:59:55.000Z monthly 0.5 https://feedbagel.com/post/gsk-receives-chmp-positive-opinion-recommending-approval-of-dostarlimab-for-wome 2021-02-26T12:32:24.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-results-evaluating-its-investigational-monoclonal-antibody-otilima 2021-02-25T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/sanofi-and-gsk-initiate-new-phase-2-study-of-their-adjuvanted-recombinant-protei 2021-02-22T10:45:30.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-vir-biotechnology-expand-coronavirus-collaboration-to-advance-new-therap 2021-02-17T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-gender-and-diversity-aspirational-targets-to-increase-representati 2021-02-17T08:30:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-starts-phase-iii-rsv-candidate-vaccine-programme-for-older-adults 2021-02-16T17:52:50.000Z monthly 0.5 https://feedbagel.com/post/gsk-to-sell-cephalosporin-antibiotics-business-to-sandoz 2021-02-11T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-receives-marketing-authorisation-for-rukobia-fostemsavir-a-first 2021-02-08T11:16:39.000Z monthly 0.5 https://feedbagel.com/post/gsk-delivers-fy-2020-reported-sales-of-34-billion-1-aer-3-cer-and-adjusted-eps-o 2021-02-03T11:43:54.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-curevac-to-develop-next-generation-mrna-covid-19-vaccines 2021-02-03T07:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-path-and-bharat-biotech-sign-product-transfer-agreement-to-help-ensure-long- 2021-01-27T12:05:02.000Z monthly 0.5 https://feedbagel.com/post/lilly-vir-biotechnology-and-gsk-announce-first-patient-dosed-in-expanded-blaze-4 2021-01-27T11:45:52.000Z monthly 0.5 https://feedbagel.com/post/gsk-ranks-1st-in-the-2021-access-to-medicine-index-with-leading-rd-pipeline-for- 2021-01-26T11:30:39.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-announces-fda-approval-of-cabenuva-cabotegravir-rilpivirine-the- 2021-01-21T21:34:21.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-novartis-announce-collaboration-to-support-scientific-research-into-gene 2021-01-19T05:18:59.000Z monthly 0.5 https://feedbagel.com/post/gsk-presents-positive-efficacy-data-of-dostarlimab-in-mismatch-repair-deficient- 2021-01-16T13:08:40.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-receives-eu-marketing-authorisation-for-the-first-ever-dispersib 2021-01-13T08:48:12.000Z monthly 0.5 https://feedbagel.com/post/vir-biotechnology-and-gsk-announce-nhs-supported-agile-study-to-evaluate-vir-783 2021-01-12T07:12:46.000Z monthly 0.5 https://feedbagel.com/post/gsk-mmv-filing-for-kozenis-tafenoquine-in-paediatric-populations-with-plasmodium 2021-01-08T11:22:13.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-announces-the-marketing-authorisation-of-the-first-complete-long 2020-12-21T12:41:07.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-ahren-announce-co-led-series-a-investment-in-adrestia-and-multi-project- 2020-12-18T07:41:43.000Z monthly 0.5 https://feedbagel.com/post/fda-approves-gsks-benlysta-as-the-first-medicine-for-adult-patients-with-active- 2020-12-17T12:41:31.000Z monthly 0.5 https://feedbagel.com/post/vir-biotechnology-and-gsk-announce-start-of-nih-sponsored-activ-3-trial-evaluati 2020-12-17T11:48:22.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-announces-positive-chmp-opinion-for-rukobia-fostemsavir-a-first- 2020-12-11T10:42:51.000Z monthly 0.5 https://feedbagel.com/post/sanofi-and-gsk-announce-a-delay-in-their-adjuvanted-recombinant-protein-based-co 2020-12-11T05:21:03.000Z monthly 0.5 https://feedbagel.com/post/fda-accepts-gsks-filing-of-nucala-mepolizumab-for-use-in-chronic-rhinosinusitis- 2020-12-08T11:45:52.000Z monthly 0.5 https://feedbagel.com/post/gsk-starts-phase-3-study-of-rsv-maternal-candidate-vaccine 2020-11-23T17:40:10.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-mmv-present-positive-data-on-treatment-for-plasmodium-vivax-malaria-in-c 2020-11-19T22:14:25.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-receives-fda-breakthrough-therapy-designation-for-investigationa 2020-11-17T18:00:26.000Z monthly 0.5 https://feedbagel.com/post/gsk-presents-phase-2b-data-on-linerixibat-for-the-treatment-of-cholestatic-pruri 2020-11-13T14:26:37.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-announces-chmp-positive-opinion-for-the-first-ever-dispersible-t 2020-11-13T13:16:35.000Z monthly 0.5 https://feedbagel.com/post/medicago-and-gsk-announce-start-of-phase-23-clinical-trials-of-adjuvanted-covid- 2020-11-12T10:33:29.000Z monthly 0.5 https://feedbagel.com/post/gsk-highlights-progress-from-the-blenrep-belantamab-mafodotin-blmf-development-p 2020-11-11T11:18:15.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-announces-investigational-injectable-cabotegravir-is-superior-to 2020-11-09T17:37:31.000Z monthly 0.5 https://feedbagel.com/post/gsk-sets-new-environmental-goals-of-net-zero-impact-on-climate-and-net-positive- 2020-11-03T07:58:32.000Z monthly 0.5 https://feedbagel.com/post/gsk-nucala-mepolizumab-filings-accepted-by-european-medicines-agency-for-three-a 2020-10-29T07:39:54.000Z monthly 0.5 https://feedbagel.com/post/european-commission-approves-zejula-niraparib-as-first-line-monotherapy-maintena 2020-10-29T06:41:59.000Z monthly 0.5 https://feedbagel.com/post/gsk-delivers-resilient-performance-strong-commercial-execution-and-further-strat 2020-10-28T11:42:13.000Z monthly 0.5 https://feedbagel.com/post/sanofi-and-gsk-to-support-covax-with-200-million-doses-of-adjuvanted-recombinant 2020-10-28T05:57:45.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-presents-continued-positive-findings-from-first-ever-implementat 2020-10-22T21:04:07.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-presents-positive-new-findings-from-two-studies-of-its-investiga 2020-10-22T07:50:25.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-announces-analysis-showing-no-antiretroviral-therapy-interruptio 2020-10-21T07:13:27.000Z monthly 0.5 https://feedbagel.com/post/gsk-presents-positive-clinical-data-on-maternal-and-older-adults-rsv-candidate-v 2020-10-21T06:29:29.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-receives-positive-chmp-opinion-for-long-acting-regimen-for-the-t 2020-10-16T10:37:30.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-presents-long-term-switch-data-for-dovato-demonstrating-non-infe 2020-10-08T10:51:30.000Z monthly 0.5 https://feedbagel.com/post/vir-biotechnology-and-gsk-announce-global-expansion-to-phase-3-of-comet-ice-stud 2020-10-06T13:22:25.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-announces-dolutegravir-plus-lamivudine-three-year-data-confirmin 2020-10-05T11:01:26.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-to-present-long-term-safety-and-efficacy-data-for-2-drug-regimen 2020-09-30T08:36:01.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-announces-start-of-implementation-science-study-to-identify-and- 2020-09-28T16:24:27.000Z monthly 0.5 https://feedbagel.com/post/fda-approves-nucala-as-the-first-and-only-biologic-treatment-for-hypereosinophil 2020-09-25T14:38:04.000Z monthly 0.5 https://feedbagel.com/post/sanofi-and-gsk-sign-agreements-with-the-government-of-canada-to-supply-up-to-72- 2020-09-22T17:49:44.000Z monthly 0.5 https://feedbagel.com/post/gsk-receives-chmp-positive-opinion-recommending-approval-of-zejula-niraparib-as- 2020-09-18T13:16:12.000Z monthly 0.5 https://feedbagel.com/post/sanofi-and-gsk-confirm-agreement-with-european-union-to-supply-up-to-300-million 2020-09-18T11:02:49.000Z monthly 0.5 https://feedbagel.com/post/gsk-highlights-scientific-advances-across-its-growing-oncology-portfolio-at-esmo 2020-09-15T08:00:00.000Z monthly 0.5 https://feedbagel.com/post/fda-approves-trelegy-ellipta-as-the-first-once-daily-single-inhaler-triple-thera 2020-09-09T14:50:30.000Z monthly 0.5 https://feedbagel.com/post/sanofi-and-gsk-initiate-phase-12-clinical-trial-of-covid-19-adjuvanted-recombina 2020-09-03T06:08:22.000Z monthly 0.5 https://feedbagel.com/post/vir-biotechnology-and-gsk-start-phase-23-study-of-covid-19-antibody-treatment 2020-08-31T08:28:15.000Z monthly 0.5 https://feedbagel.com/post/gsk-presents-promising-phase-2a-data-for-chronic-hepatitis-b-treatment 2020-08-28T07:51:54.000Z monthly 0.5 https://feedbagel.com/post/european-commission-approves-blenrep-belantamab-mafodotin-for-the-treatment-of-p 2020-08-26T22:43:43.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-first-participant-vaccinated-in-phase-3-clinical-trials-of-its-5-i 2020-08-19T09:48:43.000Z monthly 0.5 https://feedbagel.com/post/fda-approves-gsks-blenrep-belantamab-mafodotin-blmf-for-the-treatment-of-patient 2020-08-06T01:10:09.000Z monthly 0.5 https://feedbagel.com/post/sanofi-and-gsk-in-advanced-discussions-with-european-union-to-supply-up-to-300-m 2020-07-31T19:56:19.000Z monthly 0.5 https://feedbagel.com/post/sanofi-and-gsk-to-supply-european-union-with-up-to-300-million-doses-of-covid-19 2020-07-31T18:19:23.000Z monthly 0.5 https://feedbagel.com/post/sanofi-and-gsk-selected-for-operation-warp-speed-to-supply-united-states-governm 2020-07-31T12:06:10.000Z monthly 0.5 https://feedbagel.com/post/gsk-delivers-q2-sales-of-76-billion-2-aer-3-cer-pro-forma-10-cer 2020-07-29T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/sanofi-and-gsk-agree-with-the-uk-government-to-supply-up-to-60-million-doses-of- 2020-07-29T06:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-receives-positive-chmp-opinion-recommending-approval-of-belantamab-mafodotin 2020-07-24T09:16:42.000Z monthly 0.5 https://feedbagel.com/post/covid-19-prompts-increased-focus-on-self-care-with-europeans-taking-their-health 2020-07-20T09:30:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-curevac-announce-strategic-mrna-technology-collaboration 2020-07-20T07:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-fda-advisory-committee-votes-in-favour-of-positive-benefitrisk-pro 2020-07-14T16:31:28.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-announces-superior-efficacy-of-investigational-long-acting-injec 2020-07-07T13:30:34.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-medicago-announce-collaboration-to-develop-a-novel-adjuvanted-covid-19-c 2020-07-07T12:49:28.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-presents-positive-data-from-first-ever-implementation-research-s 2020-07-04T08:00:00.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-announces-us-fda-approval-for-rukobia-fostemsavir-a-first-in-cla 2020-07-02T16:06:42.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-to-present-new-data-on-long-acting-regimens-for-hiv-prevention-a-2 2020-07-02T08:04:44.000Z monthly 0.5 https://feedbagel.com/post/gsk-receives-first-regulatory-approval-for-duvroq-daprodustat-in-japan-for-patie 2020-06-29T08:00:16.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-fda-advisory-committee-meeting-to-review-belantamab-mafodotin-for- 2020-06-19T15:35:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-covid-19-vaccine-development-collaboration-with-clover-biopharmaceuticals-be 2020-06-19T08:00:11.000Z monthly 0.5 https://feedbagel.com/post/gsk-prices-280336000-senior-notes-due-2023-exchangeable-into-theravance-biopharm 2020-06-18T11:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-proposed-unregistered-offering-of-senior-notes-exchangeable-into-t 2020-06-17T11:00:35.000Z monthly 0.5 https://feedbagel.com/post/ideaya-and-gsk-announce-a-broad-partnership-in-synthetic-lethality-an-emerging-f 2020-06-16T09:51:41.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-announces-us-fda-approval-of-the-first-ever-dispersible-tablet-f 2020-06-12T13:43:33.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-new-data-presentations-from-the-dreamm-programme-exploring-investi 2020-06-04T12:00:26.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-intention-to-produce-1-billion-doses-of-pandemic-vaccine-adjuvant- 2020-05-28T07:00:31.000Z monthly 0.5 https://feedbagel.com/post/dreamm-2-and-dreamm-6-data-at-asco-reinforce-the-potential-of-gsks-investigation 2020-05-27T14:00:05.000Z monthly 0.5 https://feedbagel.com/post/fda-grants-priority-review-of-nucala-for-patients-with-hypereosinophilic-syndrom 2020-05-27T08:30:23.000Z monthly 0.5 https://feedbagel.com/post/gsk-partners-with-samsung-biologics-to-secure-additional-manufacturing-capacity- 2020-05-21T20:22:50.000Z monthly 0.5 https://feedbagel.com/post/gsk-highlights-scientific-innovation-and-advances-in-its-growing-oncology-portfo 2020-05-20T14:00:06.000Z monthly 0.5 https://feedbagel.com/post/global-hiv-prevention-study-to-stop-early-after-viiv-healthcares-long-acting-inj 2020-05-18T06:06:20.000Z monthly 0.5 https://feedbagel.com/post/fda-approves-zejula-niraparib-as-the-only-once-daily-parp-inhibitor-in-first-lin 2020-04-29T20:19:25.000Z monthly 0.5 https://feedbagel.com/post/gsk-delivers-strong-q1-sales-91-billion-19-aer-19-cer-proforma-10-cer 2020-04-29T12:00:40.000Z monthly 0.5 https://feedbagel.com/post/gsk-presents-new-data-from-the-garnet-study-demonstrating-potential-of-dostarlim 2020-04-23T20:00:41.000Z monthly 0.5 https://feedbagel.com/post/sanofi-and-gsk-to-join-forces-in-unprecedented-vaccine-collaboration-to-fight-co 2020-04-14T12:00:53.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-vir-biotechnology-enter-collaboration-to-find-coronavirus-solutions 2020-04-06T13:00:01.000Z monthly 0.5 https://feedbagel.com/post/fda-approves-zejula-niraparib-as-the-only-once-daily-parp-inhibitor-in-first-lin-2 2020-04-03T13:44:48.000Z monthly 0.5 https://feedbagel.com/post/nucala-mepolizumab-is-the-first-anti-il5-biologic-to-report-positive-phase-3-res 2020-04-03T09:00:23.000Z monthly 0.5 https://feedbagel.com/post/gsk-completes-divestment-of-horlicks-and-other-consumer-healthcare-nutrition-pro 2020-04-01T13:00:04.000Z monthly 0.5 https://feedbagel.com/post/zejula-niraparib-is-the-first-and-only-once-daily-parp-inhibitor-fda-approved-as 2020-03-30T13:41:43.000Z monthly 0.5 https://feedbagel.com/post/gsk-appoints-charles-bancroft-to-the-board-as-a-non-executive-director 2020-03-20T14:00:02.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-announces-first-global-regulatory-approval-of-cabenuva-the-first 2020-03-20T13:00:56.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-presents-positive-long-term-data-from-phase-iii-study-demonstrat 2020-03-09T18:30:02.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-presents-positive-48-week-data-from-phase-iii-study-showing-ever 2020-03-09T14:15:01.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-and-unc-chapel-hill-announce-five-year-renewal-of-innovative-hiv 2020-03-09T14:00:03.000Z monthly 0.5 https://feedbagel.com/post/gsk-receives-ec-approval-for-the-sale-of-thermacare 2020-03-05T12:18:44.000Z monthly 0.5 https://feedbagel.com/post/fda-approves-gsks-advil-dual-action-with-acetaminophen-for-over-the-counter-use- 2020-03-02T19:34:58.000Z monthly 0.5 https://feedbagel.com/post/gsk-filing-accepted-by-european-medicines-agency-for-trelegy-ellipta-use-in-adul 2020-02-27T14:30:05.000Z monthly 0.5 https://feedbagel.com/post/first-of-its-kind-global-collaboration-launched-to-develop-transformative-treatm 2020-02-27T13:00:56.000Z monthly 0.5 https://feedbagel.com/post/european-medicines-agency-accepts-submission-of-gsks-marketing-authorisation-app 2020-02-27T13:00:12.000Z monthly 0.5 https://feedbagel.com/post/us-fda-accepts-gsks-snda-application-for-zejula-niraparib-for-first-line-mainten 2020-02-24T14:00:05.000Z monthly 0.5 https://feedbagel.com/post/clover-and-gsk-announce-research-collaboration-to-evaluate-coronavirus-covid-19- 2020-02-24T08:00:42.000Z monthly 0.5 https://feedbagel.com/post/fda-approves-gsks-voltaren-arthritis-pain-for-over-the-counter-use-in-the-united 2020-02-17T12:30:15.000Z monthly 0.5 https://feedbagel.com/post/gsk-delivers-2019-sales-of-338-billion-10-aer-8-cer-pro-forma-4-cer 2020-02-05T12:00:35.000Z monthly 0.5 https://feedbagel.com/post/cepi-and-gsk-announce-collaboration-to-strengthen-the-global-effort-to-develop-a 2020-02-03T23:00:08.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-european-medicines-agency-ema-accepted-marketing-authorisation-app 2020-02-03T09:00:01.000Z monthly 0.5 https://feedbagel.com/post/gsk-licenses-tuberculosis-vaccine-candidate-to-the-bill-melinda-gates-medical-re 2020-01-27T13:00:26.000Z monthly 0.5 https://feedbagel.com/post/worlds-first-meningitis-b-national-infant-vaccination-programme-shows-75-drop-in 2020-01-23T08:00:02.000Z monthly 0.5 https://feedbagel.com/post/us-food-and-drug-administration-fda-grants-priority-review-of-belantamab-mafodot 2020-01-21T14:00:32.000Z monthly 0.5 https://feedbagel.com/post/dovato-dolutegravirlamivudine-the-once-daily-single-pill-2-drug-regimen-for-the- 2020-01-15T09:00:23.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-submits-regulatory-application-to-the-european-medicines-agency- 2020-01-10T12:00:46.000Z monthly 0.5 https://feedbagel.com/post/deborah-waterhouse-ceo-of-viiv-healthcare-to-join-gsk-corporate-executive-team-c 2020-01-08T14:40:14.000Z monthly 0.5 https://feedbagel.com/post/gsk-completes-divestment-of-rabies-and-tick-borne-encephalitis-vaccines-to-bavar 2019-12-31T11:42:43.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-receives-complete-response-letter-from-us-fda-for-use-of-investi 2019-12-21T08:26:45.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-positive-headline-results-in-phase-3-study-of-benlysta-in-patients 2019-12-18T13:26:13.000Z monthly 0.5 https://feedbagel.com/post/pivotal-dreamm-2-study-demonstrated-a-clinically-meaningful-overall-response-rat 2019-12-16T18:23:41.000Z monthly 0.5 https://feedbagel.com/post/gsk-consumer-healthcare-nutritional-products-divestment 2019-12-13T10:20:46.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-files-submissions-to-the-fda-and-ema-for-the-first-ever-dispersi 2019-12-13T10:05:00.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-submits-new-drug-application-to-the-fda-for-fostemsavir-an-inves 2019-12-05T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-announces-exclusive-licensing-agreement-with-the-national-instit 2019-11-21T14:00:05.000Z monthly 0.5 https://feedbagel.com/post/nucala-mepolizumab-is-the-first-treatment-to-show-a-significant-reduction-in-fla 2019-11-13T08:00:01.000Z monthly 0.5 https://feedbagel.com/post/eacs-2019-viiv-healthcare-to-present-17-abstracts-from-its-portfolio-addressing- 2019-11-06T08:00:31.000Z monthly 0.5 https://feedbagel.com/post/gsk-delivers-sales-of-94-billion-16-aer-11-cer-pro-forma-6-cer 2019-10-30T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/intravenous-benlysta-is-the-first-biologic-treatment-to-be-approved-for-children 2019-10-29T16:00:24.000Z monthly 0.5 https://feedbagel.com/post/gsk-candidate-vaccine-demonstrates-sustained-level-of-protection-against-active- 2019-10-29T06:00:05.000Z monthly 0.5 https://feedbagel.com/post/gsk-starts-a-phase-iii-clinical-programme-for-a-potential-first-in-class-antibio 2019-10-28T09:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-agrees-to-divest-rabies-and-tick-borne-encephalitis-vaccines-to-bavarian-nor 2019-10-21T08:00:00.000Z monthly 0.5 https://feedbagel.com/post/global-fund-replenishment-2019-media-statement 2019-10-10T10:43:07.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-lyell-immunopharma-join-forces-to-develop-the-next-generation-of-cancer- 2019-10-08T14:30:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-submits-filing-to-fda-for-trelegy-ellipta-use-in-patients-with-asthma 2019-10-02T14:00:56.000Z monthly 0.5 https://feedbagel.com/post/idweek-2019-viiv-healthcare-to-present-20-abstracts-from-its-innovative-rd-portf 2019-10-02T09:30:43.000Z monthly 0.5 https://feedbagel.com/post/nucala-significantly-reduces-exacerbations-in-first-global-prospective-real-worl 2019-09-30T10:30:23.000Z monthly 0.5 https://feedbagel.com/post/phase-3-prima-trial-of-zejula-niraparib-is-the-first-study-to-show-a-parp-inhibi 2019-09-28T15:32:17.000Z monthly 0.5 https://feedbagel.com/post/gsk-presents-new-data-showing-promising-anti-tumour-activity-with-gsk3359609-an- 2019-09-28T07:45:29.000Z monthly 0.5 https://feedbagel.com/post/real-world-effectiveness-evidence-among-gsk-data-presented-at-ers-2019 2019-09-23T09:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-receives-positive-chmp-opinion-for-intravenous-benlysta-in-children-with-lup 2019-09-20T12:00:54.000Z monthly 0.5 https://feedbagel.com/post/nucala-is-the-first-biologic-approved-in-the-us-for-six-to-11-year-old-children- 2019-09-12T14:30:27.000Z monthly 0.5 https://feedbagel.com/post/gsk-to-present-data-from-its-innovative-oncology-portfolio-at-esmo-congress-2019 2019-09-10T13:00:31.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-positive-headline-results-from-the-pivotal-dreamm-2-study-for-mult 2019-08-23T06:54:28.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-reports-positive-phase-iii-study-results-of-investigational-long 2019-08-22T06:59:13.000Z monthly 0.5 https://feedbagel.com/post/gsk-submits-first-regulatory-application-for-daprodustat-in-japan-for-patients-w 2019-08-21T08:00:28.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-leadership-changes-in-the-us 2019-08-12T10:07:56.000Z monthly 0.5 https://feedbagel.com/post/gsk-grants-exclusive-technology-license-for-clinical-stage-ebola-vaccines-to-sab 2019-08-06T12:00:54.000Z monthly 0.5 https://feedbagel.com/post/nucala-receives-eu-approval-for-self-administration-by-patients-with-severe-eosi 2019-08-01T15:04:08.000Z monthly 0.5 https://feedbagel.com/post/gsk-completes-transaction-with-pfizer-to-form-new-world-leading-consumer-healthc 2019-08-01T06:27:27.000Z monthly 0.5 https://feedbagel.com/post/five-years-on-39-million-people-in-the-developing-world-have-access-to-hiv-treat 2019-07-30T09:35:48.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-submits-regulatory-application-to-european-medicines-agency-for- 2019-07-29T07:02:49.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-presents-gemini-1-2-studies-through-week-96-showing-2-drug-regim 2019-07-24T16:00:56.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-announces-positive-week-48-results-in-first-study-to-evaluate-tr 2019-07-24T16:00:46.000Z monthly 0.5 https://feedbagel.com/post/gsk-delivers-sales-and-earnings-growth-in-q2-2019 2019-07-24T14:00:38.000Z monthly 0.5 https://feedbagel.com/post/glaxosmithkline-plc-appoints-jonathan-symonds-as-non-executive-chairman-of-the-b 2019-07-24T10:00:33.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-presents-positive-96-week-data-from-phase-iii-study-of-investiga 2019-07-22T17:00:56.000Z monthly 0.5 https://feedbagel.com/post/ias-2019-viiv-healthcare-showcasing-innovation-in-hiv-science 2019-07-15T14:00:47.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-positive-headline-results-in-phase-3-prima-study-of-zejula-nirapar 2019-07-15T07:00:14.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-announces-phase-iii-study-meets-primary-endpoint-demonstrating-t 2019-07-10T07:01:37.000Z monthly 0.5 https://feedbagel.com/post/gsk-welcomes-the-uk-trial-of-subscription-style-payment-system-for-pharma-compan 2019-07-09T12:00:09.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-announces-start-of-first-ever-study-to-identify-and-evaluate-app 2019-07-08T17:17:47.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-phase-iii-start-for-its-anti-gm-csf-antibody-otilimab-in-patients- 2019-07-03T11:03:43.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-receives-eu-marketing-authorisation-for-dovato-dolutegravirlamiv 2019-07-03T09:01:10.000Z monthly 0.5 https://feedbagel.com/post/us-food-and-drug-administration-accepts-gsks-application-for-zejula-niraparib-in 2019-06-24T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-joins-forces-with-the-university-of-california-to-advance-genomic-research-a 2019-06-13T11:15:29.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-data-on-anti-bcma-antibody-drug-conjugate-in-patients-with-relapse 2019-06-12T12:10:32.000Z monthly 0.5 https://feedbagel.com/post/nucala-mepolizumab-gains-fda-approval-for-two-new-self-administration-options 2019-06-06T15:10:46.000Z monthly 0.5 https://feedbagel.com/post/nucala-mepolizumab-receives-positive-chmp-opinion-for-new-self-administration-op 2019-06-04T08:00:24.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-approval-of-shingrix-in-china-for-prevention-of-shingles-in-adults 2019-05-23T16:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-changes-sales-representative-incentive-programme 2019-05-23T14:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsks-strong-science-prominent-at-ats-2019 2019-05-16T11:20:39.000Z monthly 0.5 https://feedbagel.com/post/update-on-consumer-healthcare-joint-venture-with-pfizer 2019-05-08T18:40:36.000Z monthly 0.5 https://feedbagel.com/post/phase-iii-captain-study-of-trelegy-ellipta-in-patients-with-asthma-meets-primary 2019-05-02T16:46:02.000Z monthly 0.5 https://feedbagel.com/post/gsk-delivers-sales-of-77-billion-6-aer-5-cer 2019-05-01T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-submits-new-drug-application-to-us-fda-for-the-first-monthly-inj 2019-04-29T12:17:49.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-announces-chmp-positive-opinion-for-dovato-dolutegravirlamivudin 2019-04-26T16:04:52.000Z monthly 0.5 https://feedbagel.com/post/gsk-receives-us-approval-of-benlysta-for-intravenous-use-in-children-with-lupus- 2019-04-26T14:49:53.000Z monthly 0.5 https://feedbagel.com/post/us-fda-approves-viiv-healthcares-dovato-dolutegravirlamivudine-the-first-once-da 2019-04-08T21:15:30.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-announces-juluca-dolutegravirrilpivirine-maintains-hiv-viral-sup 2019-04-03T10:07:06.000Z monthly 0.5 https://feedbagel.com/post/gsk-publishes-product-sales-reporting-changes-and-the-impact-of-ifrs-16-leases 2019-03-28T22:48:21.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-further-positive-data-from-dreamm-1-study-of-anti-bcma-antibody-dr 2019-03-21T11:41:35.000Z monthly 0.5 https://feedbagel.com/post/data-from-garnet-study-indicates-robust-activity-of-dostarlimab-in-patients-with 2019-03-19T16:21:02.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-presents-positive-48-week-data-from-two-pivotal-phase-iii-studie 2019-03-07T12:17:33.000Z monthly 0.5 https://feedbagel.com/post/gsk-receives-a-positive-chmp-opinion-for-intravenous-zanamivir-for-the-treatment 2019-03-01T09:27:43.000Z monthly 0.5 https://feedbagel.com/post/gsk-delivers-sales-earnings-and-cash-flow-growth-in-2018 2019-02-06T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-merck-kgaa-darmstadt-germany-announce-global-alliance-to-jointly-develop 2019-02-05T12:01:03.000Z monthly 0.5 https://feedbagel.com/post/gsk-completes-acquisition-of-tesaro-an-oncology-focused-biopharmaceutical-compan 2019-01-22T13:59:14.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-succession-plan-to-appoint-new-chairman 2019-01-21T09:27:30.000Z monthly 0.5 https://feedbagel.com/post/two-positive-phase-iii-studies-of-tafenoquine-for-the-radical-cure-of-plasmodium 2019-01-16T12:31:50.000Z monthly 0.5 https://feedbagel.com/post/glaxosmithkline-plc-and-pfizer-inc-to-form-new-world-leading-consumer-healthcare 2018-12-19T07:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-reaches-agreement-to-acquire-tesaro-an-oncology-focused-biopharmaceutical-co 2018-12-03T10:16:12.000Z monthly 0.5 https://feedbagel.com/post/gsk-to-divest-horlicks-and-other-consumer-healthcare-nutrition-products-to-unile 2018-12-03T08:24:28.000Z monthly 0.5 https://feedbagel.com/post/juluca-dolutegravirrilpivirine-the-first-single-pill-2-drug-regimen-for-the-main 2018-11-26T10:39:33.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-kyowa-hakko-kirin-sign-strategic-commercialisation-deal-in-japan-for-dap 2018-11-22T07:10:15.000Z monthly 0.5 https://feedbagel.com/post/access-to-medicine-index-2018-media-statement 2018-11-20T13:23:30.000Z monthly 0.5 https://feedbagel.com/post/gsk-submits-us-regulatory-filing-to-expand-the-use-of-nucala-in-children-with-se 2018-11-19T12:06:31.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-receives-chmp-positive-opinion-for-tivicay-eu-label-update-with- 2018-11-16T15:45:23.000Z monthly 0.5 https://feedbagel.com/post/once-daily-trelegy-ellipta-gains-expanded-copd-indication-in-europe 2018-11-09T08:00:11.000Z monthly 0.5 https://feedbagel.com/post/statement-gsk-supports-gold-committees-efforts-to-further-personalise-copd-manag 2018-11-08T12:21:04.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-announces-positive-phase-3-results-from-the-brighte-study-of-fos 2018-10-31T14:02:19.000Z monthly 0.5 https://feedbagel.com/post/gsk-delivers-q3-sales-of-81-billion-3-aer-6-cer 2018-10-31T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-reports-positive-48-week-results-for-second-phase-iii-study-for- 2018-10-30T14:30:11.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-presents-three-year-data-for-investigational-long-acting-injecta 2018-10-29T10:10:35.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-positive-phase-3-results-for-daprodustat-in-patients-with-anaemia- 2018-10-29T09:34:13.000Z monthly 0.5 https://feedbagel.com/post/gsk-presents-new-efficacy-and-safety-data-of-an-anti-gm-csf-antibody-in-patients 2018-10-21T09:38:47.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-submits-new-drug-application-to-us-fda-for-single-tablet-two-dru 2018-10-18T15:43:52.000Z monthly 0.5 https://feedbagel.com/post/gsk-updates-policy-for-working-with-healthcare-professionals 2018-10-02T11:28:19.000Z monthly 0.5 https://feedbagel.com/post/positive-results-from-harmony-outcomes-study-of-albiglutide-published-in-the-lan 2018-10-02T11:09:19.000Z monthly 0.5 https://feedbagel.com/post/gsk-candidate-vaccine-helps-prevent-active-pulmonary-tuberculosis-in-hiv-negativ 2018-09-25T17:18:28.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-tres-cantos-open-lab-foundation-announce-additional-5m-funding-for-open- 2018-09-21T14:09:12.000Z monthly 0.5 https://feedbagel.com/post/trelegy-ellipta-receives-positive-chmp-opinion-supporting-expanded-copd-indicati 2018-09-21T11:44:21.000Z monthly 0.5 https://feedbagel.com/post/kozenis-tafenoquine-approved-by-the-australian-therapeutic-goods-administration- 2018-09-21T09:15:15.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-submits-regulatory-application-to-european-medicines-agency-for--2 2018-09-14T08:52:14.000Z monthly 0.5 https://feedbagel.com/post/gsk-data-presented-at-ers-further-supports-its-industry-leading-respiratory-medi 2018-09-10T10:00:48.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-results-of-indirect-treatment-comparisons-of-nucala-to-benralizuma 2018-09-10T08:00:11.000Z monthly 0.5 https://feedbagel.com/post/gsk-receives-complete-response-letter-from-us-fda-for-use-of-mepolizumab-in-copd 2018-09-07T16:49:38.000Z monthly 0.5 https://feedbagel.com/post/european-commission-approves-nucala-mepolizumab-for-the-treatment-of-children-wi 2018-08-30T07:59:42.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-reports-positive-48-week-results-for-first-pivotal-phase-iii-stu 2018-08-15T07:05:28.000Z monthly 0.5 https://feedbagel.com/post/iain-mackay-appointed-gsk-chief-financial-officer 2018-08-07T07:04:12.000Z monthly 0.5 https://feedbagel.com/post/chmp-recommend-nucala-mepolizumab-for-the-treatment-of-severe-eosinophilic-asthm 2018-07-27T14:56:53.000Z monthly 0.5 https://feedbagel.com/post/gsk-reports-on-outcome-of-the-fda-advisory-committee-on-mepolizumab-for-the-trea 2018-07-25T16:38:28.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-23andme-sign-agreement-to-leverage-genetic-insights-for-the-development- 2018-07-25T06:25:27.000Z monthly 0.5 https://feedbagel.com/post/gsk-delivers-improvements-in-sales-margins-and-cash-flow-in-q2-2018 2018-07-25T06:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-adaptimmune-complete-transition-of-ny-eso-spear-t-cell-therapy-programme 2018-07-24T13:45:59.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-announces-sword-100-week-data-for-juluca-dolutegravirrilpivirine 2018-07-24T09:38:16.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-presents-phase-iii-data-at-aids-2018-from-landmark-gemini-studie 2018-07-24T09:24:08.000Z monthly 0.5 https://feedbagel.com/post/us-fda-approves-krintafel-tafenoquine-for-the-radical-cure-of-p-vivax-malaria 2018-07-20T17:15:45.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-shares-data-from-landmark-2-drug-regimen-trials-at-aids-2018 2018-07-18T17:27:09.000Z monthly 0.5 https://feedbagel.com/post/us-fda-advisory-committee-endorses-the-effectiveness-and-safety-of-single-dose-t 2018-07-12T16:37:20.000Z monthly 0.5 https://feedbagel.com/post/james-ford-appointed-gsk-general-counsel 2018-07-12T13:50:39.000Z monthly 0.5 https://feedbagel.com/post/roivant-subsidiary-dermavant-sciences-signs-agreement-with-gsk-to-purchase-right 2018-07-12T10:53:43.000Z monthly 0.5 https://feedbagel.com/post/infants-may-now-be-protected-against-meningitis-b-with-fewer-doses-adding-flexib 2018-06-27T10:00:12.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-reports-landmark-phase-iii-studies-for-dolutegravir-and-lamivudi 2018-06-14T06:53:59.000Z monthly 0.5 https://feedbagel.com/post/gsk-presents-new-results-showing-low-rates-of-organ-damage-with-long-term-use-of 2018-06-13T13:50:49.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-changes-to-vaccines-and-global-manufacturing-supply-leadership 2018-06-12T13:16:51.000Z monthly 0.5 https://feedbagel.com/post/gsk-completes-consumer-healthcare-buyout 2018-06-01T14:12:46.000Z monthly 0.5 https://feedbagel.com/post/gsk-submits-regulatory-application-in-japan-for-once-daily-single-inhaler-triple 2018-05-29T08:38:27.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-receives-eu-marketing-authorisation-for-juluca-dolutegravirrilpi 2018-05-21T12:40:16.000Z monthly 0.5 https://feedbagel.com/post/gsk-receives-us-approval-of-arnuity-ellipta-for-use-in-children-from-5-years-old 2018-05-21T11:42:07.000Z monthly 0.5 https://feedbagel.com/post/nucala-mepolizumab-study-reports-long-term-safety-data-consistent-exacerbation-r 2018-05-21T08:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsks-industry-leading-respiratory-research-and-scientific-innovation-showcased-a 2018-05-16T10:36:36.000Z monthly 0.5 https://feedbagel.com/post/simon-dingemans-chief-financial-officer-to-retire-from-gsk 2018-05-09T12:20:55.000Z monthly 0.5 https://feedbagel.com/post/gsk-delivers-q1-sales-of-72-billion-2-aer-4-cer 2018-04-25T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/once-daily-trelegy-ellipta-gains-expanded-indication-in-the-us-for-the-treatment 2018-04-24T17:40:16.000Z monthly 0.5 https://feedbagel.com/post/landmark-impact-study-published-in-nejm-shows-significant-benefits-of-trelegy-el 2018-04-18T14:10:18.000Z monthly 0.5 https://feedbagel.com/post/gsk-appoints-kevin-sin-as-new-svp-and-head-of-worldwide-business-development-for 2018-04-18T14:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-signs-strategic-agreement-to-transfer-rare-disease-gene-therapy-portfolio-to 2018-04-12T17:51:17.000Z monthly 0.5 https://feedbagel.com/post/gsk-reaches-agreement-with-novartis-to-acquire-full-ownership-of-consumer-health 2018-03-27T05:59:33.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-gains-chmp-positive-opinion-for-juluca-dolutegravirrilpivirine-i 2018-03-23T11:18:13.000Z monthly 0.5 https://feedbagel.com/post/shingrix-approved-in-europe-and-japan-for-the-prevention-of-shingles-in-adults-a 2018-03-23T07:17:12.000Z monthly 0.5 https://feedbagel.com/post/gsk-update-regarding-pfizer-inc-consumer-healthcare 2018-03-23T06:53:10.000Z monthly 0.5 https://feedbagel.com/post/gsk-starts-phase-iii-study-of-benlysta-and-rituximab-combination-in-systemic-lup 2018-03-20T11:09:24.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-positive-eu-approval-for-labelling-update-to-relvar-ellipta-in-pat 2018-03-08T09:27:33.000Z monthly 0.5 https://feedbagel.com/post/new-clinical-data-demonstrate-high-vaccine-efficacy-of-fluarix-tetra-influenza-v 2018-03-06T10:43:52.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-announces-positive-new-dolutegravir-data-for-the-treatment-of-pe 2018-03-05T17:45:20.000Z monthly 0.5 https://feedbagel.com/post/nucala-mepolizumab-improved-asthma-control-in-patients-uncontrolled-on-xolair-om 2018-03-05T11:30:40.000Z monthly 0.5 https://feedbagel.com/post/gsk-receives-european-approval-for-expanded-indication-for-fluarix-tetra-influen 2018-02-15T10:49:56.000Z monthly 0.5 https://feedbagel.com/post/400-buick-riviera-turned-into-3m-wild-custom-car-thats-worth-more-than-bugattis- 2026-07-08T20:08:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-submits-landmark-impact-data-to-european-medicines-agency-to-support-expande 2018-02-14T09:21:42.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-launches-eighth-phase-iii-study-in-two-drug-regimen-programme-fo 2018-02-08T10:22:42.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-files-patent-infringement-litigation-against-gilead-sciences-inc 2018-02-07T15:56:42.000Z monthly 0.5 https://feedbagel.com/post/we-got-to-see-the-audi-nuvolari-up-close-and-its-easy-to-see-how-its-the-fastest 2026-07-08T15:21:48.000Z monthly 0.5 https://feedbagel.com/post/gsk-delivers-improvements-in-sales-margins-and-cash-flow-in-2017 2018-02-07T12:00:01.000Z monthly 0.5 https://feedbagel.com/post/man-who-was-only-passenger-on-united-airlines-boeing-737-900-flight-shares-what- 2026-07-08T13:24:57.000Z monthly 0.5 https://feedbagel.com/post/gsks-meningitis-b-vaccine-bexsero-receives-breakthrough-therapy-designation-from 2018-02-07T09:17:55.000Z monthly 0.5 https://feedbagel.com/post/us-man-buys-2008-saturn-vue-xe-awd-v6-sight-unseen-for-700-to-try-and-flip-it-sa 2026-07-08T12:00:08.000Z monthly 0.5 https://feedbagel.com/post/gsks-shingrix-receives-positive-opinion-from-the-chmp-in-europe-for-the-preventi 2018-01-26T12:42:24.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-chmp-positive-opinion-for-labelling-update-to-relvar-ellipta-in-pa 2018-01-26T09:11:45.000Z monthly 0.5 https://feedbagel.com/post/fake-books-on-the-400m-boeing-747-gifted-to-the-us-by-qatar-thats-become-air-for 2026-07-08T10:05:22.000Z monthly 0.5 https://feedbagel.com/post/gsk-responds-to-the-amr-benchmark 2018-01-23T16:27:42.000Z monthly 0.5 https://feedbagel.com/post/man-investigates-ev-prices-and-finds-some-133k-electric-cars-are-worth-a-simply- 2026-07-08T09:42:02.000Z monthly 0.5 https://feedbagel.com/post/fda-approves-us-label-update-on-icslaba-combinations-in-asthma-based-on-review-o 2017-12-21T09:13:22.000Z monthly 0.5 https://feedbagel.com/post/gsk-submits-regulatory-application-for-single-dose-tafenoquine-for-the-treatment 2017-12-14T10:04:19.000Z monthly 0.5 https://feedbagel.com/post/expert-explains-why-rich-people-always-buy-mercedes-g-wagens-and-its-not-about-l 2026-07-08T00:05:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-achieves-approval-for-nucala-mepolizumab-for-the-treatment-of-eosinophilic-g 2017-12-12T16:07:20.000Z monthly 0.5 https://feedbagel.com/post/canada-man-takes-his-tesla-model-y-to-a-supercharger-at-31f-to-see-what-would-ha 2026-07-07T19:55:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-presents-promising-new-data-for-priority-bcma-asset-from-its-emerging-oncolo 2017-12-11T15:01:11.000Z monthly 0.5 https://feedbagel.com/post/new-data-supports-the-safety-and-efficacy-of-gsks-shingrix-in-preventing-shingle 2017-12-06T07:17:11.000Z monthly 0.5 https://feedbagel.com/post/oklahoma-lot-has-hundreds-of-cars-wrapped-in-red-plastic-bags-hiding-secrets-and 2026-07-07T14:19:10.000Z monthly 0.5 https://feedbagel.com/post/gsk-welcomes-launch-of-the-uk-governments-life-sciences-sector-deal 2017-12-06T07:02:07.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-announces-start-of-phase-iii-study-of-long-acting-cabotegravir-f 2017-11-30T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/man-drives-434-miles-in-one-day-in-his-tesla-model-3-then-compares-costs-and-tim 2026-07-07T13:46:28.000Z monthly 0.5 https://feedbagel.com/post/gsk-submits-us-regulatory-application-for-single-dose-tafenoquine-for-plasmodium 2017-11-28T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/queen-elizabeth-ii-owned-the-second-most-expensive-car-in-the-world-which-had-a- 2026-07-07T10:07:59.000Z monthly 0.5 https://feedbagel.com/post/gsk-responds-to-uk-industrial-strategy 2017-11-27T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-starts-third-phase-iii-hiv-treatment-study-investigating-long-ac 2017-11-27T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/us-man-who-drove-his-volvo-p1800-for-over-3-million-miles-shares-what-volvo-had- 2026-07-07T09:40:03.000Z monthly 0.5 https://feedbagel.com/post/gsk-submits-landmark-impact-data-to-us-regulatory-authority-to-support-expanded- 2017-11-23T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/juluca-dolutegravir-and-rilpivirine-approved-in-us-as-first-2-drug-regimen-once- 2017-11-21T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/what-mach-50-speed-would-look-like-at-ground-level-is-displayed-in-an-epic-simul 2026-07-07T00:05:00.000Z monthly 0.5 https://feedbagel.com/post/trelegy-ellipta-once-daily-single-inhaler-triple-therapy-gains-marketing-authori 2017-11-16T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-receives-european-marketing-authorisation-for-self-injectable-formulation-of 2017-11-13T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/miami-influencer-decided-to-show-his-support-for-argentina-at-the-world-cup-with 2026-07-06T22:00:00.000Z monthly 0.5 https://feedbagel.com/post/first-long-term-efficacy-analysis-on-the-effect-of-gsks-benlysta-on-rate-of-orga 2017-11-08T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/patrick-vallance-president-rd-gsk-to-become-uk-governments-chief-scientific-advi 2017-11-08T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/incredibly-rare-look-inside-the-400m-boeing-747-gifted-to-the-us-by-qatar-thats- 2026-07-06T20:25:00.000Z monthly 0.5 https://feedbagel.com/post/dr-hal-barron-appointed-chief-scientific-officer-and-president-research-developm 2017-11-08T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/rich-people-from-texas-paid-massive-money-to-fly-concorde-from-dallas-to-washing 2026-07-06T16:02:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-submits-us-regulatory-application-for-mepolizumab-in-eosinophilic-chronic-ob 2017-11-07T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/new-multi-country-survey-reveals-need-for-improved-awareness-around-long-term-im 2017-11-06T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/more-and-more-evs-have-been-on-the-road-in-recent-years-and-its-led-to-an-unexpe 2026-07-06T13:32:00.000Z monthly 0.5 https://feedbagel.com/post/gsks-investigational-bcma-antibody-drug-conjugate-receives-breakthrough-therapy- 2017-11-02T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/the-new-alpine-a110-future-wants-to-fix-a-problem-that-plagues-all-electric-spor 2026-07-06T12:11:25.000Z monthly 0.5 https://feedbagel.com/post/gsk-study-demonstrates-superiority-of-anoro-ellipta-to-stiolto-respimat-in-impro 2017-11-01T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-announces-positive-phase-3-results-from-the-brighte-study-of-fos-2 2017-10-27T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/virginia-man-waited-four-months-for-his-30000-alibaba-bugatti-but-could-only-lau 2026-07-06T09:50:58.000Z monthly 0.5 https://feedbagel.com/post/public-private-consortium-aims-to-cut-preclinical-cancer-drug-discovery-from-six 2017-10-27T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/ferrari-just-invented-a-new-gearbox-for-the-12cilindri-thats-both-manual-and-aut 2026-07-06T08:41:09.000Z monthly 0.5 https://feedbagel.com/post/gsk-delivers-q3-sales-of-78-billion-4-aer-2-cer 2017-10-25T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/cdcs-advisory-committee-on-immunization-practices-recommends-shingrix-as-the-pre 2017-10-25T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/shingrix-approved-in-the-us-for-prevention-of-shingles-in-adults-aged-50-and-ove 2017-10-23T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/heres-how-much-i-wouldve-saved-on-my-tesla-model-x-with-free-supercharging-since 2026-07-06T06:04:03.000Z monthly 0.5 https://feedbagel.com/post/gsk-receives-world-health-organization-prequalification-for-synflorix-pneumococc 2017-10-18T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/man-shares-all-different-kinds-of-engines-to-explain-how-genius-the-engineering- 2026-07-06T00:01:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-first-approval-of-shingrix-in-canada 2017-10-13T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/us-man-investigates-teslas-new-austin-assembly-line-to-see-if-it-will-meet-goal- 2026-07-05T18:07:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-receives-approval-for-benlysta-in-japan-for-the-treatment-of-systemic-lupus- 2017-09-27T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-innoviva-report-positive-headline-results-from-impact-study-showing-sing 2017-09-20T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/these-are-the-cheapest-evs-in-every-single-big-country-and-continent 2026-07-05T16:12:00.000Z monthly 0.5 https://feedbagel.com/post/trelegy-ellipta-approved-as-the-first-once-daily-single-inhaler-triple-therapy-f 2017-09-18T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/trelegy-ellipta-once-daily-single-inhaler-triple-therapy-receives-positive-opini 2017-09-15T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/former-concorde-pilot-explains-why-he-thinks-its-one-of-humankinds-greatest-tech 2026-07-05T14:02:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-receives-chmp-positive-opinion-for-self-injectable-formulation-of-benlysta-f 2017-09-15T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/fda-advisory-committee-votes-unanimously-for-shingrix-hzsu-in-the-us-for-prevent 2017-09-13T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-phase-iii-results-published-in-nejm-of-mepolizumab-in-patients-wit 2017-09-12T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/positive-results-from-pioneering-salford-lung-study-in-asthma-published-in-the-l 2017-09-11T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-exercises-option-on-phase-iii-ny-eso-t-cell-therapy-gsk3377794 2017-09-07T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-presents-respiratory-data-from-pipeline-to-clinical-practice-at-ers 2017-09-04T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-responds-to-uk-life-sciences-industrial-strategy 2017-08-30T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-delivers-further-progress-in-q2-and-sets-out-new-priorities-for-the-group 2017-07-26T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/karenann-terrell-appointed-chief-digital-technology-officer-gsk 2017-07-25T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/switching-to-a-dolutegravir-regimen-from-a-boosted-protease-inhibitor-regimen-ma 2017-07-25T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-announces-superior-efficacy-of-dolutegravir-versus-lopinavirrito 2017-07-25T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/phase-ii-study-results-showed-comparable-viral-suppression-rates-at-96-weeks-for 2017-07-24T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-submits-us-regulatory-filing-of-arnuity-ellipta-in-children-with-asthma 2017-07-24T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-receives-fda-approval-for-a-new-self-injectable-formulation-of-benlysta-beli 2017-07-21T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-submits-eu-filing-for-extended-use-of-relvar-ellipta-in-patients-with-contro 2017-07-21T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-board-and-committee-changes 2017-07-21T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-shares-data-from-its-innovative-portfolio-with-hiv-community-at- 2017-07-20T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-updates-on-uk-manufacturing-network 2017-07-19T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-us-regulatory-submission-for-mepolizumab-in-eosinophilic-granuloma 2017-06-28T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-starts-phase-iii-study-with-mepolizumab-in-patients-with-nasal-polyps 2017-06-27T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-receives-chmp-positive-opinion-for-synflorix-pneumococcal-vaccine-four-dose- 2017-06-27T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-presents-positive-results-from-phase-iii-revaccination-study-of-its-candidat 2017-06-21T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-results-from-10-year-continuation-study-showing-sustained-disease- 2017-06-16T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-mmv-announce-positive-headline-phase-iii-results-showing-single-dose-taf 2017-06-12T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/four-innovations-to-tackle-under-five-deaths-win-us1-million-healthcare-innovati 2017-06-05T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-submits-regulatory-applications-for-the-first-hiv-maintenance-re 2017-06-01T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare 2017-06-01T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-presents-data-at-ats-on-treatment-effect-of-nucala-mepolizumab-in-severe-ast 2017-05-22T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-nejm-publication-of-positive-phase-iii-study-investigating-mepoliz 2017-05-17T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-headline-phase-iii-results-of-mepolizumab-in-patients-with-severe- 2017-05-10T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/relvar-ellipta-significantly-improved-asthma-control-in-salford-lung-study-patie 2017-05-05T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-delivers-another-quarter-of-continued-progress 2017-04-26T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-regulatory-submission-in-japan-of-its-candidate-vaccine-for-preven 2017-04-18T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/togo-becomes-first-country-in-africa-to-validate-the-elimination-of-lymphatic-fi 2017-04-18T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-makes-change-to-financial-reporting-framework 2017-04-11T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-starts-phase-iii-study-with-mepolizumab-in-patients-with-severe-hypereosinop 2017-03-31T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-new-scholarships-to-recognise-retiring-ceo-sir-andrew-wittys-contr 2017-03-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/uk-biobank-gsk-and-regeneron-announce-largest-gene-sequencing-initiative-on-worl 2017-03-23T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsks-musca-study-shows-nucala-mepolizumab-significantly-improves-quality-of-life 2017-03-06T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-confirms-closure-of-agreement-to-divest-anaesthesia-portfolio-to-aspen 2017-03-01T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/positive-results-for-relvar-ellipta-lung-function-study-in-patients-with-well-co 2017-02-23T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-announces-detailed-positive-phase-iii-results-for-investigationa 2017-02-13T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/results-announcement-for-the-fourth-quarter-2016 2017-02-08T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/abbas-hussain-to-leave-gsk 2017-01-19T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/luke-miels-appointed-president-global-pharmaceuticals-gsk 2017-01-19T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-confirms-closure-of-agreement-to-divest-non-core-assets-to-aspen 2017-01-03T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-announces-start-of-phase-iii-study-evaluating-long-acting-cabote 2016-12-20T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-starts-phase-iii-study-of-once-daily-closed-triple-combination-therapy-ffume 2016-12-19T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-board-changes 2016-12-19T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-announces-positive-results-from-first-phase-iii-studies-of-two-d 2016-12-19T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-announces-chmp-positive-opinion-to-lower-the-age-and-weight-limi 2016-12-16T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-submits-regulatory-application-in-japan-for-belimumab-in-systemic-lupus-eryt 2016-12-13T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-opens-new-global-vaccines-rd-center-in-rockville-md-usa 2016-12-13T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/dominique-limet-to-step-down-as-ceo-of-viiv-healthcare-deborah-waterhouse-to-suc 2016-12-05T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/relvar-ellipta-10025-mcg-gains-approval-in-japan-for-use-in-patients-with-copd 2016-12-02T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-files-eu-regulatory-submission-for-once-daily-closed-triple-combination-ther 2016-12-02T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-eu-regulatory-submission-of-candidate-vaccine-for-prevention-of-sh 2016-11-25T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-starts-phase-iii-programme-with-daprodustat-for-anaemia-associated-with-chro 2016-11-24T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-phase-lll-study-of-mepolizumab-meets-co-primary-endpoints-and-all- 2016-11-23T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-files-regulatory-submission-in-us-for-once-daily-closed-triple-combination-t 2016-11-21T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-launches-phase-iii-programme-to-evaluate-a-long-acting-injectabl 2016-11-18T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-receives-fda-approval-for-expanded-indication-for-flulaval-quadrivalent-infl 2016-11-18T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-new-data-from-phase-iii-studies-of-sirukumab-in-adult-patients-wit 2016-11-16T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsks-benlysta-belimumab-shows-sustained-benefits-in-patients-with-sle 2016-11-16T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-leads-access-to-medicine-index-2016 2016-11-14T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-positive-results-in-fourth-consecutive-pivotal-trial-of-benlysta-b 2016-11-13T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-statement-in-response-to-new-york-times-article-on-china 2016-11-02T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-presents-new-data-for-shingles-candidate-vaccine-at-idweek-scientific-confer 2016-10-27T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/results-announcement-for-the-third-quarter-2016 2016-10-26T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-us-regulatory-submission-of-candidate-vaccine-for-prevention-of-sh 2016-10-24T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/new-data-published-for-gsks-nucala-investigating-hospitalisation-reduction-in-se 2016-10-07T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/glaxosmithkline-plc-appoints-brian-mcnamara-as-ceo-of-gsk-consumer-healthcare 2016-09-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/glaxosmithkline-completes-sale-of-remaining-aspen-shares 2016-09-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/glaxosmithkline-announces-intention-to-sell-remaining-holding-in-aspen 2016-09-28T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-us-regulatory-submission-for-sirukumab-in-rheumatoid-arthritis 2016-09-23T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-regulatory-submissions-for-subcutaneous-formulation-of-benlysta-be 2016-09-23T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/emma-walmsley-to-succeed-andrew-witty-as-chief-executive-officer-of-glaxosmithkl 2016-09-20T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-sets-out-further-steps-to-address-emerging-global-health-security-challenges 2016-09-19T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsks-candidate-shingles-vaccine-shows-high-efficacy-against-shingles-and-its-com 2016-09-14T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-eu-regulatory-submission-for-sirukumab-in-rheumatoid-arthritis 2016-09-12T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-divests-non-core-assets-to-aspen 2016-09-12T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-presents-positive-results-from-phase-iii-fulfil-study-of-closed-triple-combi 2016-09-06T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/real-world-data-shows-83-percent-effectiveness-for-bexsero-in-infants-in-first-y 2016-09-05T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announce-positive-results-from-the-copd-salford-lung-study-published-in-the- 2016-09-04T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/nejm-publishes-results-of-gsks-long-term-laba-safety-study-of-advair-diskus-in-c 2016-09-01T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsks-continued-commitment-to-innovative-respiratory-research-demonstrated-in-eur 2016-08-27T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-launches-phase-iii-programme-evaluating-a-two-drug-regimen-combi 2016-08-16T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-verily-to-establish-galvani-bioelectronics-a-new-company-dedicated-to-th 2016-08-01T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/results-announcement-for-the-second-quarter-2016-and-half-yearly-financial-repor 2016-07-27T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-significant-new-investment-in-uk-manufacturing-network 2016-07-27T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-in-licenses-anti-il-33r-monoclonal-antibody-for-severe-asthma-from-janssen 2016-07-27T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/aria-study-shows-superior-efficacy-of-triumeq-for-treatment-naive-women-living-w 2016-07-18T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/update-on-gsks-response-to-the-zika-virus-disease-outbreak 2016-07-07T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-save-the-children-call-for-developing-country-innovations-to-enter-1-mil 2016-07-07T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-start-of-phase-i-oncology-study-with-its-icos-agonist-antibody 2016-06-30T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/fulfil-study-shows-superiority-of-closed-triple-combination-therapy-ffumecvi-ver 2016-06-20T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/executive-director-change 2016-06-14T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-announces-fda-approval-to-lower-the-weight-limit-for-dolutegravi 2016-06-10T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-phase-iii-study-of-sirukumab-meets-both-co-primary-endpoints-in-pa 2016-06-08T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/new-phase-iii-data-shows-greater-treatment-response-with-gsks-benlysta-belimumab 2016-06-08T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-announces-public-tender-agreement-with-botswana-ministry-of-heal 2016-06-03T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/regulatory-update-on-us-filing-plans-for-closed-triple-combination-therapy-ffume 2016-06-02T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/strimvelistm-receives-european-marketing-authorisation-to-treat-very-rare-diseas 2016-05-27T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/board-and-committee-changes-2 2016-05-27T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-fondazione-telethon-and-ospedale-san-raffaele-announce-publication-of-pivota 2016-05-25T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/salford-lung-study-results-show-copd-patients-treated-with-relvar-ellipta-achiev 2016-05-24T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-presents-new-data-from-breo-ellipta-summit-study-in-patients-with-copd-at-at 2016-05-18T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-presents-efficacy-data-for-anoro-ellipta-in-copd-patients-who-remained-sympt 2016-05-18T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsks-bexseroachieves-primary-and-secondary-endpoints-with-reduced-3-dose-schedul 2016-05-13T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/european-agency-endorses-antiseptic-gel-developed-through-gsk-and-save-the-child 2016-04-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-statement-on-pneumococcal-vaccine-pricing 2016-04-27T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/results-announcement-for-the-first-quarter-2016 2016-04-27T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-extends-medicines-patent-pool-licence-agreement-for-dolutegravir 2016-04-25T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-start-of-a-phase-ii-study-to-evaluate-an-anti-gm-csf-antibody-for- 2016-04-18T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-opens-new-state-of-the-art-respiratory-manufacturing-facility-in-ware-uk 2016-04-18T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-receives-positive-chmp-opinion-in-europe-for-strimvelistm-the-first-gene-the 2016-04-01T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-expands-graduated-approach-to-patents-and-intellectual-property-to-widen-acc 2016-03-31T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-receives-marketing-authorisation-for-nucala-mepolizumab-in-japan 2016-03-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/sir-andrew-witty-to-retire-from-gsk-in-march-2017 2016-03-17T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/glaxosmithkline-plc-the-company-directorate-changes 2016-03-17T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsks-advair-diskus-achieves-primary-endpoint-in-laba-safety-study-of-children-ag 2016-03-17T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-miltenyi-biotec-establish-cell-and-gene-therapy-collaboration 2016-03-16T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-presents-data-at-aaaai-on-efficacy-of-nucala-mepolizumab-in-severe-asthma-pa 2016-03-07T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/nejm-publishes-results-of-gsks-long-term-laba-safety-study-of-advair-diskus-in-a 2016-03-06T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-presents-new-data-on-the-long-term-efficacy-safety-of-nucala-for-the-treatme 2016-03-05T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-names-winners-of-2015-discovery-fast-track-challenge 2016-03-04T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/new-long-term-organ-damage-analysis-published-for-gsks-benlysta-belimumab 2016-03-03T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-announces-first-phase-ii-hiv-prevention-study-results-for-invest 2016-02-24T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/four-inspiring-innovations-which-help-reduce-child-deaths-in-developing-countrie 2016-02-23T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-announces-phase-ii-study-results-for-first-two-drug-long-acting- 2016-02-23T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsks-global-hiv-business-viiv-healthcare-completes-transactions-to-acquire-brist 2016-02-22T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/results-announcement-for-the-fourth-quarter-2015 2016-02-03T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-adaptimmune-expand-strategic-immunotherapy-collaboration 2016-02-02T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-us-regulatory-submission-seeking-expanded-indication-for-flulaval- 2016-02-02T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/global-pharmaceutical-industry-calls-on-governments-to-work-with-them-to-beat-th 2016-01-21T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-to-progress-collaboration-with-janssen-to-develop-the-first-long 2016-01-07T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-appoints-dr-jesse-goodman-to-the-board-as-a-non-executive-director 2015-12-23T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-completes-divestment-of-rights-to-ofatumumab-for-auto-immune-indications-to- 2015-12-21T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsks-global-hiv-business-viiv-healthcare-to-acquire-bristol-myers-squibbs-rd-hiv 2015-12-18T07:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-receives-positive-top-line-results-from-sirukumab-phase-iii-programme-suppor 2015-12-16T14:00:00.000Z monthly 0.5 https://feedbagel.com/post/comic-relief-and-gsk-form-five-year-partnership-to-fight-malaria-and-strengthen- 2015-12-15T08:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-receives-european-marketing-authorisation-for-nucala-mepolizumab-in-31-count 2015-12-02T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-start-of-phase-iii-study-of-sirukumab-in-giant-cell-arteritis 2015-11-25T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-receives-european-marketing-authorisation-to-expand-indication-for-volibris- 2015-11-24T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-positive-results-from-phase-iii-bliss-sc-study-of-benlysta-belimum 2015-11-07T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsks-nucala-mepolizumab-receives-approval-from-us-fda 2015-11-04T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-announces-positive-headline-results-from-a-study-of-two-drug-inj 2015-11-03T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-merck-to-study-immunotherapy-combination-as-potential-cancer-treatment 2015-11-03T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-profiles-innovative-rd-portfolio-to-investors 2015-11-03T11:55:00.000Z monthly 0.5 https://feedbagel.com/post/results-announcement-for-the-third-quarter-2015 2015-10-28T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsks-candidate-shingles-vaccine-demonstrates-90-efficacy-against-shingles-in-peo 2015-10-27T10:55:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-provides-update-on-latitude-timi-60-losmapimod-cardiovascular-study 2015-10-27T10:45:00.000Z monthly 0.5 https://feedbagel.com/post/gsks-advair-diskus-achieves-primary-endpoint-in-laba-safety-study-of-patients-wi 2015-10-27T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-receives-chmp-positive-opinion-to-expand-indication-for-volibris-in-pulmonar 2015-10-23T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-positive-new-data-comparing-incruse-ellipta-to-tiotropium-and-glyc 2015-10-20T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-submits-regulatory-application-for-chlorhexidine-gel-for-the-prevention-of-u 2015-10-12T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-presents-post-hoc-analysis-of-anoro-ellipta-data-assessing-markers-of-copd-d 2015-09-27T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/regulatory-update-gsk-and-theravance-announce-intention-to-file-relvar-ellipta-f 2015-09-24T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-receives-positive-chmp-opinion-in-europe-for-novel-anti-il5-biological-nucal 2015-09-24T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/new-phase-iiibiv-data-show-switching-to-once-daily-triumeq-maintains-hiv-viral-s 2015-09-23T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-theravance-announce-results-from-the-summit-copd-cv-survival-study 2015-09-08T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-starts-build-of-its-largest-indian-tablet-manufacturing-pharmaceutical-facto 2015-09-08T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-nejm-publication-of-phase-3b4-study-of-ambrisentan-and-tadalafil-a 2015-08-26T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-to-divest-ofatumumab-for-auto-immune-indications-to-novartis-for-up-to-1-bil 2015-08-21T06:30:00.000Z monthly 0.5 https://feedbagel.com/post/results-announcement-for-the-second-quarter-2015 2015-07-29T12:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsks-synflorixtm-receives-chmp-positive-opinion-for-major-label-extension 2015-07-27T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsks-malaria-candidate-vaccine-mosquirixtm-rtss-receives-positive-opinion-from-e 2015-07-24T06:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-save-the-children-launch-2015-call-for-developing-country-healthcare-inn 2015-07-15T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-the-francis-crick-institute-join-forces-in-collaboration-to-forge-new-sc 2015-07-14T08:00:00.000Z monthly 0.5 https://feedbagel.com/post/regulatory-update-on-divestment-of-nimenrix-and-mencevax 2015-06-22T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-to-create-independent-research-institute-with-goal-of-radically-changing-and 2015-06-16T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-outcome-of-us-fda-advisory-committee-recommending-approval-of-mepo 2015-06-11T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-submits-japan-regulatory-application-for-mepolizumab-in-severe-eosinophilic- 2015-05-22T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-to-support-training-of-frontline-health-workers-across-ghana-kenya-and-niger 2015-05-22T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-presents-data-at-ats-on-the-role-of-blood-eosinophil-levels-as-a-potential-b 2015-05-19T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsks-eclipse-study-shows-association-between-improving-health-status-and-reduced 2015-05-18T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-responds-to-latest-report-from-the-oneill-review-on-antibiotic-resistance 2015-05-14T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-unc-chapel-hill-announce-novel-partnership-to-accelerate-search-for-hiv- 2015-05-10T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/glaxosmithkline-plc-announces-board-and-committee-changes 2015-05-07T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/results-announcement-for-the-first-quarter-2015 2015-05-06T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-begins-phase-iii-programme-with-dolutegravirrilpivirine-combinat 2015-05-06T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-fondazione-telethon-and-ospedale-san-raffaele-announce-eu-regulatory-submiss 2015-05-05T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/fda-approves-breo-ellipta-for-the-treatment-of-adults-with-asthma-in-the-us 2015-04-30T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-candidate-vaccine-for-the-prevention-of-shingles-demonstrates-overall-effica 2015-04-28T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/malaria-vaccine-candidate-has-demonstrated-efficacy-over-3-4-years-of-follow-up 2015-04-24T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-to-establish-global-vaccines-rd-centre-in-the-us 2015-04-02T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-statement-on-meningitis-vaccination-in-the-uk 2015-03-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-receives-approval-for-encruse-ellipta-in-japan-for-the-treatment-of-copd 2015-03-26T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsks-2015-discovery-fast-track-challenge-seeks-early-drug-discovery-partnerships 2015-03-24T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-theravance-announce-outcome-of-us-fda-advisory-committee-on-breo-ellipta 2015-03-19T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-start-of-phase-iii-programme-to-evaluate-retosiban-for-spontaneous 2015-03-17T01:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-becomes-partner-in-new-global-fund-to-accelerate-dementia-research 2015-03-17T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-transaction 2015-03-13T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-transaction-launch 2015-03-12T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-major-new-commitment-to-asia 2015-03-10T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-completes-major-three-part-transaction-with-novartis 2015-03-02T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/glaxosmithkline-plc-announces-changes-to-its-board 2015-02-26T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/update-on-three-part-transaction-with-novartis 2015-02-25T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-strengthens-early-stage-vaccine-pipeline-with-acquisition-of-glycovaxyn-ag 2015-02-11T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-theravance-announce-start-of-phase-iii-lung-function-study-with-closed-t 2015-02-09T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-positive-overall-survival-results-from-phase-iii-combi-d-study-of- 2015-02-06T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-eu-regulatory-submission-seeking-additional-indication-for-eltromb 2015-02-06T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/results-announcement-for-the-fourth-quarter-2014 2015-02-04T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/four-initiatives-from-across-africa-win-share-of-global-us1-million-healthcare-i 2015-01-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/regulatory-update-on-three-part-transaction-with-novartis 2015-01-28T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-statement-on-oxford-university-phase-i-trial-results-of-an-ebola-candidate-v 2015-01-28T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/board-committee-change 2015-01-27T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-extends-its-price-freeze-commitment-to-ten-years-for-countries-graduating-fr 2015-01-26T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/major-milestone-for-gsknih-candidate-ebola-vaccine-as-first-doses-shipped-to-lib 2015-01-23T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-confronts-copd-to-deliver-new-insights-from-across-the-globe-to-promote-impr 2015-01-22T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-us-regulatory-submission-seeking-additional-indication-for-eltromb 2014-12-22T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/pivotal-phase-iii-study-of-gsk-shingles-candidate-vaccine-meets-its-primary-endp 2014-12-18T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/new-european-consortium-formed-to-help-further-advance-development-of-a-gsknih-e 2014-12-16T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-eu-regulatory-submission-seeking-extended-indication-for-ambrisent 2014-12-11T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-statement-on-established-products-portfolio 2014-12-04T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-names-winners-of-2014-discovery-fast-track-challenge 2014-12-01T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-statement-on-first-phase-1-trial-results-of-a-candidate-ebola-vaccine 2014-11-26T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/regulatory-update-on-transaction-with-novartis 2014-11-26T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/publication-of-circular-and-notice-of-general-meeting-relating-to-the-proposed-m 2014-11-24T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-leads-access-to-medicine-index-2014 2014-11-17T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/new-england-journal-of-medicine-publishes-positive-results-from-combi-v-study-of 2014-11-16T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-launches-first-call-for-proposals-for-research-in-to-non-communicable-diseas 2014-11-14T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-eu-regulatory-submission-seeking-additional-indication-for-eltromb-2 2014-11-12T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-regulatory-submissions-for-mepolizumab-in-severe-eosinophilic-asth 2014-11-05T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/results-announcement-for-the-third-quarter-2014 2014-10-22T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-update-on-current-development-status-of-the-gsknih-ebola-vaccine-candidate 2014-10-18T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/data-published-on-anoro-ellipta-demonstrate-improved-lung-function-compared-to-t 2014-10-17T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/stiefel-a-gsk-company-announces-start-of-phase-iii-study-of-subcutaneous-ofatumu 2014-10-07T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-appoints-mr-urs-rohner-to-its-board-as-a-non-executive-director 2014-10-03T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-commits-further-funding-to-advance-bioelectronics-research-with-creation-of- 2014-09-30T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-overall-survival-results-from-phase-iii-break-3-study-of-tafinlar- 2014-09-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/glaxosmithkline-plc-appoints-sir-philip-hampton-to-the-board-of-directors 2014-09-25T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/international-collaboration-to-develop-inhaled-form-of-oxytocin-to-manage-bleedi 2014-09-25T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-china-investigation-outcome 2014-09-19T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-joins-with-research-councils-in-uk-and-south-africa-to-tackle-non-communicab 2014-09-09T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-data-presented-at-ers-demonstrate-potential-of-blood-eosinophil-levels-to-he 2014-09-08T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/new-england-journal-of-medicine-and-ers-publish-positive-results-from-gsk-phase- 2014-09-08T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-first-line-combination-of-ambrisentan-and-tadalafil-reduces-risk-o 2014-09-08T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-gold-and-the-copd-foundation-announce-formation-of-a-new-external-expert-gov 2014-09-08T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-receives-eu-marketing-authorisation-for-triumeq-dolutegravirabac 2014-09-03T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/ebola-vaccine-trials-fast-tracked-by-international-consortium 2014-08-28T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsks-promacta-eltrombopag-receives-fda-approval-of-an-additional-indication 2014-08-26T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-receives-fda-approval-for-triumeq-abacavir-dolutegravir-and-lami 2014-08-22T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-receives-fda-approval-for-arnuitytm-ellipta-fluticasone-furoate-in-the-usa-f 2014-08-20T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-genmab-announce-positive-interim-result-for-phase-iii-study-of-ofatumuma 2014-07-31T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-eu-regulatory-submission-for-malaria-vaccine-candidate-rtss 2014-07-24T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/fda-approves-flonase-allergy-relief-for-sale-over-the-counter-in-the-united-stat 2014-07-24T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/results-announcement-for-the-second-quarter-2014 2014-07-23T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-presents-phase-iii-data 2014-07-22T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/trametinib-mekinisttm-and-dabrafenib-tafinlartm-combination-demonstrated-overall 2014-07-17T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-theravance-announce-initiation-of-phase-iii-programme-with-fixed-dose-tr 2014-07-16T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-receives-eu-marketing-authorisation-for-mekinisttm-trametinib-for-patients-w 2014-07-04T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/anoro-ellipta-umeclidiniumvilanterol-gains-approval-in-japan-for-the-treatment-o 2014-07-04T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-statement-in-response-to-recent-media-coverage-related-to-our-china-business 2014-07-03T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-genmab-receive-eu-authorisation-for-arzerra 2014-07-03T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-statement-on-uk-government-initiated-review-of-antibiotic-resistance 2014-07-02T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-statement-on-recent-media-coverage-related-to-our-china-business 2014-06-30T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-theravance-announce-submission-to-us-regulatory-authorities-for-fluticas 2014-06-30T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-save-the-children-offer-1-million-award-for-healthcare-innovations-in-de 2014-06-30T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/triumeq-dolutegravirabacavirlamivudine-single-tablet-regimen-receives-positive-c 2014-06-27T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-genmab-announce-top-line-results-from-a-phase-iii-study-of-ofatumumab-ve 2014-06-27T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-the-start-of-a-phase-iii-study-with-eltrombopag-in-patients-with-m 2014-06-25T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-presents-new-data-for-once-weekly-tanzeumeperzan-albiglutide-showing-blood-g 2014-06-14T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-results-of-phase-iii-petit2-study-of-eltrombopag-promactatmrevolad 2014-06-13T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-announces-new-collaboration-with-janssen-to-investigate-single-t 2014-06-12T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-theravance-announce-positive-data-from-two-studies-evaluating-the-effica 2014-06-11T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-start-of-phase-iii-cardiovascular-outcomes-study-with-losmapimod-i 2014-06-05T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-phase-iii-altto-results-for-anti-her2-therapy-combination-in-the-a 2014-06-01T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/serious-fraud-office-investigation 2014-05-27T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-regulatory-submission-for-umeclidinium-monotherapy-for-copd-in-jap 2014-05-23T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-genmab-receive-fda-approval-for-arzerra-ofatumumab 2014-05-23T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-new-commitment-to-improve-access-to-vaccines-with-5-year-price-fre 2014-05-20T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/motherapy-for-the-treatment-of-relapsed-or-refractory-diffuse-large-b-cell-lymph 2014-05-19T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-presents-positive-data-at-ats-2014-from-study-evaluating-efficacy-and-safety 2014-05-19T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-comment-china-investigation 2014-05-14T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-phase-iii-study-with-darapladib-did-not-meet-primary-endpoint-in-p 2014-05-13T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/anoro-umeclidiniumvilanterol-gains-marketing-authorisation-in-europe-for-the-tre 2014-05-08T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/results-announcement-for-the-first-quarter-2014 2014-04-30T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-receives-approval-for-incrusetm-ellipta-umeclidinium-in-the-us-for-the-treat 2014-04-30T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-start-of-phase-iii-programme-for-mepolizumab-in-patients-with-copd 2014-04-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-receives-eu-marketing-authorisation-for-incruse-umeclidinium-for-the-treatme 2014-04-28T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-mmv-announce-start-of-phase-iii-programme-of-tafenoquine-for-plasmodium- 2014-04-28T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-receives-positive-chmp-opinion-for-mekinisttm-trametinib-in-metastatic-melan 2014-04-25T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-plc-announces-major-three-part-transaction-with-novartis-to-drive-sustainabl 2014-04-22T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-theravance-announce-phase-iii-study-of-fluticasone-furoatevilanterol-in- 2014-04-22T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-approval-in-canada-for-incruse-ellipta-umeclidinium-as-a-treatment 2014-04-17T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-genmab-receive-fda-approval-for-arzerra 2014-04-17T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-statement-on-media-reports 2014-04-16T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-receives-us-approval-for-once-weekly-type-2-diabetes-treatment-tanzeumtm-alb 2014-04-15T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-statement-on-bbc-panorama-programme 2014-04-14T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/update-on-phase-iii-clinical-trial-of-investigational-mage-a3-antigen-specific-c 2014-04-02T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-announces-new-initiatives-to-improve-access-to-dolutegravir-lice 2014-04-01T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/results-from-phase-iii-patient-preference-study-of-gsks-votrient-pazopanib-vs-su 2014-04-01T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/regulatory-update-votrient-pazopanib-as-maintenance-therapy-for-advanced-ovarian 2014-03-31T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-new-strategic-investments-in-africa-to-increase-access-to-medicine 2014-03-31T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-presents-data-from-phase-iii-stability-study-of-darapladib-in-patients-with- 2014-03-30T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-acquires-full-ownership-of-its-indonesian-consumer-healthcare-business 2014-03-28T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/where-do-you-start-when-developing-a-new-medicine 2014-03-27T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/regulatory-update-combined-use-of-mekinisttm-trametinib-and-tafinlar-dabrafenib- 2014-03-26T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/generalisability-of-proposed-clinical-sepsis-phenotypes-questioned-by-internatio 2026-07-07T15:32:20.000Z monthly 0.5 https://feedbagel.com/post/gsk-receives-european-authorisation-for-once-weekly-type-2-diabetes-treatment-ep 2014-03-26T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-publishes-historical-quarterly-restated-financial-information 2014-03-21T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/investigational-mage-a3-antigen-specific-cancer-immunotherapeutic-does-not-meet- 2014-03-20T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/nirsevimab-linked-to-marked-reduction-in-paediatric-rsv-hospitalisations-real-wo 2026-07-06T14:22:15.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-theravance-announce-positive-results-from-studies-comparing-anorotm-elli 2014-03-14T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/patient-recruitment-completes-in-landmark-relvar-breo-ellipta-study-to-understan 2014-03-13T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/evidence-linking-legume-and-soy-intake-with-reduced-hypertension-risk-strengthen 2026-07-06T08:57:53.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-positive-results-from-phase-iii-studies-for-mepolizumab-in-severe- 2014-03-12T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-increases-stake-in-indian-pharmaceuticals-subsidiary-to-75-per-cent-after-op 2014-03-10T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/delgocitinib-cream-linked-to-low-systemic-exposure-in-chronic-hand-eczema-post-h 2026-07-03T12:16:58.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-submission-to-us-regulatory-authorities-for-promactatm-eltrombopag 2014-02-28T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/shaping-the-future-of-cardio-oncology-insights-from-esc-cardio-oncology-2026-and 2026-07-03T12:12:17.000Z monthly 0.5 https://feedbagel.com/post/gsk-kicks-off-2014-discovery-fast-track-challenge-for-academic-drug-hunters-in-e 2014-02-25T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-receives-positive-chmp-opinion-for-incruse-umeclidinium-for-the-treatment-of 2014-02-20T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/respiratory-oscillometry-shows-considerable-potential-for-infant-lung-assessment 2026-07-02T13:42:27.000Z monthly 0.5 https://feedbagel.com/post/anoro-umeclidinium-vilanterol-receives-positive-opinion-from-the-chmp-in-europe- 2014-02-20T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-start-of-phase-lll-study-for-mepolizumab-in-patients-with-eosinoph 2014-02-14T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/bidirectional-phenotype-switching-between-psoriasis-and-atopic-dermatitis-charac 2026-07-02T09:38:49.000Z monthly 0.5 https://feedbagel.com/post/results-announcement-for-fourth-quarter-2013 2014-02-05T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-gains-fda-breakthrough-therapy-designation-for-promactarevolade-eltrombopag- 2014-02-03T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/blood-eosinophil-count-may-identify-preschool-children-at-greater-risk-of-wheeze 2026-07-01T14:50:41.000Z monthly 0.5 https://feedbagel.com/post/gsk-receives-positive-opinion-from-the-chmp-in-europe-for-once-weekly-eperzantm- 2014-01-24T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/post-diagnostic-statin-use-and-survival-in-hormone-receptor-positive-early-breas 2026-07-01T08:52:17.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-headline-results-for-phase-iii-study-of-the-combination-of-tafinla 2014-01-24T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcares-new-hiv-medicine-tivicaytm-dolutegravir-is-approved-in-europe 2014-01-21T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/risankizumab-outperforms-deucravacitinib-in-moderate-psoriasis-interim-trial-dat 2026-06-30T14:51:20.000Z monthly 0.5 https://feedbagel.com/post/prosensa-regains-rights-to-drisapersen-from-gsk-and-retains-rights-to-all-other- 2014-01-13T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/clinical-benefit-of-vitamin-d-and-calcium-supplements-for-fracture-prevention-qu 2026-06-30T10:19:56.000Z monthly 0.5 https://feedbagel.com/post/tafinlar-receives-fda-breakthrough-therapy-designation-for-non-small-cell-lung-c 2014-01-13T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/supporting-patients-with-rmds-to-optimise-the-gut-microbiome-tips-from-eular-202 2026-06-29T16:44:55.000Z monthly 0.5 https://feedbagel.com/post/gsk-gains-accelerated-fda-approval-for-combination-use-of-mekinist-trametinib-an 2014-01-09T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-adds-detailed-clinical-trial-data-to-multi-sponsor-request-system-as-part-of 2014-01-02T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/rsv-rapidly-rebounded-in-european-infants-after-covid-19-meta-analysis-finds 2026-06-29T15:26:03.000Z monthly 0.5 https://feedbagel.com/post/gsk-completes-divestment-of-lucozade-and-ribena-to-suntory 2013-12-31T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/digital-platforms-and-artificial-intelligence-view-from-eular-2026 2026-06-26T07:50:55.000Z monthly 0.5 https://feedbagel.com/post/gsk-completes-divestment-of-thrombosis-brands-and-related-manufacturing-site-to- 2013-12-31T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/mesh-placement-linked-to-recurrence-and-bowel-obstruction-risk-after-ventral-her 2026-06-25T07:48:45.000Z monthly 0.5 https://feedbagel.com/post/gsk-cervarix-two-dose-schedule-receives-european-marketing-authorisation 2013-12-20T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-mmv-announce-fda-breakthrough-therapy-designation-for-tafenoquine-for-pl 2013-12-20T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/novel-troponin-t-assay-could-double-the-rapid-rule-out-of-myocardial-infarction- 2026-06-23T09:44:36.000Z monthly 0.5 https://feedbagel.com/post/update-on-patent-ruling-on-viiv-healthcares-epzicom-and-trizivir 2013-12-18T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-1-million-innovation-prize-for-bioelectronics-research 2013-12-18T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/anorotm-elliptatm-approved-as-first-once-daily-dual-bronchodilator-for-the-treat 2013-12-18T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-changes-to-its-global-sales-and-marketing-practices-to-further-ens 2013-12-17T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-genmab-receive-priority-review-from-fda-for-arzerra-ofatumumab-as-1st-li 2013-12-17T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-initiates-voluntary-open-offer-to-increase-stake-in-its-pharmaceuticals-subs 2013-12-16T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-200-million-investment-in-uk-advanced-manufacturing-and-science 2013-12-11T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/update-regarding-2010-nature-medicine-study 2013-12-06T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-theravance-announce-positive-results-from-pivotal-phase-iii-study-for-fl 2013-12-06T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/synflorixtm-receives-european-marketing-authorisation-for-additional-pneumonia-i 2013-12-05T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-launches-global-consortium-with-six-renowned-cancer-research-centres 2013-12-05T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/regulatory-update-gsk-receives-positive-chmp-opinion-for-cervarixtm-two-dose-sch 2013-11-28T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/h5n1-vaccine-approved-by-the-us-fda-as-pandemic-influenza-preparedness-measure 2013-11-25T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-responds-to-fda-decision-on-avandia-rosiglitazone 2013-11-25T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/tivicay-dolutegravir-receives-positive-chmp-opinion-in-europe-for-the-treatment- 2013-11-22T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-amicus-therapeutics-announce-revised-fabry-agreement 2013-11-20T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/relvar-ellipta-receives-european-marketing-authorisation-for-the-treatment-of-as 2013-11-18T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/five-inspirational-organisations-from-malawi-bangladesh-mali-kenya-and-colombia- 2013-11-14T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-top-line-results-from-pivotal-phase-iii-study-of-darapladib-in-chr 2013-11-12T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-names-inaugural-winners-in-unique-competition-for-academic-drug-hunters 2013-11-06T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-new-apprentice-and-graduate-engineering-opportunities-in-the-uk-du 2013-11-05T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-data-to-support-cervarix-two-dose-schedule-for-the-prevention-of-c 2013-11-04T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/new-partnership-between-gsk-and-the-bill-melinda-gates-foundation-to-accelerate- 2013-10-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-to-create-a-new-centre-of-excellence-for-sustainable-chemistry-in-brazil 2013-10-25T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-announces-european-regulatory-submission-for-a-single-tablet-reg 2013-10-25T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/synflorixtm-receives-positive-opinion-from-the-chmp-in-europe-for-additional-pne 2013-10-25T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/results-announcement-for-the-third-quarter-2013 2013-10-23T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-us-regulatory-submission-for-fluticasone-furoate-monotherapy-for-a 2013-10-23T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-announces-us-regulatory-submission-for-a-single-tablet-regimen-c 2013-10-22T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/regulatory-update-gsk-and-genmab-announce-submission-to-us-regulatory-authoritie 2013-10-18T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/malaria-vaccine-candidate-reduces-disease-over-18-months-of-follow-up-in-late-st 2013-10-08T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/regulatory-update-gsk-and-genmab-announce-european-submission-to-regulatory-auth 2013-10-04T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/glaxosmithkline-reaches-agreement-with-aspen-to-divest-thrombosis-brands-and-rel 2013-09-30T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-barclays-form-partnership-to-increase-access-to-healthcare-and-promote-e 2013-09-27T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-receives-marketing-authorisation-from-the-european-commission-for-additional 2013-09-24T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-prosensa-announce-primary-endpoint-not-met-in-phase-iii-study-of-drisape 2013-09-20T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/relvartm-elliptatm-gains-approval-in-japan-for-the-treatment-of-asthma 2013-09-20T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-signs-a-multi-year-agreement-with-barda-to-supply-the-us-government-with-ant 2013-09-19T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/relvartm-elliptatm-receives-positive-opinion-from-the-chmp-in-europe-for-the-tre 2013-09-19T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-receives-priority-review-from-fda-for-dabrafenibtrametinib-combination-in-me 2013-09-16T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-statement-in-response-to-patent-ruling-reversal-on-lovaza 2013-09-13T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/fda-grants-gsk-and-genmabs-arzerra-ofatumumab-breakthrough-therapy-designation-f 2013-09-13T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-presents-positive-data-from-phase-iiibiv-study-of-dolutegravir-v 2013-09-12T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/fda-advisory-committee-recommends-approval-in-us-of-umeclidiniumvilanterol-for-t 2013-09-10T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-reaches-agreement-to-divest-lucozade-and-ribena-for-135-billion 2013-09-09T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/the-investigational-mage-a3-antigen-specific-cancer-immunotherapeutic-does-not-m 2013-09-05T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-receives-marketing-authorisation-from-the-european-commission-for-tafinlartm 2013-09-02T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-phase-iii-study-of-vercirnon-in-patients-with-moderate-to-severe-c 2013-08-23T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-receives-marketing-authorisation-from-the-european-commission-for-additional-2 2013-08-14T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-announces-us-approval-of-tivicay-dolutegravir-for-the-treatment- 2013-08-13T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-launches-50-million-venture-capital-fund-to-invest-in-pioneering-bioelectron 2013-08-08T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/regulatory-update-gsk-announces-eu-submission-seeking-additional-indication-for- 2013-08-07T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/regulatory-update-gsk-announces-eu-submission-for-cervarix-two-dose-schedule 2013-08-07T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/regulatory-update-albiglutide-us-pdufa-date-extended-by-three-months 2013-08-02T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-adds-to-its-commitment-to-gavi-alliance-to-help-protect-millions-more-childr 2013-07-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-receives-positive-chmp-opinion-for-revolade-in-thrombocytopenia-associated-w 2013-07-26T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/results-announcement-for-the-second-quarter-2013 2013-07-24T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-statement-regarding-recent-meeting-with-chinese-authorities 2013-07-22T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/update-on-gsk-consumer-nigeria-plc-scheme-of-arrangement 2013-07-22T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-response-to-china-investigation 2013-07-15T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/regulatory-update-fluticasone-furoatevilanterol-submission-in-japan 2013-07-12T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/regulatory-update-gsk-announces-us-submission-for-dabrafenibtrametinib-combinati 2013-07-09T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/regulatory-update-gsk-receives-positive-chmp-opinions-for-tafinlar-dabrafenib-an 2013-06-28T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/glaxosmithklines-drisapersen-previously-gsk2402968pro051-to-receive-food-and-dru 2013-06-27T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-save-the-children-launch-1-million-award-to-discover-new-healthcare-inno 2013-06-27T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-data-from-five-phase-iii-studies-of-albiglutide-an-investigational 2013-06-24T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-receives-offer-for-its-thrombosis-brands-and-related-manufacturing-site 2013-06-18T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-statement-regarding-2010-nature-medicine-study 2013-06-10T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-statement-in-response-to-fda-advisory-committees-vote-on-availability-of-ava 2013-06-06T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-phase-iii-data-for-tykerbtyverb-lapatinib-in-combination-with-chem 2013-06-03T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-late-stage-clinical-data-for-votrient-pazopanib-following-chemothe 2013-06-01T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-genmab-announce-positive-top-line-results-from-pivotal-trial-of-arzerra- 2013-05-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/two-new-gsk-oral-oncology-treatments-braf-inhibitor-tafinlar-dabrafenib-capsules 2013-05-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-strengthens-vaccines-business-with-acquisition-of-okairos 2013-05-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/grant-to-help-coordinate-campaign-to-train-one-million-community-health-workers- 2013-05-24T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/glaxosmithkline-awarded-up-to-200-million-by-us-government-to-develop-new-antibi 2013-05-22T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/breotm-elliptatm-gains-us-approval-for-the-treatment-of-copd 2013-05-10T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-enters-new-commitment-with-the-gavi-alliance-to-supply-cervical-cancer-vacci 2013-05-09T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-save-the-children-form-unique-partnership-to-save-the-lives-of-one-milli 2013-05-09T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-gives-update-on-plans-to-share-detailed-clinical-trial-data-as-part-of-its-c 2013-05-07T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/funding-boost-for-gsks-open-innovation-research-into-diseases-affecting-the-deve 2013-05-03T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/regulatory-update-trametinib-us-pdufa-date-extended-to-3-september-2013 2013-05-01T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-regulatory-submission-for-umeclidinium-monotherapy-in-us 2013-04-30T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/glaxosmithkline-and-impax-pharmaceuticals-terminate-their-collaboration-on-ipx06 2013-04-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-regulatory-submission-for-umeclidinium-monotherapy-in-european-uni 2013-04-26T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/results-announcement-for-the-first-quarter-2013 2013-04-24T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-theravance-announce-regulatory-submission-for-anorotm-elliptatm-umecvi-i 2013-04-22T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-statement-in-response-to-oft-statement-of-objections 2013-04-19T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/fda-advisory-committee-recommends-approval-of-breotm-elliptatm-for-the-treatment 2013-04-17T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-first-four-strain-seasonal-influenza-vaccine-granted-marketing-aut 2013-04-03T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/glaxosmithkline-announces-start-of-phase-iii-study-of-benlysta-belimumab-in-pati 2013-04-03T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/regulatory-update-glaxosmithkline-receives-complete-response-from-fda-for-candid 2013-03-25T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-publishes-2012-corporate-responsibility-report 2013-03-20T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/500000-endowment-gift-from-the-glaxosmithkline-foundation-expands-program-to-hel 2013-03-18T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/young-scientists-challenged-by-gsk-and-mclaren-to-help-drive-science-behind-form 2013-03-13T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/regulatory-update-gsk-announces-regulatory-submission-for-albiglutide-in-europe 2013-03-07T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-presents-data-from-phase-iii-study-of-dolutegravir-vs-raltegravi 2013-03-06T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-announces-a-voluntary-licence-agreement-with-the-medicines-paten 2013-02-27T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-theravance-announce-fda-acceptance-of-new-drug-application-nda-submissio 2013-02-19T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/viiv-healthcare-announces-fda-priority-review-designation-for-dolutegravir-as-a- 2013-02-15T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/regulatory-update-gsk-announces-european-submission-for-mek-monotherapy-and-braf 2013-02-07T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/results-announcement-for-the-fourth-quarter-2012 2013-02-06T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-increases-stake-in-its-publicly-listed-consumer-healthcare-subsidiary-in-ind 2013-02-05T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-support-for-alltrials-campaign-for-clinical-data-transparency 2013-02-05T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/glaxosmithkline-starts-phase-iii-study-to-test-combined-brafmek-inhibition-in-pa 2013-02-01T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-response-to-news-article-in-the-guardian-on-uk-legal-proceedings-related-to- 2013-01-30T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-biological-e-announce-joint-venture-to-develop-combination-vaccine-for-i 2013-01-28T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-appoints-hans-wijers-to-its-board-as-a-non-executive-director 2013-01-24T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-signs-up-to-uk-governments-public-health-responsibility-deal 2013-01-22T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/regulatory-update-gsk-announces-submission-of-albiglutide-bla-to-the-us-fda-for- 2013-01-14T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-theravance-announce-regulatory-submission-for-anorotm-umecvi-in-europe 2013-01-09T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-theravance-announce-regulatory-submission-for-umecvi-lamalaba-in-the-us 2012-12-18T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/fda-approves-glaxosmithklines-four-strain-seasonal-influenza-vaccine-for-use-in- 2012-12-17T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/results-from-five-phase-iii-studies-presented-for-gsks-two-candidate-quadrivalen 2012-10-22T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-further-initiatives-to-advance-openness-and-collaboration-to-help- 2012-10-11T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/millions-of-children-in-pakistan-to-be-protected-against-pneumococcal-disease-wi 2012-10-09T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/shionogi-viiv-healthcare-announces-completion-of-initial-clinical-registration-p 2012-10-04T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-theravance-announce-fda-acceptance-of-ffvi-new-drug-application-nda-subm 2012-09-26T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/glaxosmithkline-plc-announces-changes-to-its-board-and-committees 2012-09-26T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/regulatory-update-gsk-announces-submission-for-a-new-indication-for-synflorixtm- 2012-09-17T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-to-acquire-five-million-shares-in-response-genetics-for-us110-per-share-in-c 2012-09-13T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-theravance-announce-completion-of-the-phase-iii-programme-for-once-daily 2012-08-24T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-start-of-phase-iii-programme-of-sirukumab-in-rheumatoid-arthritis 2012-08-23T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/glaxosmithkline-reaches-agreement-to-divest-majority-of-classic-brands-in-austra 2012-08-15T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/european-commission-grants-marketing-authorisation-for-pazopanib-votrient-in-the 2012-08-07T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-completes-acquisition-of-human-genome-sciences 2012-08-03T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/regulatory-update-gsk-announces-submissions-in-the-eu-and-us-for-dabrafenib-and- 2012-08-03T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-acquisition-of-79-of-human-genome-sciences-shares-commences-subseq 2012-07-30T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/maximuscle-powers-vodafone-mclaren-mercedes-drivers-through-the-2012-formula-1tm 2012-07-27T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/results-announcement-for-the-second-quarter-2012 2012-07-25T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-pre-broadcast-statement-on-bbc-panorama-the-truth-about-sports-products-19-j 2012-07-19T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/glaxosmithkline-and-amicus-therapeutics-expand-fabry-disease-collaboration 2012-07-17T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/glaxosmithkline-celebrates-its-role-in-supporting-the-biggest-anti-doping-operat 2012-07-16T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-to-acquire-human-genome-sciences-for-us1425-per-share-in-cash 2012-07-16T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/us-regulatory-update-tykerb-lapatinib 2012-07-12T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/shionogi-viiv-healthcare-announces-positive-initial-data-from-phase-iii-study-of 2012-07-11T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-positive-data-from-harmony-8-and-completion-of-clinical-registrati 2012-07-11T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/glaxosmithkline-concludes-previously-announced-agreement-in-principle-to-resolve 2012-07-02T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-sets-20-july-for-expiration-of-tender-offer-to-acquire-human-genome-sciences 2012-06-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-continues-with-tender-offer-to-acquire-all-outstanding-shares-of-human-genom 2012-06-15T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-receives-fda-approval-for-menhibrix 2012-06-14T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/stiefel-signs-worldwide-acquisition-and-license-agreement-for-toctino 2012-06-11T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-new-52-week-data-from-phase-iii-study-of-once-weekly-albiglutide-i 2012-06-09T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-extends-tender-offer-for-all-outstanding-shares-of-human-genome-sciences 2012-06-08T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-xenoport-receive-fda-approval-for-horizant-for-postherpetic-neuralgia 2012-06-07T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-expiration-of-hart-scott-rodino-waiting-period-for-tender-offer-fo 2012-06-01T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-epsrc-announce-creation-of-new-chair-in-sustainable-chemistry-at-the-uni 2012-05-31T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/regulatory-update-gsk-announces-submissions-in-the-eu-us-for-new-indications-for 2012-05-30T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-secures-future-of-local-playing-fields-with-fields-in-trust-as-part-of-londo 2012-05-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-start-of-phase-iii-programme-for-combination-of-dabrafenib-gsk2118 2012-05-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/glaxosmithkline-confirms-us-district-court-ruling-in-pronova-biopharmas-favour-o 2012-05-29T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-receives-positive-opinion-from-european-chmp-for-pazopanib-in-the-treatment- 2012-05-25T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/innovative-public-private-collaboration-launches-to-tackle-antibiotic-research 2012-05-24T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/two-overall-winners-announced-at-prestigious-national-award-ceremony-in-londons- 2012-05-18T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-statement-on-tender-offer-to-acquire-human-genome-sciences 2012-05-17T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/glaxosmithkline-completes-transaction-to-increase-its-ownership-in-theravance 2012-05-16T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/glaxosmithkline-to-fully-acquire-cellzome-for-61-million 2012-05-15T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-statement-on-bbc-panorama-broadcast-the-truth-about-tax 2012-05-14T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/stiefel-receives-us-fda-approval-of-fabiortm-foam-01 2012-05-11T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-commences-tender-offer-to-acquire-human-genome-sciences-for-us-1300-per-shar 2012-05-10T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-to-commence-tender-offer-to-acquire-human-genome-sciences-for-us-1300-per-sh 2012-05-09T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/james-shannon-named-glaxosmithkline-chief-medical-officer 2012-05-04T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/glaxosmithkline-plc-appoints-two-non-executive-directors-to-its-board 2012-05-03T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/glaxosmithkline-and-yale-university-establish-drug-discovery-collaboration-to-de 2012-05-01T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/glaxosmithkline-receives-european-authorisation-for-nimenrixtm-meningococcal-gro 2012-04-27T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/fda-approves-votrient-for-treatment-of-patients-with-certain-types-of-advanced-s 2012-04-26T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-university-of-nottingham-collaborate-to-create-centre-of-excellence-for- 2012-04-26T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/children-in-ghana-to-be-vaccinated-against-diarrhoeal-disease-with-the-introduct 2012-04-26T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/results-announcement-for-the-first-quarter-2012 2012-04-25T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/glaxosmithkline-reaches-agreement-to-divest-non-core-over-the-counter-otc-brands 2012-04-20T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-confirms-offer-to-acquire-human-genome-sciences-for-us1300-per-share-in-cash 2012-04-19T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-provides-update-on-corporate-responsibility-commitments-in-2011-report 2012-04-11T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-receives-further-data-from-phase-lll-studies-of-albiglutide-in-type-2-diabet 2012-04-03T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/glaxosmithkline-to-increase-its-ownership-in-theravance 2012-04-02T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/shionogi-viiv-healthcare-announces-initial-data-from-pivotal-phase-iii-study-of- 2012-04-02T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-theravance-announce-completion-of-the-relovairtm-registrational-programm 2012-03-23T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-confirms-significant-investments-in-uk-manufacturing-ulverston-in-cumbria-se 2012-03-22T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-positive-vote-from-fda-panel-for-pazopanib-in-certain-advanced-sof 2012-03-20T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/glaxosmithkline-provides-further-update-on-divestment-of-non-core-over-the-count 2012-03-15T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-reinforces-commitment-to-youth-training-with-launch-of-new-uk-apprenticeship 2012-03-09T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/regulatory-update-gsk-announces-submissions-for-two-influenza-vaccines 2012-03-05T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/innovative-uk-research-project-to-study-the-value-medicines-bring-to-patients-in 2012-03-02T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-daiichi-sankyo-vaccines-joint-venture-to-become-largest-vaccines-company 2012-03-01T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/glaxosmithkline-receives-positive-opinion-in-europe-from-the-chmp-for-nimenrixre 2012-02-17T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/eu-and-us-regulatory-update-tykerbtyverb-lapatinib 2012-02-16T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-results-announcement-for-q4-and-full-year-2011 2012-02-07T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-joins-new-global-partnership-to-help-defeat-ten-neglected-tropical-diseases- 2012-01-30T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-announces-changes-to-the-board 2012-01-27T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-responds-to-the-recent-court-ruling-on-the-compas-study-in-mendoza-argentina 2012-01-11T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-theravance-announce-initial-outcomes-from-pivotal-phase-iii-studies-for- 2012-01-09T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/glaxosmithkline-provides-update-on-divestment-of-non-core-over-the-counter-otc-b 2011-12-20T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-extends-pneumococcal-vaccine-agreement-with-gavi-alliance 2011-12-15T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/glaxosmithkline-and-human-genome-sciences-initiate-phase-iii-trial-of-belimumab- 2011-12-15T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-presents-phase-lll-data-for-lapatinib-at-san-antonio-breast-cancer-symposium 2011-12-08T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-and-help-for-heroes-partner-to-support-the-rehabilitation-of-wounded-service 2011-12-07T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-statement-in-response-to-the-prime-ministers-speech-on-life-sciences 2011-12-05T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/regulatory-update-glaxosmithkline-submits-additional-information-for-candidate-m 2011-12-01T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/reporting-on-a-core-earnings-basis-will-begin-with-effect-from-q1-2012 2011-12-01T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-welcomes-gavi-alliance-decision-to-introduce-vaccines-against-cervical-cance 2011-11-17T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/glaxosmithkline-welcomes-innovative-knowledge-sharing-collaboration-to-break-dea 2011-11-17T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/gsk-receives-initial-data-from-the-first-completed-phase-lll-study-of-albiglutid 2011-11-16T00:00:00.000Z monthly 0.5 https://feedbagel.com/post/data-published-in-the-lancet-oncology-support-high-efficacy-previously-demonstra 2011-11-09T00:00:00.000Z monthly 0.5